CN101027057B - 用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐 - Google Patents
用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐 Download PDFInfo
- Publication number
- CN101027057B CN101027057B CN200580028435.6A CN200580028435A CN101027057B CN 101027057 B CN101027057 B CN 101027057B CN 200580028435 A CN200580028435 A CN 200580028435A CN 101027057 B CN101027057 B CN 101027057B
- Authority
- CN
- China
- Prior art keywords
- cation
- salt
- pharmaceutically
- acceptable salts
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明提供了一种生物活性试剂输送组合物,所述组合物包括二酮哌嗪羧酸盐。本发明还提供了用于制备和使用所述生物活性试剂输送组合物的相关方法。
Description
相关申请
本申请根据35U.S.C.§119(e)要求2004年8月23日递交的美国临时专利申请60/603,761的优先权。
技术领域
本发明一般属于与小分子和大分子药物相关的药物输送领域。更具体地,本发明涉及2,5-二酮哌嗪盐、它们在形成包括治疗剂、预防剂和诊断剂的药物中的用途、用于药物输送的稳定试剂和系统。
背景技术
药物输送在药学领域中是一项具有持久挑战性的工作,特别是当药物在服药患者体内的场所不稳定和/或难以被吸收时。作为补救方案,一类药物输送试剂包括2,5-二酮哌嗪,该化合物由以下所示的通式1的化合物来表示,其中,E=N。
式1
已经表明这些2,5-二酮哌嗪可用在药物释放中,特别是那些带有酸性R基团的2,5-二酮哌嗪(参见例如,标题为“Self AssemblingDiketopiperazine Drug DeliverySystem”的US专利5,352,461,标题为“Method For Making Self-AssemblingDiketopiperazine Drug DeliverySystem”的5,503,852,标题为“Microparticles ForLung DeliveryComprising Diketopiperazine”的6,071,497和标题为“Carbon-SubstitutedDiketopiperazine Delivery System”的6,331,318,上述文献通过引用全文插入此处,尤其是以上文献关于二酮哌嗪和二酮哌嗪作为媒介的药物输送系 统的教导)。二酮哌嗪可以形成混入药物的颗粒或形成药物可以吸附到其上的颗粒。药物和二酮哌嗪的组合可以使药物稳定性改善。这些颗粒可以通过各种给药途径来给予。作为干粉,这些颗粒可以根据颗粒尺寸通过吸入输送到呼吸系统的特定区域。另外,可以将颗粒制得足够小用于混入静脉悬浮液剂型中。还可以采用混入悬浮液、药片或胶囊中的颗粒;或采用溶在适当溶剂中的颗粒进行口服输送。这些二酮哌嗪也可以促进缔合药物的吸收。虽然如此,但是当二酮哌嗪是二酸或是以二酸形式存在时仍会出现很多困难,因为这些二酸在非碱性pH下(即,中性或酸性pH)溶解受限。还出现另一个难点,原因是这些二酸二酮哌嗪可以与一些药物形成不利的缔合。
因此,需要一种二酮哌嗪组合物,该组合物在中性和/或酸性pH下具有高溶解度,并且需要一种以上组合物在制造治疗组合物中的使用方法。
发明内容
本发明提供了一种改善的药物释放系统,所述药物释放系统包括杂环化合物的羧酸盐以及一种或更多种药物的组合。在本发明的一个实施方式中,杂环化合物形成混合有待释放药物的微粒。这些微粒包括微胶囊,该微胶囊具有仅由杂环化合物构成的外壳或具有由杂环化合物与一种或更多种药物组合构成的外壳。本发明的杂环化合物包括,但不限于,二酮哌嗪、二酮吗啉和二酮二氧杂环己烷和它们的取代类似物。本发明的杂环组分包括带有相对杂原子(opposing heteroatom)和未成键电子对的刚性六元环。
具体优选的实施方式包括,但不限于,3,6-二(4-氨基丁基)-2,5-二酮哌嗪的衍生物,例如,3,6-二(琥珀酰-4-氨基丁基)-2,5-二酮哌嗪、3,6-二(马来酰-4-氨基丁基)-2,5-二酮哌嗪、3,6-二(柠康酰-4-氨基丁基)-2,5-二酮哌嗪、3,6-二(戊二酰-4-氨基丁基)-2,5-二酮哌嗪、3,6-二(丙二酰-4-氨基丁基)-2,5-二酮哌嗪、3,6-二(草酰-4-氨基丁基)-2,5-二酮哌嗪和3,6-二(富马酰-4-氨基丁基)-2,5-二酮哌嗪(此后被称为“富马酰基二酮哌嗪”或“FDKP”)。另外,前述化合物的不对称衍生物也是本发明考虑的。然而,此处应特别 注意到,2,5-二天冬氨酰-3,6-二酮哌嗪和2,5-二谷氨酰-3,6-二酮哌嗪的锂盐(以下进一步限定)被认为不包括在本发明的范围内,并且同样因此特别要求放弃被保护。
可用在本发明的药物释放系统中的典型药物包括,但不限于,胰岛素和其它荷尔蒙、肽、蛋白质、多糖(例如肝磷脂)、核酸(例如,质粒、低聚核苷酸、反意或siRNA)、脂类和脂多糖、抗凝血剂、细胞毒素试剂、抗原和抗体以及具有生物活性的有机分子,例如,抗生素、消炎试剂、抗病毒试剂、血管活性和神经活性试剂中的一些。
在本发明的一个实施方式中,提供了一种根据如下式1的杂环化合物的药学上可接受盐:
式1
其中,R1或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。在另一实施方式中,杂环化合物包括二酮哌嗪。在另一实施方式中,羧酸基团位于末端。在药学上可接受盐的另一实施方式中,R1和R2包括4-X-氨基丁基,X选自由琥珀酰、戊二酰、马来酰和富马酰组成的组。在另一实施方式中,阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
在本发明的另一实施方式中,药学上可接受盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
在本发明的实施方式中,提供了一种治疗组合物,该组合物包括根据式1的杂环化合物的药学上可接受盐,其中,R1或R2包括至少一个羧酸官能团;E1和E2包括N或O;所述盐还包括至少一种阳离子;该组合物还包括一种生物活性试剂。适于包括在本发明的组合物中的生物活性试剂包括荷尔蒙、抗凝血剂、免疫调节剂、细胞毒素试剂、抗生素、抗病毒试剂、反意序列、抗原、抗体和其活性片段和其类似物。在一个实施方式中,生物活性试剂是胰岛素。
在另一实施方式中,本发明的治疗组合物被配制成液体,例如,溶液或悬浮液。
在另一实施方式中,本发明的治疗组合物是沉淀物,该沉淀物被配制成适于口服、口腔给药、直肠给药或阴道给药的固体剂型。固体剂型可以是胶囊、药片和栓剂。
在一个实施方式中,本发明的治疗组合物是干粉,所述干粉的颗粒具有约0.5微米-10微米的直径。在该实施方式的一个方面中,干粉适于肺部给药。
在本发明的另一实施方式中,提供了一种制备用于药物释放的固体组合物的方法,所述方法包括:制备包含生物活性试剂和杂环化合物的药学上可接受盐在溶剂中的溶液,并将所述溶剂通过如下方法除去,所述方法选自由蒸馏、蒸发和冻干法组成的组。在一个实施方式中,该杂环化合物的药学上可接受盐具有根据式1的结构,其中,R1或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。
在本发明的另一实施方式中,制备用于药物输送的固体组合物的方法还包括如下步骤:将所述固体微粉化以形成干粉。
在本发明的实施方式中,提供了一种制备用于药物输送的干粉的方法,所述方法包括,将杂环化合物的药学上可接受盐和生物活性试剂的溶液喷雾干燥以形成干粉,其中,所述干粉释放生物活性试剂。在一个实施方式中,该杂环化合物的药学上可接受盐具有根据式1的结构,其中,R1 或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。在另一实施方式中,干粉的颗粒适于肺部释放。在另一实施方式中,干粉的颗粒具有小于2的粗糙度。
在本发明的实施方式中,提供了一种用于输送生物活性试剂的组合物,其中,所述组合物包括杂环化合物的药学上可接受盐和生物活性试剂,经喷雾干燥形成干粉使得所述干粉释放所述生物活性试剂。在一个实施方式中,所述杂环化合物的药学上可接受盐具有根据式1的结构,其中,R1或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。在另一实施方式中,干粉的颗粒适于肺部释放。在另 一实施方式中,干粉的颗粒具有小于2的粗糙度。
在本发明的另一实施方式中,提供了一种用于药物输送的微粒系统,所述系统包括杂环化合物的药学上可接受盐和生物活性试剂的组合物,并且其中,所述组合物释放生物活性试剂。在一个实施方式中,杂环化合物的药学上可接受盐具有根据式1的结构,其中,R1或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。所述生物活性试剂还可以包括荷尔蒙、抗凝血剂、免疫调节剂、细胞毒素试剂、抗生素、抗病毒试剂、反意序列、抗原、抗体和其活性片段和其类似物。
在本发明的另一实施方式中,微粒系统的组合物是干粉,该干粉在肺部系统中释放生物活性试剂。组合物还可以被输送到肺部系统中。微粒系统的组合物可以在被输送到肺部系统后被吸收到全身血液循环中或局部作用于肺脏中。
在本发明的实施方式中,微粒系统的组合物包括用于药物输送的液体,其中,二酮哌嗪促进生物活性试剂的吸收。在一个实施方式中,口服该液体。
在本发明的另一实施方式中,微粒系统的组合物包括沉淀物,其中,二酮哌嗪促进生物活性试剂的吸收。在一个实施方式中,口服该沉淀物。
在本发明的实施方式中,提供了一种用于将颗粒输送到肺部系统中的方法,所述方法包括:经由吸入给予需要治疗的患者以干粉形式的有效量的生物活性试剂,所述干粉通过如下方法制备:将包括杂环化合物的药学上可接受盐和生物活性试剂的组合物的溶液喷雾干燥,其中,所述干粉在所述肺部系统中释放所述生物活性试剂。在一个实施方式中,该杂环化合物的药学上可接受盐具有根据式1的结构,其中,R1或R2包括至少一个羧酸官能团,E1和E2包括N或O,所述盐还包括至少一种阳离子。
附图说明
图1描述了由根据本发明的一个方面的富马酰二酮哌嗪(FDKP)二钠盐制备的颗粒的激光衍射颗粒尺寸分析。(A)制备方法A;(B)制备方法B。
图2描述了通过激光衍射测定的根据本发明的教导制备的包含25%胰岛素(w∶w)的FDKP二钠盐的配制品的颗粒尺寸。
图3描述了根据本发明的教导制备的包含25%胰岛素的FDKP二钠盐的喷雾干燥微粒制剂的扫描电子显微镜图(SEM)。
图4描述了与对照冻干的粉末(阴影线)相比,根据本发明的教导制备的包含25%胰岛素的FDKP二钠盐/胰岛素配制品的喷雾干燥微粒(点画线)的加速稳定性研究。
图5描述了与对照冻干的粉末相比,溶液浓度对根据本发明的教导制备的包含25%胰岛素的FDKP二钠盐/胰岛素配制品的喷雾干燥微粒的胰岛素稳定性的影响。
图6描述了根据本发明的教导通过溶剂/反溶剂沉淀方法形成的胰岛素/FDKP二钠盐微粒的SEM分析。
图7描述了通过激光衍射测定的根据本发明的教导制备的包含25%胰岛素(w∶w)的FDKP二铵盐/胰岛素配制品的喷雾干燥微粒的颗粒尺寸。
图8描述了通过激光衍射测定的根据本发明的教导制备的包含50%胰岛素(w∶w)的FDKP二铵盐/胰岛素配制品的喷雾干燥微粒的颗粒尺寸。
图9描述了通过激光衍射测定的根据本发明的教导制备的包含25%胰岛素(w∶w)的琥珀酰二酮哌嗪(SDKP)二铵盐的喷雾干燥微粒的颗粒尺寸。
图10描述了根据本发明的教导采用25%胰岛素配制的FDKP铵盐的SEM。
图11描述了根据本发明的教导采用25%胰岛素配制的SDKP铵盐的SEM。
图12描述了与对照冻干的粉末相比,根据本发明的教导制备的包含25%或50%胰岛素的FDKP二铵盐/胰岛素配制品的喷雾干燥微粒的加速稳定性研究。
图13描述了与对照冻干的粉末相比,在进行根据本发明的教导制备的包含25%或50%胰岛素的FDKP二铵盐/胰岛素配制品的喷雾干燥微粒的加速稳定性研究期间,A21降解物的生成。
图14描述了与对照冻干的粉末相比,根据本发明的教导制备的包含25%胰岛素的SDKP二铵盐/胰岛素配制品的喷雾干燥微粒的加速稳定性研究。
图15描述了与对照冻干的粉末相比,在进行根据本发明的教导制备的包含25%胰岛素的SDKP二铵盐/胰岛素配制品的喷雾干燥微粒的加速稳定性研究期间,A21降解物的生成。
图16描述了根据本发明的教导制备的包含浓度增加的胰岛素的喷雾干燥FDKP二钠盐/胰岛素颗粒的空气动力学性能。
图17描述了根据本发明的教导制备的包含浓度增加的胰岛素的喷雾干燥FDKP二铵盐/胰岛素颗粒的空气动力学性能。
术语定义
在阐述本发明以前,对此后使用的某些术语提供一些解释是有益的。
酸性:在本文中,“酸性”指pH范围为0到至多6,但不包括6。
碱性:在本文中,“碱性”指pH范围为8到至多14,但不包括14。
生物试剂:见以下“药物”。
货物:见以下“药物”。
二酮哌嗪:在本文中,“二酮哌嗪”或“DKP”包括二酮哌嗪和其衍生物和修饰物,这些衍生物和修饰物落在式1的范围内。
药物:在本文中,“药物”、“货物”或“生物试剂”指与本文所讨论的微粒混合的具有药学活性的试剂。实例包括蛋白质和肽(其中,蛋白质被定义为由100个或更多个氨基酸残基构成,肽是小于100个氨基酸残基),例如,胰岛素和其它荷尔蒙;多糖,例如,肝磷脂;核酸,例如,质粒、低聚核苷酸、反意序列或siRNA;脂类和脂多糖;和具有生物活性的有机分子,例如,抗生素、消炎试剂、抗病毒试剂、血管活性和神经活性试剂中的一些。具体实例包括荷尔蒙、抗凝血剂、免疫调节剂、细胞毒素试剂、抗生素、抗病毒试剂、反意序列、抗原和抗体。
干粉:在本文中,“干粉”指未悬浮在或未溶解在推进剂、载体或其它液体中的精细颗粒组合物。这并不意味着其暗示所有水分子全部不存 在。
微粒:在本文中,术语“微粒”包括微胶囊,该微胶囊具有仅由二酮哌嗪构成的外壳或具有由二酮哌嗪与一种或更多种药物组合构成的外壳。它还包括微球(包含分散在整个球体的药物)、不规则形状的颗粒和如下颗粒,即其中药物被涂敷在该颗粒的表面上或填充到其中的空隙中的颗粒。
中性:在本文中,“中性”指pH范围为6到至多8,但不包括8。
弱碱性:在本文中,“弱碱性”指pH范围为8到至多10,但不包括10。
具体实施方式
本发明提供了一种改善的药物输送系统,该药物释放系统包括杂环化合物的羧酸盐,以及一种或更多种药物。在本发明的一个实施方式中,杂环化合物形成混合有待输送药物的微粒。这些微粒包括微胶囊,该微胶囊具有仅由杂环化合物构成的外壳或具有由杂环化合物与一种或更多种药物组合构成的外壳。本发明的杂环化合物包括,但不限于,二酮哌嗪、二酮吗啉和二酮二氧杂环己烷和它们的取代类似物。本发明的杂环组分包括带有相对杂原子和未成键电子对的刚性六元环。
本发明的一个方面包括一种药物输送系统,该药物释放系统包括杂环化合物的羧酸盐以及一种或更多种药物的组合。在本发明的一个实施方式中,杂环化合物形成混合有待输送药物的微粒。这些微粒包括微胶囊,该微胶囊具有仅由杂环化合物构成的外壳或具有由杂环化合物与一种或更多种药物组合构成的外壳。这种外壳可以围绕核心材料。这些外壳还可以围绕或构成要么是实心的要么是空心的或其组合的微球,该微球包含一种或更多种分散在整个球体和/或吸附在球体表面上的药物。外壳还可以仅围绕具有不规则形状的微粒或围绕这种微粒与前述微球组合的微粒。
在用于肺部释输送放的优选实施方式中,微粒为约0.1微米到约10微米(以直径计)。在药物输送系统中,这些微粒具有令人希望的尺寸分布和良好的药物耐受性。
本发明的杂环化合物包括,但不限于,二酮哌嗪、二酮吗啉和二酮二氧杂环己烷和它们取代类似物。这些杂环组分包括带有相对杂原子和未成键电子对的刚性六元环。二酮哌嗪和其类似物的通式示于如下式1化合物中。
式1
在式1化合物中,在1位和4位上的环原子E1和E2是O或N。分别位于3位和6位的侧链R1和R2中的至少一个包含羧酸基团(即,OR)。在本发明的一个实施方式中,这些羧酸基团沿着侧链(R1和/或R2)作为悬垂基团(pendent group),在另一实施方式中,羧酸位于链内(酯),在另一实施方式中,羧酸基团是末端基。
合成二酮哌嗪的通用方法是本领域已知的,并且已经在美国专利5,352,461、5,503,852和6,331,318中进行了描述,这些文献通过以上引用已经引入和插入此处。在本发明的优选实施方式中,二酮哌嗪是3,6-二(4-氨基丁基)-2,5-二酮哌嗪的衍生物,该化合物可以通过氨基酸赖氨酸的缩合形成。示例性的衍生物包括,3,6-二(琥珀酰-4-氨基丁基)-(即琥珀酰二酮哌嗪或SDKP)、3,6-二(马来酰-4-氨基丁基)-、3,6-二(柠康酰-4-氨基丁基)-、3,6-二(戊二酰-4-氨基丁基)-、3,6-二(丙二酰-4-氨基丁基)-、3,6-二(草酰-4-氨基丁基)-和3,6-二(富马酰-4-氨基丁基)-2,5-二酮哌嗪(此后被称为富马酰二酮哌嗪或FDKP)。另外,前述化合物的不对称衍生物也是本发明考虑的。然而,此处特别注意到,2,5-二天冬氨酰-3,6-二酮哌嗪和2,5-二谷氨酰-3,6-二酮哌嗪的锂盐被认为不包括在本发明的范围内,并且同样因此特别要求放弃被保护。这些要求放弃被保护的化合物的游离酸分别描述在如下式2和式3中。
式2
(5-羧甲基-3,6-二氧代-哌嗪-2-基)-乙酸
式3
3-[5-(2-羧基-乙基)-3,6-二氧代-哌嗪-2-基]-丙酸
为了方便,式2的化合物此后将被称为2,5-二天冬氨酰-3,6-二酮哌嗪。式3的化合物此后被称为2,5-二谷氨酰-3,6-二酮哌嗪。应理解到,所有基于式1的其它杂环化合物被认为在本发明的范围内。
为了示例性目的,二酮哌嗪盐和它们的衍生物将被详细描述。这些化合物是本发明的优选实施方式。然而,这不排除基于式1化合物的其它杂环化合物。
在2005年8月23日递交并且标题为“Pulmonary Delivery of InhibitorsofPhosphodiesterase Type 5”的共同待审美国专利申请XX/XXX.XXX中、以及美国临时申请60/603,764中描述了DKP盐用于输送磷酸二酯酶5型抑制剂的用途,该文献通过引用全文插入此处。在标题为“Method For DrugDelivery To The Pulmonary System”的US专利6,428,771中公开了利用DKP微粒进行肺部药物输送,该文献通过引用全文插入此处。
二酮哌嗪有利于生物活性试剂穿过生物组织进行转细胞运输,但是它们不是促渗剂。促渗剂是一种通过破坏细胞膜改善药物穿过生物组织的运动的化合物。促渗剂的实例是表面活性剂和皂类。二酮哌嗪既不在生物体外也不在生物体内破坏细胞膜。体外研究表明,FDKP不会破坏细胞膜或紧密连接,并且也不会危及细胞的发育能力。二酮哌嗪/胰岛素粉末组合物在肺部表面的生理学pH下可溶,并且在吸入后快速溶解。一旦溶解了,DKP有利于胰岛素的被动细胞间运输。
申请人已经发现,经改善的二酮哌嗪组合物在中性和/或酸性pH下具有高溶解度。申请人还发现了,可以在经改善的二酮哌嗪和有益的药物之 间形成治疗配合物。
本发明的盐可以通过如下方法制备:将二酮哌嗪游离酸与在以下实施例1和2中所描述的适当碱反应。在优选的实施方式中,盐是药学上可接受盐,例如,二酮哌嗪的钠(Na)、钾(K)、锂(Li)、镁(Mg)、钙(Ca)、铵、或一、二或三烷基铵(源自三乙胺、丁基胺、二乙醇胺、三乙醇胺或吡啶等)盐。该盐可以是单盐、二盐或混合盐。还可以考虑二酮哌嗪的更高级别盐,在二酮哌嗪中,R基团包含一个以上酸基团。在本发明的另一方面,碱性试剂可以与DKP混合以形成DKP的药物盐,结果该药物是DKP的反阳离子。
对于药物输送,生物活性试剂或具有治疗性、预防性或诊断活性的药物可以利用二酮哌嗪输送。根本上来说,生物活性试剂与本发明的二酮哌嗪颗粒缔合。在本文中,“缔合”意指,通过将二酮哌嗪与生物活性试剂共沉淀、喷雾干燥或键合(络合)等方法形成生物活性试剂-二酮哌嗪组合物。所得二酮哌嗪颗粒包括那些已经截留、封装和/或被生物活性试剂涂敷的颗粒。尽管没有最终确定缔合的确切机理,但认为缔合是物理截留(分子缠结)以及包括氢键、范德华力和吸附的静电吸引的作用。
可以与本发明的二酮哌嗪颗粒缔合的生物活性试剂包括,但不限于,有机或无机化合物、蛋白质或各种其它化合物,包括营养剂,例如,维生素、矿物质、氨基酸、碳水化合物、糖和脂肪。在优选的实施方式中,药物包括在口内输送后在由GI管道运输后在循环系统中释放的生物活性试剂。在另一优选的实施方式中,材料是在肺部或鼻内输送后在循环系统中释放的生物活性试剂。在另一优选的实施方式中,材料是在鼻内输送后在中枢神经系统中释放的生物活性试剂。另外,药物可以通过例如直肠组织、阴道组织和/或口腔组织的黏膜组织吸收。生物活性试剂的非限定性实例包括,蛋白质和肽(其中,蛋白质被定义为由100个或更多个氨基酸残基构成,肽是小于100个氨基酸残基),例如,胰岛素和其它荷尔蒙;多糖,例如,肝磷脂;核酸,例如,质粒、低聚核苷酸、反意或siRNA;脂类和脂多糖;和具有生物活性的有机分子,例如,抗生素、消炎试剂、血管活性试剂(包括用于治疗勃起功能障碍的试剂)和神经活性试剂中的一 些。具体的非限定性实例包括类固醇、荷尔蒙、减充血药、抗凝血剂、免疫调节剂、细胞毒素试剂、抗生素、抗病毒试剂、麻醉剂、镇静剂、抗抑郁剂、大麻类物质、抗凝血剂、反意试剂、抗原和抗体。在一些情况下,蛋白质可以是抗体或抗原,该抗体或抗原否则将不得不通过注射给药以引起适当响应。更具体地,可以与本发明的二酮哌嗪组合物缔合的化合物包括:胰岛素、肝磷脂、降钙素、非氨酯(felbamate)、甲状旁腺激素和其片段、生长激素、红细胞生长素、胰高血糖素样肽-1、生长激素释放激素、卵泡刺激素、色甘酸、酯联素(adiponectin)、RNAse、脑肠肽(ghrelin)、齐多夫定、去羟肌苷(didanosine)、四氢大麻酚(即,大麻类物质)、阿托品、粒性白细胞群刺激因子、拉莫三嗪(lamotrigine)、绒毛膜促性腺激素释放因子、黄体释放激素、β-牛乳糖和阿加曲班(Argatroban)。例如每分子可以缔合具有宽分子量范围(例如100-500000克每摩尔)的化合物。
包括金属、放射性同位素、不透射线试剂和X射线阻碍试剂的显影剂也可以混入二酮哌嗪输送系统中。放射性同位素和不透射线试剂包括镓、锝、铟、锶、碘、钡和磷。
另外,药物可以是各种形式,例如,无电荷的分子、金属或有机盐,或前体药物。对于酸性药物,在一些情况下可以使用金属盐、胺或有机阳离子(例如,季铵)。
在一些实施方式中,药物包括在口内输送后在由胃肠道运输后在循环系统中释放的生物活性试剂。在另一些实施方式中,生物活性试剂在肺部或鼻内输送后在循环系统中释放。在另一些实施方式中,生物活性试剂在鼻内输送后在中枢神经系统中释放。另外,药物可以通过例如直肠组织、阴道组织和/或口腔组织的黏膜组织吸收。
这些生物试剂中的一些具有如下性质:在胃酸中不稳定、通过胃肠膜扩散缓慢、在生理学pH下可溶性差和/或在胃肠道中易于被酶破坏。生物试剂释放到血流中以前与二酮哌嗪盐组合,以使它们在胃肠道中受到保护。在优选的实施方式中,二酮哌嗪不是生物活性的,并且不会改变治疗试剂的药学性质。
为了将一种或更多种药物与DKP盐缔合,将该药物和DKP盐优选在溶液或悬浮液中混合,并随后干燥。任一种组分可以作为溶质或悬浮质。在不同的实施方式中,将混合物喷雾干燥或冻干。
喷雾干燥是一种热处理方法,用于由各种溶液或悬浮液形成、负载或干燥颗粒固体。使用喷雾干燥用于形成干燥的颗粒医药品的用途是本领域中已知,然而,过去,由于喷雾干燥方法的性质,该方法与生物大分子(包括,蛋白质、肽和核酸)药物不相容性,使其使用受到局限。在喷雾干燥期间,溶液或悬浮液通过气溶胶化(aerosolization)形成液滴,然后将其通过具有充足热能的经加热的气流,以在收集颗粒以前将颗粒中的水和溶剂蒸发到理想水平。入口温度是离开气流源的气流的温度,该入口温度水平可以根据被处理的大分子的不稳定性来选择。出口温度是入口温度、干燥产物所需热负荷以及其它因素的函数。
令人出乎意料,本发明人已经测定,本发明的颗粒具有随着生物活性试剂含量的增加而改善的空气动力学性能,这一点在其它颗粒中未曾见到。本发明的喷雾干燥颗粒的可吸入分数(%rf)(直径在0.5-5.8微米的颗粒的百分率)随着胰岛素含量的增加而增加,而非如以前预期的随着含量增加而降低。因此,使用本发明的方法,可以形成二酮哌嗪微粒,该微粒具有比以前可达到的生物活性试剂含量更高的生物活性试剂含量。
另外,令人惊讶地,本发明人已经测定,随着FDKP二钠盐在初始溶液中的浓度增加,经喷雾干燥的FDKP二钠盐/胰岛素组合物的胰岛素稳定性增加。稳定性通过在40℃/75%的相对湿度下17天后胰岛素的损耗来测量。例如,由包含37mg/mL(FDKP二钠盐/胰岛素的总重)固体的溶液喷雾干燥得到的粉末损耗8.5%的胰岛素。作为比较,由包含45mg/mL固体的溶液喷雾干燥得到的粉末损耗4.5%的胰岛素,而由包含67mg/mL固体的溶液喷雾干燥得到的粉末损耗2.7%的胰岛素。
在另一项观测报告中,发现入口温度对胰岛素的稳定性具有令人惊讶的影响。数据表明,粉末中胰岛素的稳定性随着入口温度的增加而增加,该稳定性通过在40°/75%RH下17天后胰岛素的损耗来测量。例如,在180℃的入口温度下喷雾干燥的粉末损耗约4%的胰岛素。作为比较,在 200℃的入口温度下喷雾干燥的粉末损耗<1%的胰岛素。
在本发明的实施方式中,提供了一种适用于输送到肺部系统中的微粒,其中,该微粒具有小于2的粗糙度。受喷雾干燥影响的本发明的另一方面是通过粗糙度衡量的颗粒形貌,粗糙度即由颗粒尺寸分布和颗粒密度计算的该颗粒的比面积与表面积的比。可以控制干燥操作以提供具有例如粗糙度的特定特征的干燥颗粒。经喷雾干燥的颗粒的粗糙度是颗粒的表面形貌的量度,例如,折叠度或褶合度。
先前认为,需要粗糙度大于2以得到具有足够分散性的颗粒,从而形成自由流动的粉末。令人惊讶地,本发明已经制备出了适于肺部释放、具有小于2粗糙度的颗粒。
可以以液体或固体剂型服用本发明的微粒配制品。这些剂型可以包括溶液、悬浮液、干粉、药片、胶囊、栓剂、用于透皮输送的贴剂等。这些不同剂型具有独特但相互重叠的优点。固体剂型使药物散装运输便利,并可以改善药物的稳定性。它们还可以根据微粒的尺寸形成能够通过吸入被特别给药到鼻黏膜内或肺部深处的微粒。即使当二酮哌嗪以溶液形式输送,它也可以促进所缔合药物的吸收。DKP盐中的一些(例如,钠盐和钾盐)与游离酸相比在中性和酸性pH下具有改善的稳定性,这可以使得在胃中对经口服的固体剂型的吸收改善了。
可以选择二酮哌嗪盐的反阳离子以制备具有各种溶解性的盐。这些变化的溶解性使得溶解速率和/或固有溶解度不同。通过控制DKP盐的溶解速率,还可以控制DKP盐/药物组合物中的药物吸收速率以提供具有立即释放和/或持续释放特征的配制品。例如,有机化合物的钠盐在生物系统中具有高度易溶的特征,而钙盐在生物系统中具有仅仅微溶的特征。因此,由DKP钠盐/药物组合物组成的配制品使药物立即吸收,而由DKP钙盐/药物组合物组成的配制品使药物吸收较慢。包含后二两种配制品组合的配制品可以用于使药物立即吸收,接着使吸收持续一定时期。
生物活性试剂的二酮哌嗪盐配制品可以口服。取决于微粒的化学性质和尺寸,该颗粒通过胃肠道的上皮衬里吸收到血流或淋巴系统中。可替换地,组合物可以以溶液形式服用,其中,DKP盐有利于药物的吸收。另 外,微粒可以以完全溶解并且在溶解后被吸收的悬浮液剂型形式或固体剂型形式服用。
对于肠胃外给药,小于5微米的微粒易于通过用于静脉内给药的针孔。合适的药学载体(例如,磷酸盐缓冲盐水)是已知的并且是商业可得的。类似地,微粒可以皮下、肌肉或腹腔内注射或植入。另外,微粒可以置于可植入装置内以利于持续释放和/或可控释放。
对于局部给药或透皮给药,微粒可以利用适于给药载体和场所的方法悬浮于适用于给药的合适药学载体中。例如,微粒可以在pH约为7.4的缓冲盐溶液中或在例如矿物油的药膏中给药到眼中。剂型依赖于待释放的化合物以及释放的速率。微粒或聚集形成膜、圆片或药片的微粒与被混合的化合物一起可以以药膏、乳膏或贴剂形式给药到皮肤上。合适的药学载体是已知的并且是商业可得的。还可以考虑黏膜给药,包括,口腔给药、阴道给药、直肠给药、鼻内给药。
肺部输送可以利用包括本发明微粒的干粉非常有效地完成,并且可以导致快速吸收到循环系统(血流)中。干粉吸入器是本领域已知的,在两篇标题均为“Unit DoseCapsules and Dry Powder Inhaler”的US.专利申请09/621,092和10/655,153中描述了特别合适的吸入器系统,这些文献通过引用全文插入此处。在标题为“Method for DrugDelivery to the PulmonarySystem”的U.S.专利6,428,771中可以找到关于利用包括二酮哌嗪的微粒的肺部输送系统的信息,该文献通过引用全文插入此处。以下实施例意欲说明本发明的一个或更多个实施方式,但并不意味着将本发明限制于以下所述。
实施例
实施例1:FDKP二钠盐的制备方法A
将13克富马酰二酮哌嗪(FDKP)(28.73mmol,1当量)置于装有回流冷凝器、磁力搅拌棒和温度计的250mL 3口圆底烧瓶中。该反应在氮气氛下进行。将水(150mL)和50%氢氧化钠(4.48g,1.95当量)依次加入烧瓶中。将所得黄色溶液加热到50℃,并保持2小时。然后,将溶液 热滤以除去任意不可溶物质。将水通过旋转蒸发从样品中除去。将获得的固体在真空烘箱中(50℃,30英寸汞柱)干燥整夜。然后,分析该盐的水分含量(Karl Fischer)和钠含量(元素分析和滴定)。该盐的产率为约90%到约95%。
分子式:C20H26N4Na2O8·1.4809H2O
通过Karl Fischer滴定测定的%水:5.1%
元素分析:
计算值C 45.92H 5.58N 10.71Na 8.79
测试值C 45.05H 5.23N 10.34Na 9.18
滴定:97%二钠盐(重量百分比)
表1.激光衍射颗粒尺寸分析(制备方法A颗粒)
Lot# | X10 | X16 | X50 | X84 | X90 | X99 | VMD | GSD |
制备方法A | 1.60μm | 1.44μm | 2.89μm | 4.60μm | 5.47μm | 19.20μm | 3.70μm | 1.59 |
VMD=体积中值直径;GSD=几何标准偏差
实施例2.FDKP二钠盐的制备方法B
将13克FDKP(28.73mmol,1当量)和乙醇(150mL)置于装有回流冷凝器、磁力搅拌棒和温度计的250mL 3口圆底烧瓶中。该反应在氮气氛下进行。将浆液加热到50℃。将氢氧化钠50%w/w的水溶液(4.71g,2.05当量)一次性加入。将所得浆液在50℃下加热2小时。然后,将反应物冷却到室温(20-30℃),并真空过滤分离出固体。将获得的盐采用乙醇(300mL)和丙酮(150mL)洗涤,并在真空烘箱中(50℃,30英寸汞柱)干燥整夜。不需进行进一步纯化。然后,分析该盐的水分含量 (Karl Fischer)和钠含量(元素分析和滴定)。该盐的产率为约90%到约95%。
分子式:C20H26N4Na2O8·1.4503H2O
通过Karl Fischer滴定测定的%水:5%
元素分析:
计算值C 45.97H 5.57N 10.72Na 8.8
测试值C 46.28H 5.26N 10.60Na 8.96
滴定:98.8%二钠盐(重量百分比)
表2.激光衍射颗粒尺寸分析(制备方法B颗粒)
Lot# | X10 | X16 | X50 | X84 | X90 | X99 | VMD | GSD |
制备方法A | 1.55μm | 1.36μm | 3.11μm | 5.53μm | 6.64μm | 14.04μm | 3.76μm | 1.75 |
VMD=体积中值直径;GSD=几何标准偏差
实施例3.FDKP二锂盐的制备方法A
将10克FDKP(22.10mmol,1当量)和100mL水置于装有回流冷凝器、磁力搅拌棒和温度计的200mL 3口圆底烧瓶中。该反应在氮气氛下进行。在另一单独烧瓶中,制备氢氧化锂(1.81g,1.95当量)在40mL水中的水性溶液。一旦所有氢氧化锂已经溶解了,将该溶液一次性加入FDKP的水性浆液中。将所得溶液加热到50℃,并保持1小时。然后,将反应物冷却到室温,并过滤以除去任意不可溶颗粒。将水通过旋转蒸发从样品中除去。将获得的固体在真空烘箱中(50℃,30英寸汞柱)干燥整夜。然后,分析该盐的水分含量(Karl Fischer)和锂含量(元素分析和滴定)。该盐的产率为约98%。
分子式:C20H26N4Li2O8·0.0801H2O
Karl Fischer:0.31%
元素分析:
计算值C 51.57H 5.66N 12.03Li 2.98
测试值C 50.98H 5.74N 11.95Li 2.91
滴定:98.3%二锂盐(重量百分比)
实施例4.FDKP二钾盐的制备方法A
将12克FDKP(26.52mmol,1当量)置于装有回流冷凝器、磁力搅拌棒和温度计的250mL 3口圆底烧瓶中。该反应在氮气氛下进行。将氢氧化钾(0.5N,105g,1.98当量)加入该烧瓶中。将所得溶液加热到50℃,并保持2小时。然后,将反应物冷却到室温,并将水通过旋转蒸发从样品中除去。将获得的固体在真空烘箱中(50℃,30英寸汞柱)干燥整夜。然后,分析该盐的水分含量(Karl Fischer)和钾含量(元素分析和滴定)。该盐的产率为约95%到约98%。
分子式:C20H26N4K2O8·0.4529H2O
Karl Fischer:4.98%
元素分析:
计算值C 44.75H 5.05N 10.44K 14.56
测试值C 44.88H 4.74N 10.36K 14.34
滴定:97.0%二钾盐(重量百分比)
实施例5.FDKP二钾盐的制备方法B
将10克FDKP(22.10mmol,1当量)和乙醇(150mL)置于装有回流冷凝器、磁力搅拌棒和温度计的250mL 3口圆底烧瓶中。该反应在氮气氛下进行。将浆液加热到50℃。将氢氧化钾(10N,4.64g,2.10当量)一次性加入。将所得浆液在50℃下保持最少3小时。将反应物冷却到室温(20-30℃),并真空过滤分离出固体。将获得的盐采用乙醇(100mL)和丙酮(200mL)洗涤,并在真空烘箱中(50℃,30英寸汞柱)干燥整 夜。不需进一步纯化。然后,分析该盐的水分含量(Karl Fischer)和钾含量(元素分析和滴定)。该盐的产率为约94%到约98%。
分子式:C20H26N4K2O8·0.6386H2O
Karl Fischer:2.13%
元素分析:
计算值C 44.47H 5.09N 10.37K 14.47
测试值C 44.48H 5.03N 10.31K 13.92
滴定:97%二钾盐(重量百分比)
实施例6.FDKP二钠-胰岛素微粒的制备方法A
将2.5克FDKP二钠盐(制备方法A)置于装有磁力搅拌棒的250mL烧杯中。将原料悬浮于75mL的去离子水中。将胰岛素(0.84g)加入FDKP盐的悬浮液中。将所得浆液采用NH4OH滴定至8.3pH以形成溶液。将FDKP二钠盐和胰岛素溶液采用去离子水调至体积100mL,并通过0.22μm的聚醚砜膜过滤。将该溶液利用 Mini Spray Dryer B-191(BuchiLabortechnik AG,Switzerland)在如下条件下喷雾干燥。
入口温度设置为170℃
出口温度=75℃
最大采气量的80%
雾化=600l/hr干燥氮气
最大物料泵吸速率的25%(8.5ml/min)
喷嘴冷却器回水22℃
实施例7.FDKP二钠-胰岛素微粒的制备方法B
将5克FDKP二钠盐(制备方法B)置于装有磁力搅拌棒的250mL烧杯中。将原料悬浮于75mL的去离子水中。将胰岛素(1.68g)加入FDKP盐的悬浮液中。将所得浆液采用NH4OH滴定至8.3pH以形成溶液。将FDKP二钠盐和胰岛素溶液采用去离子水调至体积100mL,并通过0.22μm的聚醚砜膜过滤。将该溶液利用 Mini Spray Dryer B-191 (BuchiLabortechnik AG,Switzerland)在如下条件下喷雾干燥。
入口温度设置为149℃
出口温度=75℃
最大采气量的80%
雾化=600l/hr干燥氮气
最大物料泵吸速率的25%(8.5ml/min)
喷嘴冷却器回水23℃
实施例8.表征FDKP二钠-胰岛素微粒
将实施例6和7中所描述的微粒进行激光衍射颗粒尺寸分析(SympatecGmbH,Germany)(图1A和1B)。实施例6的颗粒具有87.93%的平均可吸入分数(根据0.5-5.8微米的USP定义),具有1.60的标准偏差和1.82的%CV(变差系数)。实施例7的颗粒具有81.36%的平均可吸入分数,具有4.20的标准偏差和5.16的%CV。
实施例9.FDKP二钠-胰岛素的肺部给药
将包含FDKP二钠盐和胰岛素的干粉在开始进餐时吸入。包含干粉的颗粒优选具有约0.5-5.8微米的尺寸。精确的剂量遵医嘱,但通常为每剂量约5-150单位胰岛素。由这种给药方案进行胰岛素吸收模拟生理学上第一阶段的胰岛素释放,并削弱了餐后血糖偏移。
实施例10.口服剂型的制备方法
将实施例6或7中所描述的经喷雾干燥的FDKP二钠/胰岛素粉末装入硬质凝胶胶囊中。该胶囊可以包含约50-100mg的粉末。实施例6和7中制备的FDKP盐/胰岛素粉末中胰岛素为25重量%,胰岛素活性为约26单位/mg。因此,50mg为约1300单位,这明显高于通常剂量。将约2-30mg FDKP盐/胰岛素粉末与甲基纤维素(本领域已知的其它增量剂)混合以弥补所需质量差额。
实施例11.口服FDKP二钠-胰岛素
将包含FDKP盐和胰岛素的胶囊饭前服用。精确的剂量遵医嘱,但通常服用量为每剂量约10-150单位胰岛素。随后的胰岛素吸收削弱了餐后血糖偏移。这种口服胰岛素配制品用于替代患有糖尿病的患者的饭前胰岛素注射。另外,通过胃肠道吸收的胰岛素模拟了内原胰岛素分泌。内原胰岛素通过胰腺分泌到门脉循环中。口服后吸收的胰岛素也会直接进入门脉循环中。因此,胰岛素给药的口服途径使胰岛素输送到肝脏中的作用场所中,为控制葡萄糖水平提供了可能性,同时限制对胰岛素的系统药物暴露(systemic exposure)。利用胰岛素和FDKP二酸形式组合的口服胰岛素输送受FDKP二酸在低pH环境的胃肠道中溶解性差的阻碍。然而,FDKP盐提供了局部缓冲作用,该作用促进了它们在低pH下溶解。
实施例12.FDKP二钠盐的制备方法C
将5克富马酰二酮哌嗪(FDKP,221.01mmol,1当量),水(200mL)和10N氢氧化钠(21.9mL,437.61mmol,1.98当量)加入装有回流冷凝器、悬臂式搅拌器、氮气入口和温度计的1升4口圆底烧瓶中。将混合物加热到50℃以得到黄色溶液,将乙醇(650mL)在15分钟内加入。当添加完成后,将浆液在50℃下保持30-60分钟。将反应混合物真空过滤,并将经分离的固体采用乙醇(150mL)和丙酮(150mL×2)洗涤,并在真空烘箱中(50℃,30英寸汞柱)干燥整夜。不需进行进一步纯化。分析该盐的水分含量(Karl Fischer)和钾含量(元素分析和滴定)。该盐的产率为约90%到约95%。
Karl Fischer:7.19%
元素分析:
计算值C 44.91 H 5.70 N 10.47 Na 8.6
测试值C 45.29 H 5.47 N 10.59 Na 8.24
滴定:98.8%二钠盐(重量百分比)
以下是根据本发明的各种配制品所描述的各种方法。
实施例13.通过喷雾干燥制备的FDKP盐/胰岛素粉末
将FDKP二钠盐(5g)溶于去离子水中(150mL),并加入胰岛素(1.69g)。将悬浮液的pH采用氢氧化铵(NH4OH)调节至8.3以得到溶液,该溶液采用去离子水稀释到200mL并过滤。该溶液采用以下条件喷雾干燥:
入口温度-200℃
出口温度-80℃
雾化气体-600升N2/hr
处理气体-最大量的80%
将喷雾喷嘴冷却到28℃
分析所得颗粒的空气动力学性质,数据列于表3中。
表3.经喷雾干燥的FDKP二钠/胰岛素的空气动力学性质
样品 | %rf | %倒空 | %rf填充 | Mmad | gsd | 入口℃ | %负载 | LOD |
具有25%胰岛素的 FDKP二钠盐(w∶w) | 44.5 | 85.6 | 38.1 | 3.1 | 1.9 | 200 | 25.00 | 5.4 |
表3示出了:可吸入分数(%rf)(该分数是直径为0.5-5.8微米的颗粒的百分率),卸载过程中从药桶中倒出的粉末的百分率(%倒空),每单位填充量中可吸入部分的百分率(%rf填充,%rf×%倒空,这测量了在从药桶中倒出的粉末中可吸入颗粒的%)、质量中值空气动力学直径(mmad),入口℃(以摄氏度计的入口温度),负载百分率(%负载-颗粒中胰岛素的含量,以重量%计)和干燥过程中的损耗(LOD)(粉末中残余水的量度,以当粉末在烘箱中干燥整夜时所除去的%挥发性原料来表达)。
通过激光衍射测量的颗粒尺寸具有约2μm-15μm的尺寸范围,数据列于表4中和图2中。
表4
利用扫描电子显微镜(SEM)研究颗粒的形貌。具有代表性的SEM示于图3中。颗粒形貌为塌陷的空心球体。
二钠盐/胰岛素颗粒的稳定性在加速室温条件下(40°/75%相对湿度[RH])进行评估。与通过冻干法制备的对照配制品相比,经喷雾干燥的颗粒具有极高的胰岛素稳定性,该胰岛素稳定性通过胰岛素的降解来测量(图4)。
评估在喷雾干燥以前的FDKP二钠盐/25%胰岛素溶液的初始浓度对最终颗粒稳定性的影响。数据(图5)表明,颗粒中胰岛素的稳定性随着溶液浓度的增加而增加,该稳定性根据在40°/75%RH下17天后通过胰岛素的损耗来测量。
实施例14.采用有机溶剂进行的FDKP盐/胰岛素溶液的溶剂/反溶剂沉淀
沉淀使用谐波超声雾化来控制。也可应用交替气穴法以及高剪切混合和均质化。
将FDKP的二钠盐(5g)溶于去离子水(80mL)中。将胰岛素(0.65g)加入该溶液中以产生悬浮液。将悬浮液的pH采用NH4OH调节至8.3以得到溶液,该溶液采用去离子水稀释到100mL并过滤。颗粒通过如下方法沉淀:将胰岛素/FDKP二钠盐的溶液与乙醇以1∶5的比通过一个在20kHz和40kHz频率下振动的双入口雾化料斗(duel inletatomization horn)抽吸。将沉淀物收集在包含乙醇(200mL)的媒介瓶中。沉淀后,将材料采用乙醇洗涤,并通过旋转蒸发或通过将氮气鼓泡吹过悬浮液来干燥。颗粒包含12.5重量%胰岛素。颗粒形貌通过SEM评估(图6)。
图6A(10k×)和图6B(20k×)所示的颗粒在1-5微米的范围内,同时在较低的放大倍数下,看到在10-40微米范围内的颗粒(图6C,2.5k×和图6D,1.0k×)。如下是本发明人的非约束性假设:在此项研究中所利用的干燥方法使初始颗粒重结晶成更大的次级颗粒,并且,使用将 有机组分和水性组分在整个干燥过程(例如喷雾干燥)中维持在恒定比的方法可以维持初级颗粒而没有形成明显数量的次级颗粒。
实施例15.二铵盐的原位形成和配制品
FDKP或SDKP(琥珀酰DKP)二铵盐/胰岛素颗粒通过喷雾干燥形成。对于包含25%胰岛素的FDKP铵盐/胰岛素配制品给出了典型的过程。
将FDKP(5g)悬浮于去离子水(150mL)中,并采用氢氧化铵(NH4OH)滴定至7.5-8.0pH。将胰岛素(1.69g)加入所得溶液(FDKP)中以得到悬浮液。将悬浮液的pH采用氢氧化铵(NH4OH)调节至8.3以得到溶液,该溶液采用去离子水稀释到200mL并过滤。该粉末在如下条件下通过喷雾干燥溶液制备。
入口温度-200℃
出口温度-80℃
雾化气体-600升N2/hr
处理气体-最大量的80%
将喷雾喷嘴冷却到28℃
二铵盐的%rf比二钠盐的%rf高约10%。反阳离子对颗粒性能具有很大影响。而且,50%FDKP铵盐/胰岛素粉末的%rf与相应的25%FDKP铵盐/胰岛素粉末的%rf是相当的。这点令人惊讶,因为由FDKP游离酸通过冻干法制备的颗粒的%rf随着胰岛素的增加而降低。
分析所得颗粒的空气动力学性质,数据列于表5中。
表5.经喷雾干燥的FDKP二铵/胰岛素和SDKP二铵/胰岛素的空气动力学性质
样品 | %rf | %倒空 | %rf填充 | mmad | gsd | 入口℃ | %负载 | LOD |
具有25%胰岛素的 FDKP二铵盐(w∶w) | 52.1 | 88.7 | 46.2 | 2.9 | 1.9 | 200 | 25.00 | 6.6 |
具有50%胰岛素的 FDKP二铵盐(w∶w) | 55.7 | 85.4 | 47.5 | 2.9 | 1.8 | 200 | 50.00 | 6.2 |
具有25%胰岛素的 | 56.0 | 90.1 | 55.7 | 3.0 | 2.0 | 200 | 25.00 | 38 |
SDKP二铵盐(w∶w) |
通过激光衍射测量颗粒尺寸,数据列于表6和图7-9中。
表6
Lot# | Run | X10 | X50 | X90 | VMD | GSD | 细颗粒分数 (<5.8μm) |
具有25%胰岛素的 FDKP二铵盐(w∶w) | 078 | 1.70μm | 4.10μm | 8.40μm | 4.68μm | 1.86 | 72.13% |
包含25%胰岛素(w∶w)的FDKP二铵盐制剂的颗粒尺寸通过激光衍射测定,实验表明:采用25%胰岛素配制的FDKP铵盐的尺寸范围为约1.7μm-8.4μm(图7和表7)。
表7
Lot# | Run | X10 | X50 | X90 | VMD | GSD | 细颗粒分数 (<5.8μm) |
具有50%胰岛素的 FDKP二铵盐(w∶w) | 076 | 1.57μm | 4.51μm | 8.79μm | 4.97μm | 1.91 | 66.95% |
包含50%胰岛素(w∶w)的FDKP二铵盐制剂的颗粒尺寸通过激光衍射测定,实验表明:采用50%胰岛素配制的FDKP铵盐的尺寸范围为约1.6μm-8.8μm(表8)。
表8
Lot# | Run | X10 | X50 | X90 | VMD | GSD | 细颗粒分数 (<5.8μm) |
具有25%胰岛素的 SDKP二铵盐(w∶w) | 084 | 1.66μm | 4.64μm | 9.27μm | 5.17μm | 1.92 | 64.69% |
包含25%胰岛素(w∶w)的SDKP二铵盐制剂的颗粒尺寸通过激光衍射测定,实验表明:采用25%胰岛素配制的SDKP铵盐的尺寸范围为约1.7μm-9.3μm。
利用扫描电子显微镜研究颗粒的形貌。具有代表性的SEM示于图10(FDKP)和图11(SDKP)中。颗粒形貌为塌陷的空心球体。
二铵盐/胰岛素颗粒的原位成盐和配制品的稳定性在加速室温条件下 (40°/75%RH)进行评估。与通过冻干法制备的对照配制品相比,经喷雾干燥的颗粒具有很高的胰岛素稳定性,该胰岛素稳定性通过胰岛素的降解(FDKP,图12;SDKP,图14)和去氨基降解物的形成(A21)(FDKP,图13;SDKP,图15)来测量。
实施例16.表征经喷雾干燥的微粒
经喷雾干燥的FDKP盐/胰岛素颗粒在空气动力学性能中具有令人惊讶、出乎意料的趋势。先前观察到,由DKP游离酸微粒形成的含胰岛素微粒的空气动力学性能随着胰岛素含量的增加而降低,上述含胰岛素微粒通过将胰岛素负载到DKP游离酸微粒上、并将溶剂通过冻干法除去来制备。例如,25%负载的颗粒的%rf(可吸入分数)显著低于5%负载的颗粒的%rf。对于包含胰岛素的经喷雾干燥的FDKP盐微粒,观察到相反的趋势。随着胰岛素负载的增加,%rf增加。
制备具有11.4%、50.0%、70.0%或90.0%胰岛素含量(w∶w)的FDKP二钠盐的喷雾干燥粉末。图16表明,随着胰岛素负载的增加,%rf增加。
在具有11.4%、50.0%、70.0%或90.0%胰岛素含量(w∶w)的经喷雾干燥的FDKP二铵盐/胰岛素粉末中,也观察到类似的趋势。
评估在喷雾干燥以前的FDKP二钠盐溶液的初始浓度对最终胰岛素稳定性的影响。数据表明,粉末中的胰岛素稳定性随着溶液浓度的增加而增加,稳定性通过在40°/75%的相对湿度下17天后胰岛素的损耗来测量。例如,由包含37mg/mL固体的溶液喷雾干燥得到的粉末损耗8.5%的胰岛素。作为比较,由包含45mg/mL固体的溶液喷雾干燥得到的粉末损耗4.5%的胰岛素,而由包含67mg/mL固体的溶液喷雾干燥得到的粉末损耗2.7%的胰岛素。
评估用于喷雾干燥FDKP二钠盐和胰岛素的溶液以形成包含50%胰岛素的颗粒的入口温度对最终颗粒胰岛素稳定性的影响。数据表明,粉末中胰岛素的稳定性随着入口温度的增加而增加,该稳定性通过在40°/75%RH下17天后胰岛素的损耗来测量。例如,在180℃的入口温度下喷雾干燥的 粉末损耗约4%的胰岛素。作为比较,在200℃的入口温度下喷雾干燥的粉末损耗<1%的胰岛素。
另外,本发明人出乎意料地发现,适用于肺部输送的这些颗粒具有约1的粗糙度。
除非另有指明,本说明书和权利要求书中使用的表示成分的数量、以及表示分子量、反应条件等性质的所有数字都应当被理解为:在所有情况下,用术语“大约”加以了修饰。因此,除非有相反含义的说明,本说明书和所附权利要求书中示出的数量参数都是约数,它们可以根据本发明想要获得的性质而变动。至少,并且并非对权利要求书范围等同原则的应用加以限制,每个数量参数至少应按照报道的有效数字的数,以及应用普通的凑整技术来解释。虽然示出本发明宽广范围的数字范围和参数是约数,但是特别实施例中所示的数值却被尽可能地精确报道。但是,任何数值,必然含有一定误差,这是它们各自的检验测量方法中发现的标准偏差必然导致的。
除非本文另有指明,或与上下文明显矛盾,描述本发明的上下文中使用的术语“一个”、“一种”和“该”(“所述”)以及类似提法应当被理解为既包括单数又包括复数。本文中数值范围的引述仅仅用作速记方法,其包括该范围内每个单独的值。除非本文另有指明,每个单独的值被包括进说明书,就像它们在本文个别引述一样。本文所述的所有方法都可以以任何合适的顺序来进行,除非本文另有指明,或与上下文明显矛盾。除非另有指明,本文提供的任何及所有例子,或者示例性的语言(例如,“例如”)仅用来更好地阐述本发明,而非对发明范围加以限制。说明书中任何语句都不应被解释为:表示对本发明的实践来说必要的、未被要求保护的要素。
本文公开的本发明的替换性要素或实施方式的分组不应被理解为限制。每个组成员可被个别提到和被个别要求保护,或以与该组其它成员或本文中找到的其它要素的任何组合被提到和要求保护。可以预见到,为了方便和/或可专利性的理由,组中的一个或多个成员可被包括进一组或从中删除。当任何此类包括或删除发生时,说明书在本文中被看作为含有经过 改动的组,因此满足对所附权利要求书中所用的任意和全部马库什组的支持。
本文中描述了本发明的优选实施方式,其包括发明人已知用来开展本发明的最佳模式。当然,在阅读前述说明书的基础上,对这些优选实施方式中的改动对于本领域普通技术人员来说将是明显的。本发明的发明人期待本领域技术人员合适地采用此类改动,发明人希望本发明以除了本文特别描述的方式之外的方式被实现。因此,只要适用法律允许,本发明包括对所附权利要求中提到的主体进行的所有改动和等同物。此外,所有可能的变化中,上面提到的要素的任何组合都被包括进本发明,除非本文另有指明,或与上下文明显矛盾。
此外,本说明书中提到了大量参考文献,包括专利和印刷出版物。上述参考文献和印刷出版物中的每种在此都通过引用被个别地整体包括进本文。
最后,应当理解,本文公开的本发明实施方式是为了阐述本发明的原理。可以进行的其它改动也落在本发明的范围内。因此,举例而言,而非限制,可按照本文的教导来使用本发明的替代性构造。因此,本发明不被限制为:与本文所述和所示出的完全一致。
Claims (75)
1.一种根据式1的杂环化合物的药学上可接受盐:
其中,R1或R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组;
E1和E2包括N或O;
所述盐还包括至少一种阳离子;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐;并且
所述药学上可接受盐是喷雾干燥固体。
2.如权利要求1所述的药学上可接受盐,其中,所述杂环化合物包括二酮哌嗪。
3.如权利要求1所述的药学上可接受盐,其中,所述羧酸基团位于末端。
4.如权利要求1所述的药学上可接受盐,其中,X是富马酰基。
5.如权利要求1所述的药学上可接受盐,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
6.如权利要求5所述的药学上可接受盐,其中,所述阳离子是钠。
7.一种治疗组合物,所述组合物包括根据式1的杂环化合物的药学上可接受盐:
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;
所述盐还包括至少一种阳离子;
其中所述药学上可接受盐是干燥固体;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐;且
一种生物活性试剂,所述生物活性试剂由胰岛素组成;
其中所述治疗组合物通过喷雾干燥形成。
8.如权利要求7所述的治疗组合物,其中,所述组合物被配制成液体。
9.如权利要求8所述的治疗组合物,其中,所述液体是溶液或悬浮液。
10.如权利要求7所述的治疗组合物,其中,所述组合物包括沉淀物。
11.如权利要求10所述的治疗组合物,其中,所述沉淀物被配制成适于口服、口腔给药、直肠给药或阴道给药的固体剂型。
12.如权利要求11所述的治疗组合物,其中,所述固体剂型选自由胶囊、药片和栓剂组成的组。
13.如权利要求7所述的治疗组合物,其中,所述组合物包括干粉。
14.如权利要求13所述的治疗组合物,其中,所述干粉的颗粒具有约0.5微米到约10微米的直径。
15.一种制备用于药物输送的固体组合物的方法,所述方法包括:
制备一种包含生物活性试剂和杂环化合物的药学上可接受盐在溶剂中的溶液,所述生物活性试剂由胰岛素组成;
喷雾干燥除去所述溶剂;
其中,所述杂环化合物的药学上可接受盐具有根据式1的结构:
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;
所述盐还包括至少一种阳离子;并且
其中,所述药学上可接受盐是干燥固体;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
16.如权利要求15所述的方法,所述方法还包括将所述固体微粉化以形成干粉的步骤。
17.一种制备用于药物输送的干粉的方法,所述方法包括;
制备一种包含生物活性试剂和杂环化合物的药学上可接受盐在溶剂中的溶液,所述生物活性试剂由胰岛素组成,其中所述药学上可接受盐是干燥固体;
将所述杂环化合物的药学上可接受盐和所述生物活性试剂的所述溶液喷雾干燥以形成干粉;
其中,在给予生物体系后所述生物活性试剂从所述干粉释放;和
其中,所述杂环化合物的药学上可接受盐具有式1的结构
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;
所述盐还包括至少一种阳离子;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
18.如权利要求17所述的方法,其中,所述干粉的颗粒适用于肺部输送。
19.如权利要求17所述的方法,其中,所述干粉的颗粒具有小于2的粗糙度。
20.一种用于输送生物活性试剂的组合物,所述生物活性试剂由胰岛素组成,其中,所述组合物包括杂环化合物的药学上可接受盐和生物活性试剂,经喷雾干燥以形成干粉使得所述干粉在给予生物体系后释放所述生物活性试剂,并且所述杂环化合物的药学上可接受盐具有根据式1的结构:
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;且
所述盐还包括至少一种阳离子;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
21.如权利要求20所述的组合物,其中,所述干粉的颗粒适于肺部输送。
22.如权利要求20所述的组合物,其中,所述干粉的颗粒具有小于2的粗糙度。
23.一种用于药物输送的通过喷雾干燥形成的微粒系统,所述系统包括:杂环化合物的药学上可接受盐和由胰岛素组成的生物活性试剂的组合物,其中,所述组合物在给予生物体系后释放所述生物活性试剂,并且所述杂环化合物具有根据式1的结构:
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;
所述盐还包括至少一种阳离子;且
所述药学上可接受盐是干燥固体;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
24.如权利要求23所述的微粒系统,其中,所述药物被输送到所述肺部系统中。
25.如权利要求23所述的微粒系统,其中,所述生物活性试剂被吸收到全身血液循环中。
26.如权利要求23所述的微粒系统,其中,所述生物活性试剂局部作用在肺脏中。
27.如权利要求23所述的微粒系统,其中,所述组合物包括用于药物输送的液体,其中,所述二酮哌嗪促进所述生物活性试剂的吸收。
28.如权利要求27所述的微粒系统,其中,所述液体被口服。
29.杂环化合物的药学上可接受盐在制造用于输送颗粒到肺部系统的药剂的用途,所述用途包括:
通过吸入将干粉形式的有效量生物活性试剂给予需要治疗的患者,所述干粉通过如下方法制备:将包括由杂环化合物的药学上可接受盐和生物活性试剂组成的组合物的溶液喷雾干燥,所述生物活性试剂由胰岛素组成;
其中,所述干粉在所述肺部系统中释放所述生物活性试剂;
其中,所述杂环化合物的药学上可接受盐具有根据式1的结构:
其中,R1或R2包括至少一个羧酸官能团;
E1和E2包括N;
所述杂环化合物是二酮哌嗪;且
所述盐还包括至少一种阳离子;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
30.一种根据式1的杂环化合物的药学上可接受盐:
其中,R1或R2包括结构4-X-氨基丁基的至少一个羧酸官能团,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组;
E1和E2包括N或O;
所述杂环化合物包括二酮哌嗪;
所述盐还包括至少一种阳离子;且
其中,所述药学上可接受盐是喷雾干燥固体;
其中,所述盐不是2,5-二天冬氨酰-3,6-二酮哌嗪或2,5-二谷氨酰-3,6-二酮哌嗪的锂盐。
31.如权利要求7所述的治疗组合物,其中,所述羧酸基团位于末端。
32.如权利要求31所述的治疗组合物,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
33.如权利要求32所述的治疗组合物,其中,X是富马酰基。
34.如权利要求7所述的治疗组合物,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
35.如权利要求34所述的治疗组合物,其中,所述阳离子是钠。
36.如权利要求1所述的药学上可接受盐,其中,所述阳离子包括Mg++或Ca++。
37.如权利要求36所述的药学上可接受盐,其中,所述阳离子包括Mg++。
38.如权利要求7所述的治疗组合物,其中,所述阳离子包括Mg++或Ca++。
39.如权利要求38所述的治疗组合物,其中,所述阳离子包括Mg++。
40.如权利要求15所述的方法,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
41.如权利要求40所述的方法,其中,所述阳离子是钠。
42.如权利要求15所述的方法,其中,所述阳离子包括Mg++或Ca++。
43.如权利要求42所述的方法,其中,所述阳离子包括Mg++。
44.如权利要求15所述的方法,其中,所述羧酸基团位于末端。
45.如权利要求44所述的方法,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
46.如权利要求45所述的方法,其中,X是富马酰基。
47.如权利要求17所述的方法,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
48.如权利要求47所述的方法,其中,所述阳离子是钠。
49.如权利要求17所述的方法,其中,所述阳离子包括Mg++或Ca++。
50.如权利要求49所述的方法,其中,所述阳离子包括Mg++。
51.如权利要求17所述的方法,其中,所述羧酸基团位于末端。
52.如权利要求51所述的方法,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
53.如权利要求52所述的方法,其中,X是富马酰基。
54.如权利要求20所述的组合物,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
55.如权利要求54所述的组合物,其中,所述阳离子是钠。
56.如权利要求20所述的组合物,其中,所述阳离子包括Mg++或Ca++。
57.如权利要求56所述的组合物,其中,所述阳离子包括Mg++。
58.如权利要求20所述的组合物,其中,所述羧酸基团位于末端。
59.如权利要求58所述的组合物,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
60.如权利要求59所述的组合物,其中,X是富马酰基。
61.如权利要求23所述的微粒系统,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
62.如权利要求61所述的微粒系统,其中,所述阳离子是钠。
63.如权利要求23所述的微粒系统,其中,所述阳离子包括Mg++或Ca++。
64.如权利要求63所述的微粒系统,其中,所述阳离子包括Mg++。
65.如权利要求23所述的微粒系统,其中,所述羧酸基团位于末端。
66.如权利要求65所述的微粒系统,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
67.如权利要求66所述的微粒系统,其中,X是富马酰基。
68.如权利要求29所述的用途,其中,所述阳离子选自由钠、钾、钙、锂、三乙胺、丁基胺、二乙醇胺和三乙醇胺组成的组。
69.如权利要求68所述的用途,其中,所述阳离子是钠。
70.如权利要求29所述的用途,其中,所述阳离子包括Mg++或Ca++。
71.如权利要求70所述的用途,其中,所述阳离子包括Mg++。
72.如权利要求29所述的用途,其中,所述羧酸基团位于末端。
73.如权利要求72所述的用途,其中,R1和R2包括4-X-氨基丁基,并且其中,X选自由琥珀酰基、戊二酰基、马来酰基和富马酰基组成的组。
74.如权利要求73所述的用途,其中,X是富马酰基。
75.如权利要求30所述的药学上可接受盐,其中,X是富马酰基。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410655195.3A CN104436170B (zh) | 2004-08-23 | 2005-08-23 | 用于药物输送的二酮哌嗪盐 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60376104P | 2004-08-23 | 2004-08-23 | |
US60/603,761 | 2004-08-23 | ||
PCT/US2005/030026 WO2006023943A1 (en) | 2004-08-23 | 2005-08-23 | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410655195.3A Division CN104436170B (zh) | 2004-08-23 | 2005-08-23 | 用于药物输送的二酮哌嗪盐 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101027057A CN101027057A (zh) | 2007-08-29 |
CN101027057B true CN101027057B (zh) | 2017-04-12 |
Family
ID=35355416
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200580028435.6A Active CN101027057B (zh) | 2004-08-23 | 2005-08-23 | 用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐 |
CN201410655195.3A Active CN104436170B (zh) | 2004-08-23 | 2005-08-23 | 用于药物输送的二酮哌嗪盐 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410655195.3A Active CN104436170B (zh) | 2004-08-23 | 2005-08-23 | 用于药物输送的二酮哌嗪盐 |
Country Status (16)
Country | Link |
---|---|
US (10) | US7820676B2 (zh) |
EP (3) | EP1791542B1 (zh) |
JP (1) | JP4990142B2 (zh) |
KR (4) | KR20130066695A (zh) |
CN (2) | CN101027057B (zh) |
AU (1) | AU2005277041B2 (zh) |
BR (2) | BR122019022692B1 (zh) |
CA (1) | CA2578175C (zh) |
DK (3) | DK2322180T3 (zh) |
ES (3) | ES2540886T3 (zh) |
HK (3) | HK1105588A1 (zh) |
HU (3) | HUE026797T2 (zh) |
IL (2) | IL181516A (zh) |
MX (1) | MX2007002189A (zh) |
PL (3) | PL2314298T3 (zh) |
WO (1) | WO2006023943A1 (zh) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
DK2280020T3 (en) | 1999-06-29 | 2016-05-02 | Mannkind Corp | Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
US20080260838A1 (en) * | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
US20040038865A1 (en) * | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
US20070027063A1 (en) * | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
CA2575692C (en) | 2004-08-20 | 2014-10-14 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
CN104288756A (zh) * | 2006-04-14 | 2015-01-21 | 曼金德公司 | 高血糖素样肽1(glp-1)药物制剂 |
WO2008014613A1 (en) * | 2006-08-04 | 2008-02-07 | Manus Pharmaceuticals (Canada) Ltd. | Multifunctional bioactive compounds |
JP5864834B2 (ja) | 2006-09-22 | 2016-02-17 | ノボ・ノルデイスク・エー/エス | プロテアーゼ耐性のインスリンアナログ |
US9387176B2 (en) | 2007-04-30 | 2016-07-12 | Novo Nordisk A/S | Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein |
AU2008316636B2 (en) * | 2007-10-24 | 2014-02-06 | Mannkind Corporation | Delivery of active agents |
JP2011500850A (ja) * | 2007-10-24 | 2011-01-06 | マンカインド コーポレイション | Glp−1による副作用を防止する方法 |
US8785396B2 (en) * | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
JP5762001B2 (ja) | 2008-03-14 | 2015-08-12 | ノボ・ノルデイスク・エー/エス | プロテアーゼ安定化インスリンアナログ |
PT2254906T (pt) | 2008-03-18 | 2017-01-03 | Novo Nordisk As | Análogos de insulina acilados, estabilizados contra proteases |
US8217047B2 (en) | 2008-05-27 | 2012-07-10 | Dmi Acquisition Corp. | Therapeutic methods and compounds |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
US20190262557A1 (en) * | 2010-03-04 | 2019-08-29 | Mannkind Corporation | Dry powder drug delivery system |
AR072114A1 (es) | 2008-06-13 | 2010-08-04 | Mannkind Corp | Un inhalador de polvo seco y sistema para suministro de farmacos |
BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
US11110151B2 (en) * | 2008-08-11 | 2021-09-07 | Mannkind Corporation | Composition and method for reducing hypoglycemia events in diabetes treatment |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
WO2010078373A1 (en) | 2008-12-29 | 2010-07-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
JP5918539B2 (ja) * | 2009-01-08 | 2016-05-18 | マンカインド コーポレイション | Glp−1を用いる高血糖症の治療方法 |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
KR101782174B1 (ko) | 2009-06-12 | 2017-09-26 | 맨카인드 코포레이션 | 한정된 이성체 함량을 갖는 디케토피페라진 마이크로입자 |
US8642548B2 (en) | 2009-08-07 | 2014-02-04 | Mannkind Corporation | Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
BR112012011591B1 (pt) * | 2009-11-02 | 2020-02-27 | Mannkind Corporation | Reator, sistema e método voltado para a produção de partículas em um processo de precipitação |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
EP2567219B1 (en) | 2010-05-07 | 2019-09-18 | MannKind Corporation | Method and apparatus for determining weight percent of microparticles of diketopiperazine in suspension using raman spectroscopy |
RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
KR101931392B1 (ko) | 2010-11-09 | 2018-12-20 | 맨카인드 코포레이션 | 세로토닌 수용체 작용제 및 디케토피페라진을 포함하는 편두통 치료용 조성물 |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
US9890200B2 (en) | 2011-04-12 | 2018-02-13 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
KR101862291B1 (ko) | 2011-04-12 | 2018-05-29 | 모레 매트릭스 인코포레이티드 | 이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
PL2766029T3 (pl) | 2011-10-10 | 2020-08-24 | Ampio Pharmaceuticals, Inc. | Leczenie choroby zwyrodnieniowej stawów |
WO2013055749A1 (en) | 2011-10-10 | 2013-04-18 | Ampio Pharmaceuticals, Inc. | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
KR102272498B1 (ko) * | 2011-10-27 | 2021-07-06 | 메사추세츠 인스티튜트 오브 테크놀로지 | 약물 캡슐화 마이크로스피어를 형성할 수 있는, n-말단 상에 관능화된 아미노산 유도체 |
JP6231484B2 (ja) | 2011-10-28 | 2017-11-15 | アンピオ ファーマシューティカルズ,インコーポレイテッド | 鼻炎の処置 |
CA2870313A1 (en) | 2012-04-11 | 2013-10-17 | Novo Nordisk A/S | Insulin formulations |
JP6241682B2 (ja) | 2012-04-27 | 2017-12-06 | マンカインド・コーポレイシヨン | 活性化したエチルフマレートの合成のための方法および中間体としてのその使用 |
SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
WO2014144895A1 (en) * | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
CN105101965B (zh) | 2013-03-15 | 2021-03-09 | 安皮奥制药股份有限公司 | 用于干细胞活动化、归巢、扩增和分化的组合物及其使用方法 |
AU2014290438B2 (en) | 2013-07-18 | 2019-11-07 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
AU2014333979B2 (en) | 2013-10-07 | 2018-02-15 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10336788B2 (en) | 2014-04-17 | 2019-07-02 | Moerae Matrix, Inc. | Inhibition of cardiac fibrosis in myocardial infarction |
EP3587409B8 (en) | 2014-05-30 | 2022-07-13 | Translate Bio, Inc. | Biodegradable lipids for delivery of nucleic acids |
RU2736513C2 (ru) | 2014-08-18 | 2020-11-17 | Ампио Фармасьютикалз, Инк. | Лечение патологических состояний суставов |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
AU2015350151A1 (en) | 2014-11-17 | 2017-06-01 | Moerae Matrix, Inc. | Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition |
JP2018512401A (ja) | 2015-03-12 | 2018-05-17 | モイライ マトリックス インコーポレイテッド | Mk2阻害剤ペプチド含有組成物を用いた非小細胞肺癌の治療を目的とするその使用 |
AU2016278970B2 (en) | 2015-06-19 | 2020-10-29 | Massachusetts Institute Of Technology | Alkenyl substituted 2,5-piperazinediones and their use in compositions for delivering an agent to a subject or cell |
EP3310375A4 (en) | 2015-06-22 | 2019-02-20 | Ampio Pharmaceuticals, Inc. | USE OF LOW MOLECULAR WEIGHT HUMAN SERUM ALBUMIN FRACTIONS FOR TREATING DISEASES |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
WO2017132601A1 (en) | 2016-01-29 | 2017-08-03 | Mannkind Corporation | Dry powder inhaler |
TW201809049A (zh) | 2016-03-31 | 2018-03-16 | 盧伯利索先進材料有限公司 | 生物可分解及/或生物可吸收的熱塑性聚胺甲酸酯 |
CN110087674B (zh) | 2016-12-16 | 2023-01-03 | 诺和诺德股份有限公司 | 含胰岛素的药物组合物 |
MX2020007745A (es) * | 2018-01-26 | 2020-09-25 | Novartis Ag | Administracion de dosis elevadas de terapias inhaladas. |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018754A1 (en) * | 1992-03-11 | 1993-09-30 | Pharmaceutical Discovery Corporation | Self-assembling diketopiperazine drug delivery system |
Family Cites Families (1105)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US644426A (en) | 1898-10-05 | 1900-02-27 | John L Heffner | Upholstering apparatus. |
GB475440A (en) | 1935-09-23 | 1937-11-19 | Mine Safety Appliances Co | Improvements in or relating to apparatus for determining the flow resistance of breathing apparatus elements |
US2549303A (en) | 1949-04-20 | 1951-04-17 | Bristol Lab Inc | Inhaler for crystalline pencilllin or the like |
BE509861A (zh) | 1952-03-13 | |||
US2754276A (en) | 1953-02-12 | 1956-07-10 | Du Pont | Cellular compositions utilizing dinitrosopentamethylene-tetramine as the blowing agent |
US3337740A (en) | 1962-02-13 | 1967-08-22 | Deering Milliken Res Corp | Process for separating acrylic acid from impurities |
US4187129A (en) | 1962-05-14 | 1980-02-05 | Aerojet-General Corporation | Gelled mechanically stable high energy fuel composition containing metal platelets |
FR1451293A (fr) | 1964-05-18 | 1966-01-07 | Entoleter | Matière composite et son procédé de préparation |
US3407203A (en) | 1965-03-22 | 1968-10-22 | Union Carbide Corp | Novel process for the preparation of diketopiperazines |
US3669113A (en) | 1966-03-07 | 1972-06-13 | Fisons Ltd | Inhalation device |
US3518340A (en) | 1968-04-15 | 1970-06-30 | Dow Corning | Method of forming silicone rubber drug carriers |
US3622053A (en) | 1969-12-10 | 1971-11-23 | Schering Corp | Aerosol inhaler with flip-up nozzle |
JPS4916108B1 (zh) * | 1970-11-11 | 1974-04-19 | ||
US3673698A (en) | 1970-11-25 | 1972-07-04 | Albert S Guerard | Process for freeze drying with carbon dioxide |
BE794951A (fr) | 1972-02-03 | 1973-05-29 | Parke Davis & Co | Conditionnement soluble dans l'eau |
US3873651A (en) | 1972-05-12 | 1975-03-25 | Atomic Energy Commission | Freeze drying method for preparing radiation source material |
US3823843A (en) | 1972-10-26 | 1974-07-16 | Lilly Co Eli | Locking capsule |
US3856142A (en) | 1973-01-24 | 1974-12-24 | Mine Safety Appliances Co | Inhalant package |
FR2224175B1 (zh) | 1973-04-04 | 1978-04-14 | Isf Spa | |
US3980074A (en) | 1973-07-18 | 1976-09-14 | Beecham Group Limited | Device for the administration of powders |
GB1479283A (en) | 1973-07-23 | 1977-07-13 | Bespak Industries Ltd | Inhaler for powdered medicament |
GB1459488A (en) | 1974-03-19 | 1976-12-22 | Wyeth John & Brother Ltd | Piperazinedione derivatives |
IT1017153B (it) | 1974-07-15 | 1977-07-20 | Isf Spa | Apparecchio per inalazioni |
US4018619A (en) | 1974-09-23 | 1977-04-19 | Iu Technology Corporation | Highly activated mixtures for constructing load bearing surfaces and method of making the same |
US4005711A (en) | 1975-01-13 | 1977-02-01 | Syntex Puerto Rico, Inc. | Inhalation device |
DE2502251A1 (de) | 1975-01-17 | 1976-07-22 | Schering Ag | Vorrichtung zur inhalation pulverfoermiger feststoffe |
US4040536A (en) | 1975-05-05 | 1977-08-09 | R. P. Scherer Corporation | Locking hard gelatin capsule |
BR7603665A (pt) | 1975-06-09 | 1977-02-01 | Nat Distillers Chem Corp | Processo para comunicar resistencia a aglomeracao a um polimero de etileno-acetano de vinila e o polimero resultant |
US4153689A (en) | 1975-06-13 | 1979-05-08 | Takeda Chemical Industries, Ltd. | Stable insulin preparation for nasal administration |
US3998226A (en) | 1975-09-22 | 1976-12-21 | Edward G. Gomez | Inhalation device for encapsulated concentrates |
GB1509979A (en) | 1975-11-28 | 1978-05-10 | Fisons Ltd | Pharmaceutical compositions containing aspirin or indomethacin |
US4102953A (en) | 1976-05-25 | 1978-07-25 | The United States Of America As Represented By The Secretary Of The Navy | Method for making extruded, solventless, composite-modified double base propellant |
USD252707S (en) | 1977-01-03 | 1979-08-21 | Joel Besnard | Inhaler |
GB1598081A (en) | 1977-02-10 | 1981-09-16 | Allen & Hanburys Ltd | Inhaler device for dispensing medicaments |
US4171000A (en) | 1977-03-23 | 1979-10-16 | Uhle Klaus P | Smoking device |
IE46865B1 (en) | 1977-04-29 | 1983-10-19 | Allen & Hanburys Ltd | Device for dispensing medicaments |
US4148308A (en) | 1977-05-31 | 1979-04-10 | Sayer William J | Mouthpiece with a tongue retractor |
US4110240A (en) | 1977-07-29 | 1978-08-29 | Wyrough And Loser, Inc. | Coprecipitation process |
US4091077A (en) | 1977-08-12 | 1978-05-23 | The United States Of America As Represented By The United States Department Of Energy | Process for recovering filler from polymer |
US4211769A (en) | 1977-08-24 | 1980-07-08 | Takeda Chemical Industries, Ltd. | Preparations for vaginal administration |
US4268460A (en) | 1977-12-12 | 1981-05-19 | Warner-Lambert Company | Nebulizer |
CA1113044A (en) | 1977-12-16 | 1981-11-24 | J. Paul Leblond | Personal repellant device |
US4356167A (en) | 1978-01-27 | 1982-10-26 | Sandoz, Inc. | Liposome drug delivery systems |
US4175556A (en) | 1978-04-07 | 1979-11-27 | Freezer Winthrop J | Inhaler with flow-through cap |
US4196196A (en) | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
US4168002A (en) | 1978-08-03 | 1979-09-18 | Crosby Leslie O | Multiple-seed package card |
US4272398A (en) | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
DE2840442C2 (de) | 1978-09-16 | 1982-02-11 | C.H. Boehringer Sohn, 6507 Ingelheim | Verwendung des Diketopiperazins L-Leu-L-Trp als Geschmacksstoff für Getränke mit bitterer Geschmacksrichtung |
DE2849493C2 (de) | 1978-11-15 | 1982-01-14 | Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems | In der Hand zu haltender Aerosolspender |
USD269463S (en) | 1978-12-08 | 1983-06-21 | Fisons Limited | Container for a medicinal inhaler |
JPS5837833Y2 (ja) | 1979-04-27 | 1983-08-26 | 凸版印刷株式会社 | アンプル収納容器 |
JPS6034925B2 (ja) | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
US4407525A (en) | 1979-10-04 | 1983-10-04 | Gao Gesellschaft Fur Automation Und Organisation Mbh | Identification card with hallmark for authentication by incident and transmitted light |
GB2072536B (en) | 1980-03-25 | 1983-12-07 | Malem H | Nebuliser |
US4289759A (en) | 1980-06-23 | 1981-09-15 | Ortho Pharmaceutical Corporation | Immunoregulatory diketopiperazine compounds |
DE3167658D1 (en) | 1980-12-12 | 1985-01-17 | Combi Co | Inhaler |
US4900730A (en) | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
GB2092136B (en) | 1981-01-17 | 1985-06-05 | Mitsui Toatsu Chemicals | Production of n-substituted amide compounds |
JPS58140026A (ja) | 1982-01-14 | 1983-08-19 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
IT1220979B (it) | 1981-06-04 | 1990-06-21 | Lofarma Farma Lab | Capsule contenenti un allergene e procedimento per la loro preparazione |
DE3274065D1 (de) | 1981-07-08 | 1986-12-11 | Draco Ab | Powder inhalator |
SE438261B (sv) | 1981-07-08 | 1985-04-15 | Draco Ab | Anvendning i dosinhalator av ett perforerat membran |
US5260306A (en) | 1981-07-24 | 1993-11-09 | Fisons Plc | Inhalation pharmaceuticals |
USD276654S (en) | 1981-09-15 | 1984-12-04 | Aktiebolaget Draco | Medical aerosol inhalation device |
KR890000664B1 (ko) | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
US4659696A (en) | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
US4483922A (en) | 1982-05-14 | 1984-11-20 | Amf Inc. | Inactivation of enzymes |
US4526804A (en) | 1982-08-30 | 1985-07-02 | Ball Corporation | Method for providing sheet metal stock with finely divided powder |
US4487327A (en) | 1982-12-21 | 1984-12-11 | Grayson Robert E | Locking capsule |
JPS59163313A (ja) | 1983-03-09 | 1984-09-14 | Teijin Ltd | 経鼻投与用ペプチドホルモン類組成物 |
US4481139A (en) | 1983-04-13 | 1984-11-06 | Board Of Regents, The University Of Texas System | Peptide antagonists of substance P |
AU90762S (en) | 1983-06-29 | 1985-08-15 | Glaxo Group Ltd | Inhaler |
US4581020A (en) | 1983-07-18 | 1986-04-08 | Trimedyne, Inc. | Medication delivery device and system for percutaneous administration of medication |
GB8325529D0 (en) | 1983-09-23 | 1983-10-26 | Lilly Industries Ltd | Medicinal forms |
CH661878A5 (de) | 1983-11-04 | 1987-08-31 | Warner Lambert Co | Kapsel-dosierungsformen. |
US4671954A (en) | 1983-12-13 | 1987-06-09 | University Of Florida | Microspheres for incorporation of therapeutic substances and methods of preparation thereof |
USD295321S (en) | 1984-03-13 | 1988-04-19 | Glaxo Group Limited | Inhaler container for a medical aerosol |
JPS60248618A (ja) | 1984-05-24 | 1985-12-09 | Nippon Zoki Pharmaceut Co Ltd | ジペプチドを含有する潰瘍治療剤 |
US4927555A (en) | 1984-08-13 | 1990-05-22 | Colgate-Palmolive Company | Process for making thixotropic detergent compositions |
USD288852S (en) | 1984-08-29 | 1987-03-17 | Aruman Co., Ltd. | Disposable inhaler |
US4757066A (en) | 1984-10-15 | 1988-07-12 | Sankyo Company Limited | Composition containing a penem or carbapenem antibiotic and the use of the same |
IE58468B1 (en) | 1984-10-25 | 1993-09-22 | Warner Lambert Co | Method for sealing capsules and capsule |
US4592348A (en) | 1984-12-17 | 1986-06-03 | Waters Iv William C | Aerosol inhaler |
US4946828A (en) | 1985-03-12 | 1990-08-07 | Novo Nordisk A/S | Novel insulin peptides |
SE448277B (sv) | 1985-04-12 | 1987-02-09 | Draco Ab | Indikeringsanordning vid en doseringsanordning for lekemedel |
JPS6320301Y2 (zh) | 1985-04-18 | 1988-06-06 | ||
US5785989A (en) | 1985-05-01 | 1998-07-28 | University Utah Research Foundation | Compositions and methods of manufacturing of oral dissolvable medicaments |
US4615817A (en) | 1985-05-17 | 1986-10-07 | Mccoy Frederic C | Additives containing polytetrafluoroethylene for making stable lubricants |
CA1318730C (en) | 1985-05-30 | 1993-06-01 | C. Edward Capes | Method of separating carbonaceous components from particulate coal containing inorganic solids and apparatus therefor |
US5098590A (en) | 1988-02-04 | 1992-03-24 | Colgate Palmolive Co. | Thixotropic aqueous automatic dishwasher detergent compositions with improved stability |
US4811731A (en) | 1985-07-30 | 1989-03-14 | Glaxo Group Limited | Devices for administering medicaments to patients |
AT384552B (de) | 1985-08-01 | 1987-12-10 | Hurka Wilhelm | Inhalationsgeraet zur dosierung und verteilung von festkoerpern in die atemluft |
US4624861A (en) | 1985-09-05 | 1986-11-25 | Gte Products Corporation | Rare earth oxysulfide phosphors and processes for creating same |
US4742156A (en) | 1985-09-30 | 1988-05-03 | Mcneilab, Inc. | Peptide antagonists of neurokinin B and opthalmic solutions containing them |
PT83613B (en) | 1985-10-28 | 1988-11-21 | Lilly Co Eli | Process for the selective chemical removal of a protein amino-terminal residue |
WO1987003197A1 (en) | 1985-11-29 | 1987-06-04 | Fisons Plc | Pharmaceutical composition including sodium cromoglycate |
LU86258A1 (fr) | 1986-01-21 | 1987-09-03 | Rech Dermatologiques C I R D S | Composes benzamido aromatique,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique |
SE453566B (sv) | 1986-03-07 | 1988-02-15 | Draco Ab | Anordning vid pulverinhalatorer |
US4849227A (en) | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US5120712A (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
US4926852B1 (en) | 1986-06-23 | 1995-05-23 | Univ Johns Hopkins | Medication delivery system phase one |
USD301273S (en) | 1986-07-10 | 1989-05-23 | Leonard G Darin | Hand held fly suction device |
JPS6320301A (ja) | 1986-07-11 | 1988-01-28 | Dainichi Color & Chem Mfg Co Ltd | キトサン微小粒体 |
US5042975A (en) | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
AU612591B2 (en) | 1986-08-11 | 1991-07-18 | Innovata Biomed Limited | Pharmaceutical formulations comprising microcapsules |
USRE35862E (en) | 1986-08-18 | 1998-07-28 | Emisphere Technologies, Inc. | Delivery systems for pharmacological agents encapsulated with proteinoids |
NL8720442A (nl) | 1986-08-18 | 1989-04-03 | Clinical Technologies Ass | Afgeefsystemen voor farmacologische agentia. |
ATE76311T1 (de) | 1986-08-19 | 1992-06-15 | Genentech Inc | Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen. |
DE3639836A1 (de) | 1986-11-21 | 1988-06-01 | Sigrid Bechter | Mundstueck fuer ein inhalationsgeraet |
KR890003520Y1 (ko) | 1986-12-20 | 1989-05-27 | 주식회사 서흥캅셀 | 의약용 캅셀 |
US4861627A (en) | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US4981295A (en) | 1987-05-11 | 1991-01-01 | City Of Hope | Respiratory training using feedback |
US6645504B1 (en) | 1987-06-24 | 2003-11-11 | Autoimmune Inc. | Bystander suppression of type I diabetes by oral administration of glucagon |
DE3727894A1 (de) | 1987-08-21 | 1989-03-02 | Stephan Dieter | Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge |
GB8723846D0 (en) | 1987-10-10 | 1987-11-11 | Danbiosyst Ltd | Bioadhesive microsphere drug delivery system |
US4887722A (en) | 1987-12-11 | 1989-12-19 | Greenward Sr Edward H | Method for beneficiating by carbonaceous refuse |
DE3801326A1 (de) | 1988-01-19 | 1989-07-27 | Asea Brown Boveri | Verfahren zur herstellung einer keramiksuspension |
US4981625A (en) | 1988-03-14 | 1991-01-01 | California Institute Of Technology | Monodisperse, polymeric microspheres produced by irradiation of slowly thawing frozen drops |
GB8813338D0 (en) | 1988-06-06 | 1988-07-13 | Osprey Metals Ltd | Powder production |
USD316902S (en) | 1988-09-02 | 1991-05-14 | Hoelfing H Curt | Meter hose inhaler reservoir |
GB8821287D0 (en) | 1988-09-12 | 1988-10-12 | Ici Plc | Device |
EP0360340A1 (en) | 1988-09-19 | 1990-03-28 | Akzo N.V. | Composition for nasal administration containing a peptide |
USD321570S (en) | 1988-09-30 | 1991-11-12 | Blasdell Richard J | Inhaler |
EP0363060B1 (en) | 1988-10-04 | 1994-04-27 | The Johns Hopkins University | Aerosol inhaler |
JPH02104531A (ja) | 1988-10-14 | 1990-04-17 | Toyo Jozo Co Ltd | 経鼻投与用生理活性ペプチド組成物 |
US4984158A (en) | 1988-10-14 | 1991-01-08 | Hillsman Dean | Metered dose inhaler biofeedback training and evaluation system |
JPH02115154A (ja) | 1988-10-25 | 1990-04-27 | Kao Corp | イミド化合物及びその用途 |
USD326517S (en) | 1988-10-27 | 1992-05-26 | Glaxo Group Limited | Inhalator |
JP2692742B2 (ja) | 1988-11-30 | 1997-12-17 | 株式会社ツムラ | 新規なリグナン類 |
US5006343A (en) | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
US5075027A (en) | 1989-02-06 | 1991-12-24 | Colgate Palmolive Co. | Thixotropic aqueous scented automatic dishwasher detergent compositions |
US5514646A (en) | 1989-02-09 | 1996-05-07 | Chance; Ronald E. | Insulin analogs modified at position 29 of the B chain |
IT1228460B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore monouso con capsula pre-forata |
IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
US4983402A (en) | 1989-02-24 | 1991-01-08 | Clinical Technologies Associates, Inc. | Orally administerable ANF |
SE466684B (sv) | 1989-03-07 | 1992-03-23 | Draco Ab | Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator |
US5358734A (en) | 1989-03-30 | 1994-10-25 | Gte Products Corporation | Process for producing a blue emitting lamp phosphor |
US5215739A (en) | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
US5067500A (en) | 1989-04-24 | 1991-11-26 | Philip Morris Incorporated | Container for additive materials for smoking articles |
US4991605A (en) | 1989-04-24 | 1991-02-12 | Philip Morris Incorporated | Container for additive materials for smoking articles |
GB8909891D0 (en) | 1989-04-28 | 1989-06-14 | Riker Laboratories Inc | Device |
JPH05501505A (ja) | 1989-04-28 | 1993-03-25 | ライカー ラボラトリーズ,インコーポレイティド | 乾燥粉末吸入装置 |
WO1990013285A1 (en) | 1989-05-01 | 1990-11-15 | Enzytech, Inc. | Process for producing small particles of biologically active molecules |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
US5017383A (en) | 1989-08-22 | 1991-05-21 | Taisho Pharmaceutical Co., Ltd. | Method of producing fine coated pharmaceutical preparation |
GB8919131D0 (en) | 1989-08-23 | 1989-10-04 | Riker Laboratories Inc | Inhaler |
US5270305A (en) | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
GB8921222D0 (en) | 1989-09-20 | 1989-11-08 | Riker Laboratories Inc | Medicinal aerosol formulations |
DK544589D0 (da) | 1989-11-01 | 1989-11-01 | Novo Nordisk As | Manuel betjent apparat til dispensering af en forudbestemt maengde af et pulverformet stof |
JPH0741428Y2 (ja) | 1989-11-04 | 1995-09-27 | アップリカ葛西株式会社 | ベビーバス |
CA2071867A1 (en) | 1989-11-06 | 1991-05-07 | Edith Mathiowitz | Method for producing protein microspheres |
US5188837A (en) | 1989-11-13 | 1993-02-23 | Nova Pharmaceutical Corporation | Lipsopheres for controlled delivery of substances |
US5105291A (en) | 1989-11-20 | 1992-04-14 | Ricoh Company, Ltd. | Liquid crystal display cell with electrodes of substantially amorphous metal oxide having low resistivity |
AU6774790A (en) | 1989-12-06 | 1991-06-13 | Canon Kabushiki Kaisha | Package for ink jet cartridge |
USD331106S (en) | 1989-12-30 | 1992-11-17 | Ing. Erich Pfeiffer Gmbh & Co. Kg | Single use inhaler |
GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
US5545618A (en) | 1990-01-24 | 1996-08-13 | Buckley; Douglas I. | GLP-1 analogs useful for diabetes treatment |
US5201308A (en) | 1990-02-14 | 1993-04-13 | Newhouse Michael T | Powder inhaler |
YU48707B (sh) | 1990-03-02 | 1999-07-28 | Glaxo Group Limited | Aparat za inhaliranje - inhalator |
US6536427B2 (en) | 1990-03-02 | 2003-03-25 | Glaxo Group Limited | Inhalation device |
SK280967B6 (sk) | 1990-03-02 | 2000-10-09 | Glaxo Group Limited | Inhalačný prístroj |
US5615670A (en) | 1990-03-07 | 1997-04-01 | Fisons Plc | Powder inhaler with centrifugal force used to meter powder |
IT1240750B (it) | 1990-04-12 | 1993-12-17 | Chiesi Farma Spa | Dispositivo per la somministrazione di sostanze medicamentose in polvere |
JPH05963A (ja) | 1990-04-13 | 1993-01-08 | Toray Ind Inc | ポリペプチド類組成物 |
US5328464A (en) | 1990-04-24 | 1994-07-12 | Science Incorporated | Closed drug delivery system |
USD338268S (en) | 1990-05-04 | 1993-08-10 | Omron Corporation | Heating inhaler |
CA2081474A1 (en) | 1990-05-08 | 1991-11-09 | Manzer Durrani | Direct spray-dried drug/lipid powder composition |
IL98441A (en) | 1990-06-14 | 1995-12-31 | Rhone Poulenc Rorer Ltd | Powder inhaler |
DE4021263C2 (de) | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
GB9015522D0 (en) | 1990-07-13 | 1990-08-29 | Braithwaite Philip W | Inhaler |
US5578323A (en) | 1992-06-15 | 1996-11-26 | Emisphere Technologies, Inc. | Proteinoid carriers and methods for preparation and use thereof |
US5693338A (en) | 1994-09-29 | 1997-12-02 | Emisphere Technologies, Inc. | Diketopiperazine-based delivery systems |
US6331318B1 (en) | 1994-09-30 | 2001-12-18 | Emisphere Technologies Inc. | Carbon-substituted diketopiperazine delivery systems |
US5447728A (en) | 1992-06-15 | 1995-09-05 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5714167A (en) | 1992-06-15 | 1998-02-03 | Emisphere Technologies, Inc. | Active agent transport systems |
US5451410A (en) | 1993-04-22 | 1995-09-19 | Emisphere Technologies, Inc. | Modified amino acids for encapsulating active agents |
US5541155A (en) | 1994-04-22 | 1996-07-30 | Emisphere Technologies, Inc. | Acids and acid salts and their use in delivery systems |
US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
US5443841A (en) | 1992-06-15 | 1995-08-22 | Emisphere Technologies, Inc. | Proteinoid microspheres and methods for preparation and use thereof |
JPH04103585A (ja) | 1990-08-24 | 1992-04-06 | Nisshin Flour Milling Co Ltd | ピロリジン環を有する化合物 |
SE9002895D0 (sv) | 1990-09-12 | 1990-09-12 | Astra Ab | Inhalation devices for dispensing powders i |
US5074418A (en) | 1990-09-12 | 1991-12-24 | Pitney Bowes Inc. | Ink replenishing system transport and storage container |
DE69132850T2 (de) | 1990-09-26 | 2002-05-29 | Pharmachemie Bv | Wirbelkammer-Pulverinhalator |
US5170801A (en) | 1990-10-02 | 1992-12-15 | Glaxo Inc. | Medical capsule device actuated by radio-frequency (rf) signal |
FR2667509B1 (fr) | 1990-10-04 | 1995-08-25 | Valois | Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes. |
IL99699A (en) | 1990-10-10 | 2002-04-21 | Autoimmune Inc | Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes |
GB9024760D0 (en) | 1990-11-14 | 1991-01-02 | Riker Laboratories Inc | Inhalation device and medicament carrier |
US5124291A (en) | 1990-11-15 | 1992-06-23 | The Standard Oil Company | Method for deagglomerating and re-exposing catalyst in a fluid bed reactor |
GB9026191D0 (en) | 1990-12-01 | 1991-01-16 | Harris Pharma Ltd | Breath actuated dispensing device |
GB9027234D0 (en) | 1990-12-15 | 1991-02-06 | Harris Pharma Ltd | An inhalation device |
NZ241034A (en) | 1990-12-17 | 1995-03-28 | Minnesota Mining & Mfg | Inhaler device with a dosage control that deactivates an aerosol generator after predetermined time or dosage |
US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
GB2253200A (en) | 1991-02-01 | 1992-09-02 | Harris Pharma Ltd | Inhalation apparatus and fracturable capsule for use therewith |
AU1442592A (en) | 1991-02-20 | 1992-09-15 | Nova Pharmaceutical Corporation | Controlled release microparticulate delivery system for proteins |
US5208998A (en) | 1991-02-25 | 1993-05-11 | Oyler Jr James R | Liquid substances freeze-drying systems and methods |
US5394866A (en) | 1991-03-05 | 1995-03-07 | Aradigm Corporation | Automatic aerosol medication delivery system and methods |
US5404871A (en) | 1991-03-05 | 1995-04-11 | Aradigm | Delivery of aerosol medications for inspiration |
ES2179068T3 (es) | 1991-03-05 | 2003-01-16 | Aradigm Corp | Metodo y dispositivo para corregir el desplazamiento de deriva de un detector de presion de flujo. |
USD338062S (en) | 1991-03-06 | 1993-08-03 | Innovata Biomed Limited | Inhaler |
USD347057S (en) | 1991-03-14 | 1994-05-17 | Technosystem Limited | Inhaler |
US5797391A (en) | 1991-03-28 | 1998-08-25 | Rhone-Poulenc Rorer Limited | Inhaler |
US5413804A (en) | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
US5244653A (en) | 1991-05-01 | 1993-09-14 | Isp Chemicals Inc. | Glycine anhydride dimethylol as a biocide and preservative |
US5492112A (en) | 1991-05-20 | 1996-02-20 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US6060069A (en) | 1991-05-20 | 2000-05-09 | Dura Pharmaceuticals, Inc. | Pulmonary delivery of pharmaceuticals |
US5327883A (en) | 1991-05-20 | 1994-07-12 | Dura Pharmaceuticals, Inc. | Apparatus for aerosolizing powdered medicine and process and using |
US6055980A (en) | 1991-05-20 | 2000-05-02 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
FR2676929B1 (fr) | 1991-05-30 | 1994-02-11 | Aerosols Bouchage Ste Fse | Inhalateur de poudres. |
AU653026B2 (en) | 1991-06-07 | 1994-09-15 | Teikoku Seiyaku Kabushiki Kaisha | Physiologically active polypeptide-containing pharmaceutical composition |
IT1248059B (it) | 1991-06-14 | 1995-01-05 | Miat Spa | Insufflatore multidose per farmaci in polvere |
DE69233690T2 (de) | 1991-07-02 | 2008-01-24 | Nektar Therapeutics, San Carlos | Abgabevorrichtung für nebelförmige Medikamente |
US6681767B1 (en) | 1991-07-02 | 2004-01-27 | Nektar Therapeutics | Method and device for delivering aerosolized medicaments |
US5203768A (en) | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
US5337740A (en) | 1991-08-01 | 1994-08-16 | New England Pharmaceuticals, Inc. | Inhalation devices |
GB9116610D0 (en) | 1991-08-01 | 1991-09-18 | Danbiosyst Uk | Preparation of microparticles |
US5139878A (en) | 1991-08-12 | 1992-08-18 | Allied-Signal Inc. | Multilayer film constructions |
ES2089474T3 (es) | 1991-08-16 | 1996-10-01 | Sandoz Ltd | Inhalador para la administracion de sustancias en polvo. |
US5287850A (en) | 1991-08-20 | 1994-02-22 | Habley Medical Technology Corporation | Timing and velocity controlled powered pharmaceutical inhaler |
US6029661A (en) | 1991-08-26 | 2000-02-29 | 3M Innovative Properties Company | Powder dispenser |
USD337636S (en) | 1991-09-12 | 1993-07-20 | Devilbiss Health Care, Inc. | Ultrasonic medicament nebulizer |
US5167506A (en) | 1991-10-24 | 1992-12-01 | Minnesota Mining And Manufacturing Company | Inhalation device training system |
USD348100S (en) | 1991-10-29 | 1994-06-21 | Fisons Plc | Medicament inhaler |
USD350602S (en) | 1991-11-01 | 1994-09-13 | Rhone-Poulenc Rorer Limited | Combined dry powder inhaler and cap |
US6063910A (en) | 1991-11-14 | 2000-05-16 | The Trustees Of Princeton University | Preparation of protein microparticles by supercritical fluid precipitation |
USD350821S (en) | 1991-11-18 | 1994-09-20 | Smithkline Beecham P.L.C. | Oral inhaler |
SE9103572D0 (sv) | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
USD340975S (en) | 1991-12-02 | 1993-11-02 | Thayer Medical Corporation | Combined expansion chamber metered dose inhaler dispenser and adaptor |
US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
DE4211475A1 (de) | 1991-12-14 | 1993-06-17 | Asta Medica Ag | Pulverinhalator |
JP3121080B2 (ja) | 1991-12-19 | 2000-12-25 | アール・ピー・シーラー コーポレイション | カプセル封入用溶液 |
GB2262452B (en) | 1991-12-19 | 1995-12-20 | Minnesota Mining & Mfg | Inhalation device |
US5363842A (en) | 1991-12-20 | 1994-11-15 | Circadian, Inc. | Intelligent inhaler providing feedback to both patient and medical professional |
US5525519A (en) | 1992-01-07 | 1996-06-11 | Middlesex Sciences, Inc. | Method for isolating biomolecules from a biological sample with linear polymers |
US5320094A (en) | 1992-01-10 | 1994-06-14 | The Johns Hopkins University | Method of administering insulin |
DE69306755T2 (de) | 1992-01-21 | 1997-04-10 | Stanford Res Inst Int | Verbessertes verfahren zur herstellung von mikronisierter polypeptidarzneimitteln |
DE9209050U1 (de) | 1992-02-13 | 1992-10-01 | Schrader, Barthold von, 2400 Travemünde | Inhalationseinrichtung |
US5476093A (en) | 1992-02-14 | 1995-12-19 | Huhtamaki Oy | Device for more effective pulverization of a powdered inhalation medicament |
US5469971A (en) | 1992-02-26 | 1995-11-28 | Estee Lauder Inc. | Method and apparatus for deagglomerating powder |
EP0558879B1 (en) | 1992-03-04 | 1997-05-14 | Astra Aktiebolag | Disposable inhaler |
US5639441A (en) | 1992-03-06 | 1997-06-17 | Board Of Regents Of University Of Colorado | Methods for fine particle formation |
DK36392D0 (da) | 1992-03-19 | 1992-03-19 | Novo Nordisk As | Anvendelse af kemisk forbindelse |
USD348929S (en) | 1992-04-03 | 1994-07-19 | Norton Healthcare Limited | Medicament inhaler |
CA2096302A1 (en) | 1992-05-15 | 1993-11-16 | David Kilis | Air flow controller and recording system |
USD350193S (en) | 1992-06-11 | 1994-08-30 | Schering Corporation | Combined inhaler and cover |
USD345013S (en) | 1992-06-11 | 1994-03-08 | Schering Corporation | Combined inhaler and cover |
USD344796S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
USD344797S (en) | 1992-06-11 | 1994-03-01 | Schering Corporation | Combined inhaler and cover |
US5626871A (en) | 1992-06-12 | 1997-05-06 | Teijin Limited | Preparation for intratracheobronchial administration |
US5811127A (en) | 1992-06-15 | 1998-09-22 | Emisphere Technologies, Inc. | Desferrioxamine oral delivery system |
US5792451A (en) | 1994-03-02 | 1998-08-11 | Emisphere Technologies, Inc. | Oral drug delivery compositions and methods |
US5394868A (en) | 1992-06-25 | 1995-03-07 | Schering Corporation | Inhalation device for powdered medicaments |
GB9213874D0 (en) | 1992-06-30 | 1992-08-12 | Fisons Plc | Process to novel medicament form |
US6582728B1 (en) | 1992-07-08 | 2003-06-24 | Inhale Therapeutic Systems, Inc. | Spray drying of macromolecules to produce inhaleable dry powders |
US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
US6509006B1 (en) | 1992-07-08 | 2003-01-21 | Inhale Therapeutic Systems, Inc. | Devices compositions and methods for the pulmonary delivery of aerosolized medicaments |
GB9214819D0 (en) | 1992-07-13 | 1992-08-26 | Minnesota Mining & Mfg | Valve assemblies |
GB9216038D0 (en) | 1992-07-28 | 1992-09-09 | Bespak Plc | Dispensing apparatus for powdered medicaments |
GB2269992A (en) | 1992-08-14 | 1994-03-02 | Rh Ne Poulenc Rorer Limited | Powder inhalation formulations |
US5239993A (en) | 1992-08-26 | 1993-08-31 | Glaxo Inc. | Dosage inhalator providing optimized compound inhalation trajectory |
GB2270293A (en) | 1992-09-05 | 1994-03-09 | Medix Ltd | Drug dispensing system |
USD348928S (en) | 1992-09-21 | 1994-07-19 | Schering Corporation | Inhaler |
US5333106A (en) | 1992-10-09 | 1994-07-26 | Circadian, Inc. | Apparatus and visual display method for training in the power use of aerosol pharmaceutical inhalers |
WO1994008599A1 (en) | 1992-10-14 | 1994-04-28 | The Regents Of The University Of Colorado | Ion-pairing of drugs for improved efficacy and delivery |
SK279327B6 (sk) | 1992-10-19 | 1998-10-07 | Dura Pharmaceuticals | Zariadenie na vytváranie aerosolu z práškového lie |
AU121578S (en) | 1992-10-22 | 1994-09-20 | Fisons Plc | An inhalation device |
USD359555S (en) | 1992-11-18 | 1995-06-20 | Nippon Glaxo Limited | Nasal medicine inhaler |
USD352107S (en) | 1992-12-10 | 1994-11-01 | Ciba-Geigy Corporation | Inhaler |
USD349572S (en) | 1992-12-10 | 1994-08-09 | Schering Corporation | Aerosol inhaler |
US6250300B1 (en) | 1992-12-11 | 2001-06-26 | Ab Astra | System for dispensing pharmaceutically active compounds |
SE9203743D0 (sv) | 1992-12-11 | 1992-12-11 | Astra Ab | Efficient use |
KR0163472B1 (ko) | 1992-12-18 | 1998-11-16 | 에릭 에스. 딕커 | 분말 약품용 흡입기 |
US5401516A (en) | 1992-12-21 | 1995-03-28 | Emisphere Technologies, Inc. | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof |
US6105571A (en) | 1992-12-22 | 2000-08-22 | Electrosols, Ltd. | Dispensing device |
US6880554B1 (en) | 1992-12-22 | 2005-04-19 | Battelle Memorial Institute | Dispensing device |
US5896855A (en) | 1992-12-24 | 1999-04-27 | Rhone-Poulenc Rorer Limited | Multi dose inhaler apparatus |
FR2700279B1 (fr) | 1993-01-14 | 1995-03-17 | Valois | Dispositif portatif pour projeter des doses d'une substance fluide à l'aide d'un flux d'air comprimé. |
AU119600S (en) | 1993-01-21 | 1994-03-07 | Boehringer Ingelheim Kg | Inhaler device |
US7448375B2 (en) | 1993-01-29 | 2008-11-11 | Aradigm Corporation | Method of treating diabetes mellitus in a patient |
US5672581A (en) | 1993-01-29 | 1997-09-30 | Aradigm Corporation | Method of administration of insulin |
US6024090A (en) | 1993-01-29 | 2000-02-15 | Aradigm Corporation | Method of treating a diabetic patient by aerosolized administration of insulin lispro |
US6131567A (en) | 1993-01-29 | 2000-10-17 | Aradigm Corporation | Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
US5888477A (en) | 1993-01-29 | 1999-03-30 | Aradigm Corporation | Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin |
US5364838A (en) | 1993-01-29 | 1994-11-15 | Miris Medical Corporation | Method of administration of insulin |
US5441060A (en) | 1993-02-08 | 1995-08-15 | Duke University | Dry powder delivery system |
IL108780A (en) | 1993-02-27 | 1999-06-20 | Fisons Plc | inhaler |
WO1994023772A2 (en) | 1993-04-06 | 1994-10-27 | Minnesota Mining And Manufacturing Company | Deagglomerators for dry powder inhalers |
US5372128A (en) | 1993-04-14 | 1994-12-13 | Habley Medical Technology Corporation | Fluidizing powder inhaler |
ZA939608B (en) | 1993-04-22 | 1994-08-24 | Emisphere Tech Inc | Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof. |
JP4361601B2 (ja) | 1993-04-22 | 2009-11-11 | エミスフェアー・テクノロジーズ・インク | 経口薬剤移送組成物およびその方法 |
US5643957A (en) | 1993-04-22 | 1997-07-01 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
US5360614A (en) | 1993-04-26 | 1994-11-01 | The Estee Corporation | Method of controlling the release of carbohydrates by encapsulation and composition therefor |
JPH08509483A (ja) | 1993-04-28 | 1996-10-08 | アクゾ・ノベル・エヌ・ベー | ゴナドトロピンを含有するライオスフィア |
DK0652022T3 (da) | 1993-05-12 | 1999-09-13 | Teijin Ltd | Indretning og fremgangsmåde til afgivelse af flere doser pulverformig medicin |
US5424286A (en) | 1993-05-24 | 1995-06-13 | Eng; John | Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same |
US5533502A (en) | 1993-05-28 | 1996-07-09 | Vortran Medical Technology, Inc. | Powder inhaler with aerosolization occurring within each individual powder receptacle |
USD365876S (en) | 1993-06-16 | 1996-01-02 | Chawla Brindra P S | Medicament inhaler |
US6794357B1 (en) | 1993-06-24 | 2004-09-21 | Astrazeneca Ab | Compositions for inhalation |
IS1796B (is) | 1993-06-24 | 2001-12-31 | Ab Astra | Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband |
US6632456B1 (en) | 1993-06-24 | 2003-10-14 | Astrazeneca Ab | Compositions for inhalation |
US5747445A (en) | 1993-06-24 | 1998-05-05 | Astra Aktiebolag | Therapeutic preparation for inhalation |
TW402506B (en) | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
US5506203C1 (en) | 1993-06-24 | 2001-02-06 | Astra Ab | Systemic administration of a therapeutic preparation |
US5562909A (en) | 1993-07-12 | 1996-10-08 | Massachusetts Institute Of Technology | Phosphazene polyelectrolytes as immunoadjuvants |
GB9314614D0 (en) | 1993-07-14 | 1993-08-25 | Minnesota Mining & Mfg | Dry powder inhalers |
US5371046A (en) | 1993-07-22 | 1994-12-06 | Taiwan Semiconductor Manufacturing Company | Method to solve sog non-uniformity in the VLSI process |
JPH0741428A (ja) | 1993-07-30 | 1995-02-10 | Teijin Ltd | ペプチド、蛋白質性薬物経鼻・経肺製剤 |
US5306453A (en) | 1993-08-18 | 1994-04-26 | Edward Shulman | Apparatus and method of making a non-woven fabric |
SG82544A1 (en) | 1993-08-18 | 2001-08-21 | Fisons Plc | Inhalator with breath flow regulation |
US5524613A (en) | 1993-08-25 | 1996-06-11 | Habley Medical Technology Corporation | Controlled multi-pharmaceutical inhaler |
BE1007551A3 (nl) | 1993-09-24 | 1995-08-01 | Philips Electronics Nv | Werkwijze voor het in een rekenmachine automatisch herstellen van consistentie in een hierarchische objektstruktuur na een interaktie door een gebruiker en rekenmachine voorzien van zo een systeem voor automatische consistentieherstelling. |
US5477285A (en) | 1993-10-06 | 1995-12-19 | Thomson Consumer Electronics, Inc. | CRT developing apparatus |
GB9322014D0 (en) | 1993-10-26 | 1993-12-15 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US5726156A (en) | 1995-03-06 | 1998-03-10 | Trega Biosciences, Inc. | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
KR100241300B1 (ko) | 1993-11-16 | 2000-03-02 | Sheldon A. Schaffer | 활성물질의 조절된 방출성을 갖는 소포 |
EP0655237A1 (de) | 1993-11-27 | 1995-05-31 | Hoechst Aktiengesellschaft | Medizinische Aerosolformulierung |
USD358880S (en) | 1993-12-02 | 1995-05-30 | Tenax Corporation | Dry powder inhalator |
US5705483A (en) | 1993-12-09 | 1998-01-06 | Eli Lilly And Company | Glucagon-like insulinotropic peptides, compositions and methods |
DE4422710C1 (de) | 1994-06-29 | 1995-09-14 | Boehringer Ingelheim Kg | Inhalationsgerät mit einem Elektronikmodul zur Funktionsüberwachung |
CZ286060B6 (cs) | 1993-12-18 | 1999-12-15 | MERCK Patent Gesellschaft mit beschränkter Haftung | Zařízení k rozdělování jednotlivých dávek částicovitého materiálu |
USD357603S (en) | 1993-12-20 | 1995-04-25 | Wolff Stephen H | Base for displaying or holding items |
US5415162A (en) | 1994-01-18 | 1995-05-16 | Glaxo Inc. | Multi-dose dry powder inhalation device |
US5484606A (en) | 1994-01-24 | 1996-01-16 | The Procter & Gamble Company | Process for reducing the precipitation of difficulty soluble pharmaceutical actives |
PT101450B (pt) | 1994-02-02 | 1999-11-30 | Hovione Produtos Farmaceuticos | Novo dispositivo para inalacao |
AU680727B2 (en) | 1994-02-09 | 1997-08-07 | Kinerton Limited | Process for drying a material from solution |
SE9400462D0 (sv) | 1994-02-11 | 1994-02-11 | Astra Ab | Filling device |
US6051256A (en) * | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
KR100419037B1 (ko) | 1994-03-07 | 2004-06-12 | 넥타르 테라퓨틱스 | 폐를통한인슐린의전달방법및그조성물 |
US5505194A (en) | 1994-03-23 | 1996-04-09 | Abbott Laboratories | Aerosol inhalation device having slideably and rotatably connected elliptical cylinder portions |
AU124387S (en) | 1994-03-25 | 1995-08-11 | Astra Ab | Training device for an inhaler |
US5839429A (en) | 1994-03-25 | 1998-11-24 | Astra Aktiebolag | Method and apparatus in connection with an inhaler |
EP0677263B1 (de) | 1994-04-15 | 1997-08-13 | Fissler Gmbh | Gar- und/oder Kochgerät, welches für eine bodenseitige Zuführung von Wärmeenergie durch Wärmeleitung oder durch elektromagnetische Induktion eingerichtet ist |
US6395744B1 (en) | 1994-04-22 | 2002-05-28 | Queen's University At Kingston | Method and compositions for the treatment or amelioration of female sexual dysfunction |
FI942196A (fi) | 1994-05-11 | 1995-11-12 | Orion Yhtymae Oy | Jauheinhalaattori |
CN1073119C (zh) | 1994-05-18 | 2001-10-17 | 吸入治疗系统公司 | 干扰素干粉配方的方法及组合物 |
AU2517095A (en) | 1994-05-19 | 1995-12-18 | R.P. Scherer International Corporation | Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions |
JP3372105B2 (ja) | 1994-05-26 | 2003-01-27 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
US5483954A (en) | 1994-06-10 | 1996-01-16 | Mecikalski; Mark B. | Inhaler and medicated package |
IL110024A (en) | 1994-06-15 | 1998-04-05 | Yissum Res Dev Co | Controlled release oral drug delivery system containing hydrogel- forming polymer |
USD363775S (en) | 1994-06-21 | 1995-10-31 | Rhone-Poulenc Rorer Limited | Multidose dry powder inhaler |
USD362500S (en) | 1994-06-28 | 1995-09-19 | Thayer Medical Corporation | Medication inhaler spacer |
US5641510A (en) | 1994-07-01 | 1997-06-24 | Genentech, Inc. | Method for treating capsules used for drug storage |
US5562231A (en) | 1994-07-29 | 1996-10-08 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
US6039208A (en) | 1994-07-29 | 2000-03-21 | Ortho Pharmaceutical Corporation | Variable day start tablet dispenser |
US5623724A (en) | 1994-08-09 | 1997-04-22 | Northrop Grumman Corporation | High power capacitor |
GB9416884D0 (en) | 1994-08-20 | 1994-10-12 | Danbiosyst Uk | Drug delivery compositions |
USD359153S (en) | 1994-08-25 | 1995-06-13 | Viggiano Bernard J | Muffin top |
US5574008A (en) | 1994-08-30 | 1996-11-12 | Eli Lilly And Company | Biologically active fragments of glucagon-like insulinotropic peptide |
US5547929A (en) | 1994-09-12 | 1996-08-20 | Eli Lilly And Company | Insulin analog formulations |
CN1131080C (zh) | 1994-09-21 | 2003-12-17 | 吸入治疗系统 | 用于喷洒干的粉末药物的方法和装置 |
FR2725626A1 (fr) | 1994-10-18 | 1996-04-19 | Sofab | Dispositif pour l'inhalation de produits en poudre |
WO1996013250A1 (en) | 1994-10-27 | 1996-05-09 | Amgem Inc. | Compositions for increased bioavailability of orally delivered therapeutic agents |
SE9404140D0 (sv) | 1994-11-29 | 1994-11-29 | Astra Ab | Dose indicating device |
AU691361B2 (en) | 1994-12-01 | 1998-05-14 | Toyama Chemical Co. Ltd. | Novel 2,3-diketopiperazine derivative or salt thereof |
SE9404439D0 (sv) | 1994-12-21 | 1994-12-21 | Astra Ab | Inhalation device |
SA95160463B1 (ar) | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | مساحيق للاستنشاق |
US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
BR9606838A (pt) | 1995-01-23 | 1999-11-30 | Direct Haler A S | Inalador |
USD368364S (en) | 1995-02-02 | 1996-04-02 | Reitano Joseph R | Inhaler case |
US5901703A (en) | 1995-02-06 | 1999-05-11 | Unisia Jecs Corporation | Medicine administering device for nasal cavities |
US5660835A (en) | 1995-02-24 | 1997-08-26 | East Carolina University | Method of treating adenosine depletion |
CA2213442A1 (en) | 1995-03-10 | 1996-09-19 | The Minnesota Mining & Manufacturing Company | Aerosol valves |
US5653961A (en) | 1995-03-31 | 1997-08-05 | Minnesota Mining And Manufacturing Company | Butixocort aerosol formulations in hydrofluorocarbon propellant |
US5542539A (en) | 1995-04-04 | 1996-08-06 | Ethicon Endo-Surgery, Inc. | Container for quick release packages for surgical instruments |
USD377215S (en) | 1995-04-13 | 1997-01-07 | Glaxo Group Limited | Inhaler |
US6309671B1 (en) | 1995-04-14 | 2001-10-30 | Inhale Therapeutic Systems | Stable glassy state powder formulations |
US5990077A (en) | 1995-04-14 | 1999-11-23 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
US5645051A (en) | 1995-04-21 | 1997-07-08 | Dura Pharmaceuticals, Inc. | Unit dose dry powder inhaler |
US5921237A (en) | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5622166A (en) | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
US6428771B1 (en) * | 1995-05-15 | 2002-08-06 | Pharmaceutical Discovery Corporation | Method for drug delivery to the pulmonary system |
US5922253A (en) | 1995-05-18 | 1999-07-13 | Alkermes Controlled Therapeutics, Inc. | Production scale method of forming microparticles |
US5809997A (en) | 1995-05-18 | 1998-09-22 | Medtrac Technologies, Inc. | Electronic medication chronolog device |
US5924419A (en) | 1995-05-22 | 1999-07-20 | Kotliar; Igor K. | Apparatus for passive hypoxic training and therapy |
DE19519840A1 (de) | 1995-05-31 | 1996-12-05 | Kaewert Klaus | Gelantinekapsel |
AU128811S (en) | 1995-06-06 | 1996-12-03 | Orion Yhtymae Oy | A protective cover for example a moisture protective cover for a powder inhaler |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
US5610271A (en) | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
US5919897A (en) | 1995-06-07 | 1999-07-06 | Torrey Pines Institute For Molecular Studies | MU opioid receptor ligands: agonists and antagonists |
US6193844B1 (en) | 1995-06-07 | 2001-02-27 | Mclaughlin John R. | Method for making paper using microparticles |
US5641861A (en) | 1995-06-07 | 1997-06-24 | Torrey Pines Institute For Molecular Studies | μopioid receptor ligands: agonists and antagonists |
US5824345A (en) | 1995-06-07 | 1998-10-20 | Emisphere Technologies, Inc. | Fragrances and flavorants |
US6672304B1 (en) | 1995-06-08 | 2004-01-06 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIs) |
US6357442B1 (en) | 1995-06-08 | 2002-03-19 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIS) |
CZ294782B6 (cs) | 1995-06-21 | 2005-03-16 | Sofotec Gmbh & Co. Kg | Inhalátor pro prášková léčiva |
GB9513218D0 (en) | 1995-06-29 | 1995-09-06 | Fisons Plc | Inhalation device and method |
DE19523516C1 (de) | 1995-06-30 | 1996-10-31 | Asta Medica Ag | Inhalator zum Verabreichen von Medikamenten aus Blisterpackungen |
AU131838S (en) | 1995-07-01 | 1997-10-21 | Glaxo Group Ltd | Inhalation device |
JP3098401B2 (ja) | 1995-07-12 | 2000-10-16 | 株式会社エルティーティー研究所 | 経鼻投与用製剤 |
US5758638A (en) | 1995-07-24 | 1998-06-02 | Kreamer; Jeffry W. | Indicator for a medicament inhaler |
US5642727A (en) | 1995-07-25 | 1997-07-01 | David Sarnoff Research Center, Inc. | Inhaler apparatus using a tribo-electric charging technique |
WO1997004747A1 (en) | 1995-07-27 | 1997-02-13 | Dunn James M | Drug delivery systems for macromolecular drugs |
US6209538B1 (en) | 1995-08-02 | 2001-04-03 | Robert A. Casper | Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament |
SE9502799D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Device in inhalers |
SE9502800D0 (sv) | 1995-08-10 | 1995-08-10 | Astra Ab | Disposable inhaler |
JP3317823B2 (ja) | 1995-08-11 | 2002-08-26 | 株式会社ユニシアジェックス | 投薬器 |
US5690910A (en) | 1995-08-18 | 1997-11-25 | Baker Norton Pharmaceuticals, Inc. | Method for treating asthma |
US5746197A (en) | 1995-08-18 | 1998-05-05 | Williams; Jeffery W. | Extension for metered dose inhaler |
US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
US6852690B1 (en) | 1995-08-22 | 2005-02-08 | Amylin Pharmaceuticals, Inc. | Method and composition for enhanced parenteral nutrition |
FR2738153B1 (fr) | 1995-09-04 | 1998-01-02 | Valois | Appareil d'inhalation destine a distribuer des doses precises et reproductibles de produit pulverulent |
US5617844A (en) | 1995-09-21 | 1997-04-08 | King; Russell W. | Aerosol medication delivery system |
KR0124764Y1 (ko) | 1995-09-23 | 1998-09-15 | 양주환 | 의약 및 식품용 하드 공 캅셀 |
SE9503344D0 (sv) | 1995-09-27 | 1995-09-27 | Astra Ab | Inhalation device |
US5766620A (en) | 1995-10-23 | 1998-06-16 | Theratech, Inc. | Buccal delivery of glucagon-like insulinotropic peptides |
US5849322A (en) | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
US5807315A (en) | 1995-11-13 | 1998-09-15 | Minimed, Inc. | Methods and devices for the delivery of monomeric proteins |
DE19545257A1 (de) | 1995-11-24 | 1997-06-19 | Schering Ag | Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln |
NZ322422A (en) | 1995-12-07 | 2000-02-28 | Jago Pharma Ag | Inhalator designed to provide multiple doses of a dry pharmacological powder |
US7131441B1 (en) | 1995-12-07 | 2006-11-07 | Skyepharma Ag | Inhaler for multiple dosed administration of a pharmacological dry powder |
TR199801265T2 (xx) | 1996-01-03 | 1998-10-21 | Glaxo Group Limited | ��e soluma cihaz�. |
US6026809A (en) | 1996-01-25 | 2000-02-22 | Microdose Technologies, Inc. | Inhalation device |
US6470884B2 (en) | 1996-01-29 | 2002-10-29 | Aventis Pharma Limited | Capsule opening arrangement for use in a powder inhaler |
JPH09208485A (ja) | 1996-01-31 | 1997-08-12 | Teijin Ltd | ペプチド・蛋白質性薬物の水難溶性組成物 |
EP0880562B1 (en) | 1996-02-06 | 2000-12-06 | E.I. Du Pont De Nemours And Company | Treatment of deagglomerated particles with plasma-activated species |
USD381416S (en) | 1996-02-08 | 1997-07-22 | Astra Aktiebolag | Unit dose inhaler |
AU714886B2 (en) | 1996-02-21 | 2000-01-13 | Merck Sharp & Dohme Corp. | Powdered medication inhaler |
USD377861S (en) | 1996-02-21 | 1997-02-11 | Medport, Inc. | Inhaler carrying case |
WO1997031626A1 (fr) | 1996-02-27 | 1997-09-04 | Teijin Limited | Composition pulverulente destinee a une adminstration nasale |
US6509313B1 (en) | 1996-02-28 | 2003-01-21 | Cornell Research Foundation, Inc. | Stimulation of immune response with low doses of cytokines |
US5699789A (en) | 1996-03-11 | 1997-12-23 | Hendricks; Mark R. | Dry powder inhaler |
US6060452A (en) * | 1996-03-13 | 2000-05-09 | Cytran, Inc. | Analogs of L-Glu-L-Trp having pharmacological activity |
JP3328132B2 (ja) | 1996-03-21 | 2002-09-24 | 株式会社ユニシアジェックス | 吸入式投薬器 |
GB9606188D0 (en) | 1996-03-23 | 1996-05-29 | Danbiosyst Uk | Pollysaccharide microspheres for the pulmonary delivery of drugs |
USD395499S (en) | 1996-04-08 | 1998-06-23 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5875776A (en) | 1996-04-09 | 1999-03-02 | Vivorx Pharmaceuticals, Inc. | Dry powder inhaler |
US5858099A (en) | 1996-04-09 | 1999-01-12 | Sarnoff Corporation | Electrostatic chucks and a particle deposition apparatus therefor |
IL126701A (en) | 1996-04-29 | 2001-08-08 | Dura Pharma Inc | Inhaler system for inhalation of a dry powder drug |
US5817343A (en) | 1996-05-14 | 1998-10-06 | Alkermes, Inc. | Method for fabricating polymer-based controlled-release devices |
AU132977S (en) | 1996-05-17 | 1998-02-17 | Astrazeneca Ab | Container for inhaling apparatus |
USRE37053E1 (en) | 1996-05-24 | 2001-02-13 | Massachusetts Institute Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
US6503480B1 (en) | 1997-05-23 | 2003-01-07 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US5985309A (en) | 1996-05-24 | 1999-11-16 | Massachusetts Institute Of Technology | Preparation of particles for inhalation |
US5874064A (en) * | 1996-05-24 | 1999-02-23 | Massachusetts Institute Of Technology | Aerodynamically light particles for pulmonary drug delivery |
US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
JPH1053765A (ja) | 1996-06-04 | 1998-02-24 | Denso Corp | スメクチック液晶組成物及び液晶セル |
EP0959896B1 (en) | 1996-06-05 | 2011-05-25 | RAPOPORT, Basil | Method of producing secreted truncated variants of human thyrotropin receptor |
US5871010A (en) | 1996-06-10 | 1999-02-16 | Sarnoff Corporation | Inhaler apparatus with modified surfaces for enhanced release of dry powders |
AUPO066096A0 (en) | 1996-06-26 | 1996-07-18 | Peptide Delivery Systems Pty Ltd | Oral delivery of peptides |
US5769276A (en) | 1996-07-10 | 1998-06-23 | Terronics Development Corporation | Powder atomizer |
US5783556A (en) | 1996-08-13 | 1998-07-21 | Genentech, Inc. | Formulated insulin-containing composition |
AU133903S (en) | 1996-08-19 | 1998-05-29 | Orion Yhtymae Oy | Inhaler device |
US6277819B1 (en) | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
JP3890099B2 (ja) | 1996-09-30 | 2007-03-07 | キヤノン株式会社 | パターン認識装置及びその方法、及びそのプログラムを記憶した記憶媒体 |
JP3020141B2 (ja) | 1996-10-07 | 2000-03-15 | 株式会社富士薬品 | 経鼻投与用製剤 |
US6532437B1 (en) | 1996-10-23 | 2003-03-11 | Cornell Research Foundation, Inc. | Crystalline frap complex |
UA65549C2 (uk) | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
US6441172B1 (en) | 1996-11-07 | 2002-08-27 | Torrey Pines Institute For Molecular Studies | Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
EP1529534B1 (en) | 1996-11-12 | 2007-07-11 | Novo Nordisk A/S | Use of GLP-1 peptides |
DE19647947A1 (de) | 1996-11-20 | 1998-05-28 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
US5868774A (en) | 1996-11-21 | 1999-02-09 | Reil; Vladimir | Unique cartridge and earring stud gun system |
US6159360A (en) | 1996-11-22 | 2000-12-12 | Heinkel Industriezentrifugen Gmbh & Co. | Invertible filter centrifuge including a solids drier |
WO1998025704A1 (en) | 1996-12-11 | 1998-06-18 | Earth Sciences Limited | Methods and apparatus for use in processing and treating particulate material |
USD390651S (en) | 1996-12-12 | 1998-02-10 | Inhale Therapeutics Systems | Medicament inhaler housing |
GB9626263D0 (en) | 1996-12-18 | 1997-02-05 | Innovata Biomed Ltd | Powder inhaler |
GB9626233D0 (en) | 1996-12-18 | 1997-02-05 | Chawla Brinda P S | Medicament packaging and deliveery device |
GB2320489A (en) | 1996-12-20 | 1998-06-24 | Norton Healthcare Ltd | Inhaler dose counter |
US5976574A (en) | 1996-12-31 | 1999-11-02 | Inhale Therapeutic Systems | Processes for spray drying hydrophobic drugs in organic solvent suspensions |
USD397435S (en) | 1997-01-03 | 1998-08-25 | GGU Gesellschaft fuer Gesundheits-und Umweltforschung mbH | Combined inhaler and cover |
US5794613A (en) | 1997-01-09 | 1998-08-18 | Sepracor, Inc. | Multiple-dose dispenser for dry powder inhalers |
USD389238S (en) | 1997-01-24 | 1998-01-13 | Healthscan Products, Inc. | Inhaler mask |
PT898978E (pt) | 1997-01-30 | 2005-07-29 | Dott Ltd Co | Aplicador de medicamentos por inalacao |
US6884435B1 (en) | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
SE9700422D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler II |
SE9700423D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Disposable inhaler |
SE9700424D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Powder inhaler |
SE9700421D0 (sv) | 1997-02-07 | 1997-02-07 | Astra Ab | Single dose inhaler I |
JP3011898B2 (ja) | 1997-02-20 | 2000-02-21 | フォルテ グロウ メディカル株式会社 | 吸引器 |
DE19708406A1 (de) | 1997-03-03 | 1998-09-10 | Alfred Von Schuckmann | Gerät zur dosierten Ausgabe von Substanzen |
USD390653S (en) | 1997-03-04 | 1998-02-10 | Blasdell Richard J | Inhaler |
SE9700938D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler II and a method of construction thereof |
SE9700940D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler IV |
SE9700935D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
SE9700943D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler V |
SE9700936D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Inhalation device |
SE9700948D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler X |
TW469832U (en) | 1997-03-14 | 2001-12-21 | Astra Ab | Inhalation device |
SE9700937D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | Powder inhaler I |
US6043214A (en) | 1997-03-20 | 2000-03-28 | Novo Nordisk A/S | Method for producing powder formulation comprising an insulin |
US6006747A (en) | 1997-03-20 | 1999-12-28 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US8391104B2 (en) | 1997-03-28 | 2013-03-05 | Carlos De La Huerga | Interactive medication container labeling |
US5904139A (en) | 1997-03-28 | 1999-05-18 | Hauser; Stephen G. | Breath coordinated inhaler |
US5981488A (en) | 1997-03-31 | 1999-11-09 | Eli Lillly And Company | Glucagon-like peptide-1 analogs |
ES2296331T3 (es) | 1997-04-01 | 2008-04-16 | Cima Labs Inc. | Envase de tipo blister y comprimido envasado. |
WO1998043615A1 (en) | 1997-04-02 | 1998-10-08 | Purdue Research Foundation | Method for oral delivery of proteins |
PT101988B (pt) | 1997-04-04 | 2004-02-27 | Hovione Farmaciencia Sa | Sistema de orientacao e posicionamento de um objecto |
USD410541S (en) | 1997-06-30 | 1999-06-01 | Novartis Ag | Inhaler |
SE9702796D0 (sv) | 1997-07-25 | 1997-07-25 | Pharmacia & Upjohn Ab | A device at a pharmaceutical container or inhaler |
CA2212430A1 (en) | 1997-08-07 | 1999-02-07 | George Volgyesi | Inhalation device |
GB2327895B (en) | 1997-08-08 | 2001-08-08 | Electrosols Ltd | A dispensing device |
US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
US5846447A (en) | 1997-08-26 | 1998-12-08 | E. I. Du Pont De Nemours And Company | Process for forming a dispersion of polytetrafluoroethylene |
USD416621S (en) | 1997-09-05 | 1999-11-16 | Pharmacia & Upjohn | Two piece inhaler |
USD417271S (en) | 1997-09-10 | 1999-11-30 | Medic-Aid Limited | Drug delivery device |
JP2001516765A (ja) | 1997-09-12 | 2001-10-02 | ヴォルフ ゲオルグ フォースマン | 真性糖尿病及び肥満の治療のための組成物 |
US5848589A (en) | 1997-09-18 | 1998-12-15 | Welnetz; Robert J. | Altitude mask simulator |
AU135340S (en) | 1997-09-24 | 1998-10-12 | Innovata Biomed Ltd | An inhaler |
US6394085B1 (en) | 1997-09-25 | 2002-05-28 | Norton Healthcare Ltd. | Inhaler spacer |
US6073629A (en) | 1997-09-25 | 2000-06-13 | Norton Healthcare Ltd. | Inhaler spacer |
USD463544S1 (en) | 1997-09-26 | 2002-09-24 | 1263152 Ontario Inc. | Aerosol medication delivery inhaler |
US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
AU4894697A (en) | 1997-10-01 | 1999-04-23 | Flemington Pharmaceutical Corporation | Buccal, polar and non-polar spray or capsule |
US6228394B1 (en) | 1997-10-14 | 2001-05-08 | Boehringer Ingelheim Pharmaceuticals, Inc. | Supercritical fluid extraction of mould lubricant from hard shell capsules |
NZ504021A (en) | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
USD398992S (en) | 1997-10-21 | 1998-09-29 | Schering-Plough Healthcare Products, Inc. | Nasal inhaler |
ZA989744B (en) | 1997-10-31 | 2000-04-26 | Lilly Co Eli | Method for administering acylated insulin. |
IN188720B (zh) | 1997-11-06 | 2002-11-02 | Panacea Biotec Ltd | |
AU135120S (en) | 1997-11-14 | 1998-09-21 | Astrazeneca Ab | Inhaler |
SE9704184D0 (sv) | 1997-11-14 | 1997-11-14 | Astra Ab | Inhalation device |
US6116238A (en) | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
USD412978S (en) | 1997-12-02 | 1999-08-17 | Dura Pharmaceuticals, Inc. | Inhaler |
USD418600S (en) | 1997-12-04 | 2000-01-04 | Charmaine Haerle | Inhaler clip |
AU1617399A (en) | 1997-12-05 | 1999-06-28 | Eli Lilly And Company | Glp-1 formulations |
US6192876B1 (en) | 1997-12-12 | 2001-02-27 | Astra Aktiebolag | Inhalation apparatus and method |
US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
US5965701A (en) | 1997-12-23 | 1999-10-12 | Ferring Bv | Kappa receptor opioid peptides |
US6077940A (en) | 1997-12-24 | 2000-06-20 | Genentech, Inc. | Free solution ligand interaction molecular separation method |
US6358058B1 (en) | 1998-01-30 | 2002-03-19 | 1263152 Ontario Inc. | Aerosol dispensing inhaler training device |
JP3530004B2 (ja) | 1998-02-06 | 2004-05-24 | 株式会社日立ユニシアオートモティブ | 吸入式投薬器 |
US6158431A (en) | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
USD421800S (en) | 1998-02-19 | 2000-03-21 | Pierre Fabre Medicament | Powder and compressed-air inhaler |
USD412979S (en) | 1998-02-27 | 1999-08-17 | Diemolding Corporation | Metered dose inhaler spacer |
US7143764B1 (en) | 1998-03-13 | 2006-12-05 | Astrazeneca Ab | Inhalation device |
IL138153A0 (en) | 1998-03-16 | 2001-10-31 | Inhale Therapeutic Syst | Methods and devices for delivering aerosolized active agents |
US6998387B1 (en) | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
SE9801078D0 (sv) | 1998-03-27 | 1998-03-27 | Shl Medical Ab | Inhalator |
AU138849S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
AU138847S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
AU138848S (en) | 1998-03-30 | 1999-11-22 | Astra Ab | Inhaler with cap |
EP1067839A1 (en) | 1998-04-08 | 2001-01-17 | Eli Lilly And Company | Pulmonary and nasal delivery of raloxifene |
PL343342A1 (en) | 1998-04-09 | 2001-08-13 | Axiva Gmbh | Particulate active agent support for pulmonary application |
FR2777283B1 (fr) | 1998-04-10 | 2000-11-24 | Adir | Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6578571B1 (en) | 1998-04-20 | 2003-06-17 | Infamed Ltd. | Drug delivery device and methods therefor |
GB9810126D0 (zh) | 1998-05-13 | 1998-07-08 | Glaxo Group Ltd | |
US6257233B1 (en) | 1998-06-04 | 2001-07-10 | Inhale Therapeutic Systems | Dry powder dispersing apparatus and methods for their use |
SE9802080D0 (sv) | 1998-06-11 | 1998-06-11 | Hellstroem | Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
NZ527473A (en) | 1998-06-12 | 2005-02-25 | Amylin Pharmaceuticals Inc | Glucagon-like peptide-1 improves beta-cell response to glucose in subjects with impaired glucose tolerance |
US6152130A (en) | 1998-06-12 | 2000-11-28 | Microdose Technologies, Inc. | Inhalation device with acoustic control |
USD412572S (en) | 1998-06-19 | 1999-08-03 | Gray Gene W | Nasal inhaler adaptor for left and right nostril |
HU224243B1 (hu) | 1998-06-22 | 2005-06-28 | Astrazeneca Ab, | Készülék port tartalmazó, buborékcsomagolást képező fedőfóliával lezárt mélyedések ürítéséhez, szívás alkalmazásával |
DE69939019D1 (de) | 1998-07-07 | 2008-08-14 | Transdermal Technologies Inc | Zusammensetzungen für die schnelle und nicht-irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung |
DE19831525A1 (de) | 1998-07-14 | 2000-01-20 | Pfeiffer Erich Gmbh & Co Kg | Spender für Medien |
US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
US6087334A (en) | 1998-08-21 | 2000-07-11 | Amylin Pharmaceuticals, Inc. | Anti-diabetic peptides |
ES2263282T3 (es) | 1998-08-26 | 2006-12-01 | Teijin Limited | Composiciones en polvo para administracion nasal. |
US6720407B1 (en) | 1998-08-28 | 2004-04-13 | Eli Lilly And Company | Method for administering insulinotropic peptides |
AU764371B2 (en) | 1998-08-28 | 2003-08-14 | Eli Lilly And Company | Method for administering insulinotropic peptides |
US20020088458A1 (en) | 1998-09-24 | 2002-07-11 | Astrazeneca Ab | Inhaler |
JP2002526210A (ja) | 1998-09-24 | 2002-08-20 | アストラゼネカ・アクチエボラーグ | 吸入器 |
GB9820937D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
GB9820886D0 (en) | 1998-09-26 | 1998-11-18 | Glaxo Group Ltd | Inhalation device |
US6187291B1 (en) | 1998-09-28 | 2001-02-13 | Robert Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
USD411005S (en) | 1998-09-29 | 1999-06-15 | Pharmadesign Inc. | Arthritic aid for metered dose inhaler |
UA73924C2 (en) | 1998-10-09 | 2005-10-17 | Nektar Therapeutics | Device for delivering active agent formulation to lungs of human patient |
US6279511B1 (en) | 1998-10-23 | 2001-08-28 | Instech Laboratories, Inc. | Powered multichannel infusion and monitoring system |
US6263871B1 (en) | 1998-10-29 | 2001-07-24 | Richard I. Brown | Mouthpiece with coupler |
US6235725B1 (en) | 1998-10-30 | 2001-05-22 | Baker Norton Pharmaceuticals, Inc. | Methods and compositions for the prevention of tolerance to medications |
JP3747134B2 (ja) | 1998-11-04 | 2006-02-22 | キヤノン株式会社 | インクジェット記録ヘッドカートリッジの保管容器 |
US6261594B1 (en) | 1998-11-25 | 2001-07-17 | The University Of Akron | Chitosan-based nitric oxide donor compositions |
US6540672B1 (en) | 1998-12-09 | 2003-04-01 | Novo Nordisk A/S | Medical system and a method of controlling the system for use by a patient for medical self treatment |
GB9827145D0 (en) | 1998-12-09 | 1999-02-03 | Co Ordinated Drug Dev | Improvements in or relating to powders |
US6375975B1 (en) | 1998-12-21 | 2002-04-23 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary application |
US6552024B1 (en) | 1999-01-21 | 2003-04-22 | Lavipharm Laboratories Inc. | Compositions and methods for mucosal delivery |
SE9900215D0 (sv) | 1999-01-26 | 1999-01-26 | Pharmacia & Upjohn Ab | New use |
JP2000217917A (ja) | 1999-01-27 | 2000-08-08 | Unisia Jecs Corp | 吸入式投薬器 |
US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
CZ298489B6 (cs) | 1999-03-05 | 2007-10-17 | Chiesi Farmaceutici S. P. A. | Prášek pro použití v inhalátoru |
IT1309592B1 (it) | 1999-03-05 | 2002-01-24 | Chiesi Farma Spa | Particelle veicolo modificate da utilizzarsi nella preparazione diformulazioni farmaceutiche sotto forma di polimeri per inalazione e |
US6632258B1 (en) | 1999-03-16 | 2003-10-14 | The United States Of America As Represented By The United States Department Of Energy | Coal beneficiation by gas agglomeration |
US6803044B1 (en) | 1999-03-24 | 2004-10-12 | Zengen, Inc. | Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus |
US6630169B1 (en) | 1999-03-31 | 2003-10-07 | Nektar Therapeutics | Particulate delivery systems and methods of use |
US6440463B1 (en) | 1999-04-05 | 2002-08-27 | Pharmaceutical Discovery Corporation | Methods for fine powder formation |
USD441859S1 (en) | 1999-04-06 | 2001-05-08 | Istituto Biochimico Pavese Pharma S.P.A. | Disposable dry-powder inhaler |
US6615987B1 (en) | 1999-05-07 | 2003-09-09 | Imerys Pigments, Inc. | Method of treating an aqueous suspension of kaolin |
US6417920B1 (en) | 1999-05-11 | 2002-07-09 | Shimadzu Corporation | Particle size analyzer based on laser diffraction method |
US6514500B1 (en) | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
GB9911388D0 (en) | 1999-05-18 | 1999-07-14 | Glaxo Group Ltd | Dispenser |
MXPA01011660A (es) | 1999-05-20 | 2004-04-05 | Pharmasol Gmbh | Adyuvante optimizado en estabilidad y biocompatibilidad (sba) para aumentar la respuesta inmune humoral y celular. |
US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
US7919119B2 (en) | 1999-05-27 | 2011-04-05 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
ES2207123T3 (es) | 1999-06-14 | 2004-05-16 | Baxter International Inc. | Microesferas de liberacion sostenida. |
US6644315B2 (en) | 1999-06-18 | 2003-11-11 | Saeed Ziaee | Nasal mask |
SE516826C2 (sv) | 1999-06-18 | 2002-03-05 | Shl Medical Ab | Anordning i en inhalator med organ för aktivering och avaktivering av en kanister som svar på ett luftflöde |
US7169889B1 (en) | 1999-06-19 | 2007-01-30 | Biocon Limited | Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin |
DE60036367T2 (de) | 1999-06-21 | 2008-05-29 | Eli Lilly And Co., Indianapolis | Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin-abhängigen diabetes |
US6858199B1 (en) | 2000-06-09 | 2005-02-22 | Advanced Inhalation Research, Inc. | High efficient delivery of a large therapeutic mass aerosol |
GB2353222B (en) | 1999-06-23 | 2001-09-19 | Cambridge Consultants | Inhalers |
USD444226S1 (en) | 1999-06-24 | 2001-06-26 | Novo Nordisk A/S | Inhaler |
DK2280020T3 (en) | 1999-06-29 | 2016-05-02 | Mannkind Corp | Pharmaceutical formulations comprising a peptide complexed with a diketopiperazine |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
US6606992B1 (en) | 1999-06-30 | 2003-08-19 | Nektar Therapeutics | Systems and methods for aerosolizing pharmaceutical formulations |
ITMI991582A1 (it) | 1999-07-16 | 2001-01-16 | Chiesi Farma Spa | Polveri costituite da particelle aventi la superficie perfettamente levigata da utilizzare come veicoli per la preparazione di miscele inala |
JP2003520777A (ja) | 1999-07-22 | 2003-07-08 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 防腐医薬製剤 |
US7305986B1 (en) | 1999-07-23 | 2007-12-11 | Mannkind Corporation | Unit dose capsules for use in a dry powder inhaler |
US7464706B2 (en) | 1999-07-23 | 2008-12-16 | Mannkind Corporation | Unit dose cartridge and dry powder inhaler |
DE60030862T2 (de) | 1999-07-23 | 2007-09-06 | Mannkind Corp., Valencia | Trockenpulverinhalator |
US20010036481A1 (en) | 1999-08-25 | 2001-11-01 | Advanced Inhalation Research, Inc. | Modulation of release from dry powder formulations |
CN1175961C (zh) | 1999-09-17 | 2004-11-17 | 株式会社新王磁材 | 稀土合金的切割方法和切割装置 |
USD438612S1 (en) | 1999-09-27 | 2001-03-06 | G-Intek Co., Ltd. | Snivel inhaler |
CN1157236C (zh) | 1999-10-06 | 2004-07-14 | 劳尔·戈尔德曼 | 呼吸控制的干粉吸入装置和干粉均匀分布在空气中的方法 |
WO2001032144A1 (en) | 1999-10-29 | 2001-05-10 | Inhale Therapeutic Systems, Inc. | Dry powder compositions having improved dispersivity |
SE9903990D0 (sv) | 1999-11-02 | 1999-11-02 | Shl Medical Ab | Inhalator with aerosolizing unit |
GB9928311D0 (en) | 1999-11-30 | 2000-01-26 | Novartis Ag | Organic compounds |
IT1308581B1 (it) | 1999-12-03 | 2002-01-08 | Medel Italiana Srl | Apparato per nebulizzare un liquido, in particolare per uso medico. |
SE9904706D0 (sv) | 1999-12-21 | 1999-12-21 | Astra Ab | An inhalation device |
CO5270018A1 (es) | 1999-12-11 | 2003-04-30 | Glaxo Group Ltd | Distribuidor de medicamento |
US7204250B1 (en) | 1999-12-16 | 2007-04-17 | Compumedics Limited | Bio-mask |
US7022674B2 (en) | 1999-12-16 | 2006-04-04 | Eli Lilly And Company | Polypeptide compositions with improved stability |
DE19961300A1 (de) | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
US6669960B2 (en) | 1999-12-21 | 2003-12-30 | Rxkinetix, Inc. | Particulate drug-containing products and method of manufacture |
US7080642B2 (en) | 1999-12-22 | 2006-07-25 | 3M Innovative Properties Company | Refillable device with counting means |
PL356641A1 (en) | 1999-12-30 | 2004-06-28 | Chiron Corporation | Methods for pulmonary delivery of interleukin-2 |
US6894026B1 (en) | 2000-01-11 | 2005-05-17 | Atossa Healthcare, Inc. | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders |
AU2353701A (en) | 2000-01-11 | 2001-07-24 | Novo Nordisk A/S | Transepithelial delivery of glp-1 derivatives |
AU2001231018A1 (en) | 2000-01-19 | 2001-07-31 | Pharmaceutical Discovery Corporation | Multi-spike release formulation for drug delivery |
US7833549B2 (en) | 2000-01-19 | 2010-11-16 | Mannkind Corporation | Dry powder formulations of antihistamine for nasal administration |
US6540982B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
US6443307B1 (en) | 2000-01-25 | 2002-09-03 | Michael D. Burridge | Medication dispenser with an internal ejector |
US6540983B1 (en) | 2000-01-25 | 2003-04-01 | Aeropharm Technology Incorporated | Medical aerosol formulation |
HUP0204281A3 (en) | 2000-01-27 | 2007-03-28 | Lilly Co Eli | Process for sulubilizing glucagon-like peptide 1 (glp-1) compounds |
US6427688B1 (en) | 2000-02-01 | 2002-08-06 | Dura Pharmaceuticals, Icn. | Dry powder inhaler |
US7171965B2 (en) | 2000-02-01 | 2007-02-06 | Valois S.A.S. | Breath actuated dry powder inhaler and tape dose strip |
USD439325S1 (en) | 2000-02-08 | 2001-03-20 | Baker Norton Pharmaceuticals, Inc. | Cover for a nasal inhaler |
EP1129705A1 (en) | 2000-02-17 | 2001-09-05 | Rijksuniversiteit te Groningen | Powder formulation for inhalation |
GB0004456D0 (en) | 2000-02-26 | 2000-04-19 | Glaxo Group Ltd | Medicament dispenser |
HUP0300491A2 (en) | 2000-02-28 | 2003-07-28 | Vectura Ltd | Improvements in or relating to the delivery of oral drugs |
USD439656S1 (en) | 2000-03-06 | 2001-03-27 | Astrazeneca Uk Limited | Inhaler |
US6443151B1 (en) | 2000-03-08 | 2002-09-03 | Aradigm Corporation | Fluid velocity-sensitive trigger mechanism |
BR0109127A (pt) | 2000-03-10 | 2003-04-22 | Univ North Carolina | Dispositivos inaladores de pó seco, embalagens de múltiplas dosagens de droga de pó seco, sistemas de controle, e métodos associados |
US6608038B2 (en) | 2000-03-15 | 2003-08-19 | Novartis Ag | Methods and compositions for treatment of diabetes and related conditions via gene therapy |
GB2360218A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
US6823863B2 (en) | 2000-03-18 | 2004-11-30 | Astrazeneca Ab | Inhaler |
GB2360216A (en) | 2000-03-18 | 2001-09-19 | Astrazeneca Uk Ltd | Inhaler |
GB0006525D0 (en) | 2000-03-18 | 2000-05-10 | Astrazeneca Uk Ltd | Inhaler |
SE0000935D0 (sv) | 2000-03-21 | 2000-03-21 | Astrazeneca Ab | An inhalation device |
USD449684S1 (en) | 2000-03-24 | 2001-10-23 | Astrazeneca Ab | Inhaler |
US6432383B1 (en) | 2000-03-30 | 2002-08-13 | Generex Pharmaceuticals Incorporated | Method for administering insulin |
AU5173701A (en) | 2000-04-03 | 2001-10-15 | Iep Pharmaceutical Devices Inc | Method for improving lung delivery of pharmaceutical aerosols |
US6998137B2 (en) | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
CA2406185C (en) | 2000-04-11 | 2011-03-15 | Trudell Medical International | Aerosol delivery apparatus with positive expiratory pressure capacity |
DE10019879A1 (de) | 2000-04-20 | 2001-10-25 | Degussa | Verfahren zur Herstellung von 2,5-Diketopiperazinen, neue 2,5-Diketopiperazine und deren Verwendung |
MY136453A (en) | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
US6447750B1 (en) | 2000-05-01 | 2002-09-10 | Aeropharm Technology Incorporated | Medicinal aerosol formulation |
US6468507B1 (en) | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
USD442685S1 (en) | 2000-05-02 | 2001-05-22 | Salter Labs | Medication inhaler spacer |
US20010039442A1 (en) | 2000-05-06 | 2001-11-08 | Sal Gorge | Headache relief device |
US6948494B1 (en) | 2000-05-10 | 2005-09-27 | Innovative Devices, Llc. | Medicament container with same side airflow inlet and outlet and method of use |
US20020000225A1 (en) | 2000-06-02 | 2002-01-03 | Carlos Schuler | Lockout mechanism for aerosol drug delivery devices |
CN1141974C (zh) | 2000-06-07 | 2004-03-17 | 张昊 | 结肠定位释放的口服生物制剂 |
ATE424413T1 (de) | 2000-06-16 | 2009-03-15 | Lilly Co Eli | Analoge des glucagon-ähnlichen peptids-1 |
RU2181297C2 (ru) | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
GB0015034D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Inhalation device |
GB0015043D0 (en) | 2000-06-21 | 2000-08-09 | Glaxo Group Ltd | Medicament dispenser |
PE20020163A1 (es) | 2000-06-23 | 2002-03-04 | Norton Healthcare Ltd | Sistema presurizado de receptaculo para inhalador de medicamento |
TWI224515B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US6562807B2 (en) | 2000-06-23 | 2003-05-13 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
TWI224511B (en) | 2000-06-23 | 2004-12-01 | Norton Healthcare Ltd | De-agglomerator for breath-actuated dry powder inhaler |
USD452910S1 (en) | 2000-06-29 | 2002-01-08 | Innovata Biomend Limited | Inhaler |
USD450117S1 (en) | 2000-06-29 | 2001-11-06 | Innovata Biomed Limited | Inhaler |
HUP0301622A3 (en) | 2000-07-04 | 2006-05-29 | Novo Nordisk As | Purine derivatives inhibiting the enzyme dipeptidyl petidase iv (dpp-iv) and pharmaceutical compositions containing them |
US6363932B1 (en) | 2000-07-06 | 2002-04-02 | Clinical Technologies, Inc. | Aerosol enhancement device |
US6951215B1 (en) | 2000-07-14 | 2005-10-04 | Tufts University | Drug delivery device for animals |
US6360929B1 (en) | 2000-07-17 | 2002-03-26 | Mccarthy Madeleine | Medicinal atomizing inhaler pouch/retainer |
GB2364919A (en) | 2000-07-21 | 2002-02-13 | Cambridge Consultants | Inhalers |
AU2001284697A1 (en) | 2000-08-04 | 2002-02-18 | Dmi Biosciences, Inc. | Method of synthesizing diketopiperazines |
SE516555C2 (sv) | 2000-08-04 | 2002-01-29 | Microdrug Ag | Elektropulver |
BR0112969A (pt) * | 2000-08-04 | 2004-06-22 | Dmi Biosciences Inc | Método de utilização de dicetopiperazinas e composições contendo-as |
OA12394A (en) | 2000-08-05 | 2004-07-09 | Glaxo Group Ltd | 6.Alpha-,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl)oxyl-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fuoromethyl ester as an anti-inflammatory agent. |
JP2004515467A (ja) | 2000-08-07 | 2004-05-27 | ネクター セラピューティックス | 吸入可能な、噴霧乾燥した、最少の凝集物を有する4−ヘリックスバンドルタンパク質粉末 |
AU2001283546A1 (en) | 2000-08-14 | 2002-02-25 | Advanced Inhalation Research, Inc. | Inhalation device and method |
US6704255B2 (en) | 2000-08-22 | 2004-03-09 | Ricoh Company, Ltd. | Lens actuator |
US6613308B2 (en) | 2000-09-19 | 2003-09-02 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
US6514482B1 (en) | 2000-09-19 | 2003-02-04 | Advanced Inhalation Research, Inc. | Pulmonary delivery in treating disorders of the central nervous system |
CN1299779C (zh) | 2000-09-20 | 2007-02-14 | 弗朗哥·德伯恩 | 用于吸入设备的喷雾装置及带有喷雾装置的吸入设备 |
USD460173S1 (en) | 2000-09-20 | 2002-07-09 | P.A. Knowledge Limited | Inhaler device |
SE517225C2 (sv) | 2000-09-21 | 2002-05-14 | Microdrug Ag | Optimering av en elektrostatiskt doserad inhalator för torrt pulver |
SE517228C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator för torrt pulver med andningsaktivering |
SE517226C2 (sv) | 2000-09-25 | 2002-05-14 | Microdrug Ag | Inhalator med luftbroms för torrt pulver |
GB0023653D0 (en) | 2000-09-27 | 2000-11-08 | Cambridge Consultants | Device for dispensing particulate material |
CA2422129A1 (en) | 2000-09-29 | 2002-04-04 | Daniel Godfrey | Dosing device |
US6756062B2 (en) | 2000-11-03 | 2004-06-29 | Board Of Regents University Of Texas System | Preparation of drug particles using evaporation precipitation into aqueous solutions |
AU1850302A (en) | 2000-11-29 | 2002-06-11 | Itoham Foods Inc | Powdery preparations and proecss for producing the same |
GB0029562D0 (en) | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
USD455208S1 (en) | 2000-12-05 | 2002-04-02 | Clinical Designs Limited | Inhaler |
CN1501809B (zh) | 2000-12-13 | 2012-10-10 | 伊莱利利公司 | 应用胰高血糖素样促胰岛肽的长期治疗方案 |
DE60127175T2 (de) | 2000-12-21 | 2007-11-08 | Nektar Therapeutics, San Carlos | Lagerstabile pulverzusammensetzungen mit interleukin-4 rezeptor |
US7077130B2 (en) | 2000-12-22 | 2006-07-18 | Chrysalis Technologies Incorporated | Disposable inhaler system |
US6799572B2 (en) | 2000-12-22 | 2004-10-05 | Chrysalis Technologies Incorporated | Disposable aerosol generator system and methods for administering the aerosol |
US20020141946A1 (en) | 2000-12-29 | 2002-10-03 | Advanced Inhalation Research, Inc. | Particles for inhalation having rapid release properties |
CA2433335C (en) | 2000-12-29 | 2010-04-20 | Advanced Inhalation Research, Inc. | Particles for inhalation having sustained release properties |
US6626173B2 (en) | 2001-01-08 | 2003-09-30 | Iep Pharmaceutical Devices Inc. | Dry powder inhaler |
US6644309B2 (en) | 2001-01-12 | 2003-11-11 | Becton, Dickinson And Company | Medicament respiratory delivery device and method |
FI20010144A0 (fi) | 2001-01-24 | 2001-01-24 | Valtion Teknillinen | Menetelmä ja laite aerosolilähteiden tutkimiseksi |
AUPR272901A0 (en) | 2001-01-25 | 2001-02-22 | Gainful Plan Limited | Method of preparing biological materials and preparations produced using same |
US20040022861A1 (en) | 2001-01-30 | 2004-02-05 | Williams Robert O. | Process for production of nanoparticles and microparticles by spray freezing into liquid |
GB2374010B (en) | 2001-02-26 | 2004-12-29 | Council Scient Ind Res | Novel vitamin B12 - biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines |
DE60101451T2 (de) | 2001-03-05 | 2004-10-21 | Pera Ivo E | Inhaliergerät zur Verteilung von in einer Kapsel enthaltenen Medikamenten in Pulverform durch die Atemwege |
US6523536B2 (en) | 2001-03-12 | 2003-02-25 | Birdsong Medical Devices, Inc. | Dual-canister inhaler having a spacer and easy to operate lever mechanism |
US6698422B2 (en) | 2001-03-12 | 2004-03-02 | Birdsong Medical Devices, Inc. | Canister inhaler having a spacer and easy to operate lever mechanism and a flexible, elastic mouthpiece |
USD453264S1 (en) | 2001-03-30 | 2002-02-05 | Benjamin Acevedo, Jr. | Pouch for medical inhaler |
GB0108213D0 (en) | 2001-04-02 | 2001-05-23 | Glaxo Group Ltd | Medicament dispenser |
US6652838B2 (en) | 2001-04-05 | 2003-11-25 | Robert E. Weinstein | Method for treating diabetes mellitus |
SE518397C2 (sv) | 2001-04-05 | 2002-10-01 | Microdrug Ag | Förfarande och anordning för frigörande av pulver och inhalatoranordning för administrering av medicinskt pulver |
JP2004536047A (ja) | 2001-04-11 | 2004-12-02 | ブリストル−マイヤーズ スクイブ カンパニー | 糖尿病処置用c−アリールグルコシドのアミノ酸複合体および方法 |
US6766799B2 (en) | 2001-04-16 | 2004-07-27 | Advanced Inhalation Research, Inc. | Inhalation device |
US6447751B1 (en) | 2001-04-18 | 2002-09-10 | Robert E. Weinstein | Method and device for facilitating combined aerosol and oral treatments for diabetes mellitus |
EP1387656B1 (en) | 2001-04-19 | 2009-12-23 | Technology Innovation Limited | Medicament container |
USD451597S1 (en) | 2001-04-24 | 2001-12-04 | G-Intek Co.,Ltd | Snivel inhaler |
US7232897B2 (en) | 2001-04-24 | 2007-06-19 | Harvard University, President And Fellows Of Harvard College | Compositions and methods for modulating NH2-terminal Jun Kinase activity |
JP4663906B2 (ja) | 2001-04-26 | 2011-04-06 | 富士フイルム株式会社 | セルロースアシレートフイルム |
US20040211419A1 (en) | 2001-05-10 | 2004-10-28 | Eason Stephen William | Inhalers |
AU2002303869B2 (en) | 2001-05-21 | 2007-08-16 | Novartis Ag | Pulmonary administration of chemically modified insulin |
SE0101825D0 (sv) | 2001-05-22 | 2001-05-22 | Astrazeneca Ab | An Inhalation device |
AU2002308706A1 (en) | 2001-06-01 | 2002-12-16 | Eli Lilly And Company | Glp-1 formulations with protracted time action |
US7035294B2 (en) | 2001-06-04 | 2006-04-25 | Calix Networks, Inc. | Backplane bus |
EG24184A (en) | 2001-06-15 | 2008-10-08 | Otsuka Pharma Co Ltd | Dry powder inhalation system for transpulmonary |
FI20011317A0 (fi) | 2001-06-20 | 2001-06-20 | Orion Corp | Jauheinhalaattori |
DE60205487T2 (de) | 2001-06-22 | 2006-06-01 | 3M Innovative Properties Co., St. Paul | Verfahren zur verbesserung des durchflusses einer aerosolformulierung in einem dosierventil für einen dosierinhalator |
US6681768B2 (en) | 2001-06-22 | 2004-01-27 | Sofotec Gmbh & Co. Kg | Powder formulation disintegrating system and method for dry powder inhalers |
US7414720B2 (en) | 2001-07-27 | 2008-08-19 | Herbert Wachtel | Measuring particle size distribution in pharmaceutical aerosols |
DE10136555A1 (de) | 2001-07-27 | 2003-02-13 | Boehringer Ingelheim Int | Optimierte Verfahren zur Bestimmung der Aerosol-Partikelgrößenverteilung und Vorrichtung zur Durchführung derartiger Verfahren |
GB0120018D0 (en) | 2001-08-16 | 2001-10-10 | Meridica Ltd | Pack containing medicament and dispensing device |
CN1638801A (zh) * | 2001-08-22 | 2005-07-13 | 安万特医药德国有限公司 | 芳基取代的丙醇胺衍生物与其他活性成分的联用产品及其应用 |
KR100593348B1 (ko) | 2001-08-23 | 2006-06-26 | 일라이 릴리 앤드 캄파니 | 글루카곤-유사 펩티드-1 유사체 |
CA2452044A1 (en) | 2001-08-28 | 2003-03-13 | Eli Lilly And Company | Pre-mixes of glp-1 and basal insulin |
GB0121709D0 (en) | 2001-09-07 | 2001-10-31 | Imp College Innovations Ltd | Food inhibition agent |
EP1487417A4 (en) | 2001-09-17 | 2010-03-17 | Glaxo Group Ltd | DRY POWDER DRUG FORMULATIONS |
CN1313171C (zh) | 2001-09-19 | 2007-05-02 | 埃德文特药物有限公司 | 吸入器 |
US6568390B2 (en) | 2001-09-21 | 2003-05-27 | Chrysalis Technologies Incorporated | Dual capillary fluid vaporizing device |
US6640050B2 (en) | 2001-09-21 | 2003-10-28 | Chrysalis Technologies Incorporated | Fluid vaporizing device having controlled temperature profile heater/capillary tube |
EP1450885B1 (en) | 2001-09-28 | 2015-04-22 | Kurve Technology, Inc. | Nasal nebulizer |
EP1436030A1 (en) | 2001-10-08 | 2004-07-14 | Eli Lilly And Company | Portable medication inhalation kit |
DE60227393D1 (de) | 2001-10-16 | 2008-08-14 | Internat Non Toxic Composites | Nontoxischen verbundwerkstoffe höher dichte welche wolfram-, ein anderes metall- und polymerpulver beinhalten |
USD461239S1 (en) | 2001-10-18 | 2002-08-06 | Anna L. Cassidy | Inhaler sleeve with spring clip |
JP2005508360A (ja) | 2001-10-19 | 2005-03-31 | イーライ・リリー・アンド・カンパニー | Glp−1およびインスリンの二相混合物 |
RU2279292C2 (ru) | 2001-10-24 | 2006-07-10 | Пари Гмбх | Набор для приготовления фармацевтической композиции |
USD473298S1 (en) | 2001-11-01 | 2003-04-15 | Astrazeneca Ab | Inhaler refill |
CN101024842A (zh) | 2001-11-07 | 2007-08-29 | 曼康公司 | 编码靶相关抗原表位的表达载体及其设计方法 |
CA2468958C (en) | 2001-12-19 | 2012-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
US6994083B2 (en) | 2001-12-21 | 2006-02-07 | Trudell Medical International | Nebulizer apparatus and method |
GB0130857D0 (en) | 2001-12-22 | 2002-02-06 | Glaxo Group Ltd | Medicament dispenser |
USD474536S1 (en) | 2002-01-07 | 2003-05-13 | Aerogen, Inc. | Inhaler for dispensing medications |
US20030198666A1 (en) | 2002-01-07 | 2003-10-23 | Richat Abbas | Oral insulin therapy |
USD479745S1 (en) | 2002-01-07 | 2003-09-16 | Aerogen, Inc. | Inhaler for dispensing medications |
USD469866S1 (en) | 2002-01-07 | 2003-02-04 | Aerogen, Inc. | Inhaler for dispensing medication |
USD471273S1 (en) | 2002-01-07 | 2003-03-04 | Aerogen, Inc. | Inhaler for dispensing medication |
ITMI20020078A1 (it) | 2002-01-16 | 2003-07-16 | Fabrizio Niccolai | Dispositivo utilizzabile nel tratamento di affezzioni delle vie respiratorie |
AU2003205226A1 (en) | 2002-01-18 | 2003-09-02 | Mannkind Corporation | Compositions for treatment or prevention of bioterrorism |
US7105489B2 (en) | 2002-01-22 | 2006-09-12 | Amylin Pharmaceuticals, Inc. | Methods and compositions for treating polycystic ovary syndrome |
US7258118B2 (en) | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
MXPA04008068A (es) | 2002-02-20 | 2004-11-26 | Lilly Co Eli | Metodo para administrar moleculas de glp-1. |
US6591832B1 (en) | 2002-02-21 | 2003-07-15 | Saint-Gobain Calmar Inc. | Dry powder dispenser |
US6830149B2 (en) | 2002-03-08 | 2004-12-14 | Musculoskeletal Transplant Foundation | Package with insert for holding allograft implant to preclude lipid transfer |
US7008644B2 (en) | 2002-03-20 | 2006-03-07 | Advanced Inhalation Research, Inc. | Method and apparatus for producing dry particles |
ES2300568T3 (es) | 2002-03-20 | 2008-06-16 | Mannkind Corporation | Aparato de inhalacion. |
UA80123C2 (en) | 2002-04-09 | 2007-08-27 | Boehringer Ingelheim Pharma | Inhalation kit comprising inhalable powder of tiotropium |
US20030235538A1 (en) | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
US20030194420A1 (en) | 2002-04-11 | 2003-10-16 | Richard Holl | Process for loading a drug delivery device |
USD475133S1 (en) | 2002-04-18 | 2003-05-27 | Mcluckie Lynne E. | Luminescent-colored inhaler |
US7316748B2 (en) | 2002-04-24 | 2008-01-08 | Wisconsin Alumni Research Foundation | Apparatus and method of dispensing small-scale powders |
US6830046B2 (en) | 2002-04-29 | 2004-12-14 | Hewlett-Packard Development Company, L.P. | Metered dose inhaler |
US20040151059A1 (en) | 2002-05-01 | 2004-08-05 | Roberts Ii William Leroy | Deagglomerator apparatus and method |
USD478983S1 (en) | 2002-05-01 | 2003-08-26 | Chrysalis Technologies Incorporated | Inhaler |
WO2003094951A1 (en) | 2002-05-07 | 2003-11-20 | Novo Nordisk A/S | Soluble formulations comprising insulin aspart and insulin detemir |
US6889690B2 (en) | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
USD473640S1 (en) | 2002-05-13 | 2003-04-22 | Iep Pharmaceutical Devices Inc. | Breath actuated inhaler |
USD492769S1 (en) | 2002-05-24 | 2004-07-06 | Glaxosmithkline K.K. | Lens for an inhaler |
USD477665S1 (en) | 2002-06-12 | 2003-07-22 | Microdrug Ag | Inhaler |
AU154760S (en) | 2002-06-20 | 2004-03-02 | Astrazeneca Ab | Inhaler |
US8003179B2 (en) | 2002-06-20 | 2011-08-23 | Alcan Packaging Flexible France | Films having a desiccant material incorporated therein and methods of use and manufacture |
EP3308772B8 (en) | 2002-06-28 | 2021-03-17 | Civitas Therapeutics, Inc. | Inhalable epinephrine |
US20060003316A1 (en) | 2002-07-15 | 2006-01-05 | John Simard | Immunogenic compositions derived from poxviruses and methods of using same |
GB0217198D0 (en) | 2002-07-25 | 2002-09-04 | Glaxo Group Ltd | Medicament dispenser |
GB0217382D0 (en) | 2002-07-26 | 2002-09-04 | Pfizer Ltd | Process for making orally consumable dosage forms |
EP1386630B1 (en) | 2002-07-31 | 2006-05-17 | CHIESI FARMACEUTICI S.p.A. | Powder inhaler |
USD489448S1 (en) | 2002-07-31 | 2004-05-04 | Advanced Inhalations Revolutions, Inc. | Vaporization apparatus |
US20150283213A1 (en) | 2002-08-01 | 2015-10-08 | Mannkind Corporation | Method for treating hyperglycemia with glp-1 |
EP1545457A4 (en) | 2002-08-01 | 2009-07-01 | Mannkind Corp | CELL TRANSPORT COMPOSITIONS AND ITS USES |
DE10235168A1 (de) | 2002-08-01 | 2004-02-12 | Aventis Pharma Deutschland Gmbh | Verfahren zur Reinigung von Preproinsulin |
US20040038865A1 (en) | 2002-08-01 | 2004-02-26 | Mannkind Corporation | Cell transport compositions and uses thereof |
US20080260838A1 (en) | 2003-08-01 | 2008-10-23 | Mannkind Corporation | Glucagon-like peptide 1 (glp-1) pharmaceutical formulations |
GB0315791D0 (en) | 2003-07-07 | 2003-08-13 | 3M Innovative Properties Co | Two component molded valve stems |
US20040121964A1 (en) | 2002-09-19 | 2004-06-24 | Madar David J. | Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV) |
USD509296S1 (en) | 2002-09-21 | 2005-09-06 | Aventis Pharma Limited | Inhaler |
US7322352B2 (en) | 2002-09-21 | 2008-01-29 | Aventis Pharma Limited | Inhaler |
JP2004121061A (ja) | 2002-10-01 | 2004-04-22 | Sanei Gen Ffi Inc | 粉末組成物の製造方法 |
MXPA04005500A (es) | 2002-10-11 | 2005-09-08 | Otsuka Pharma Co Ltd | Dispositivo para inhalacion de polvo. |
CN1176649C (zh) | 2002-10-16 | 2004-11-24 | 上海医药工业研究院 | 舒马普坦干粉吸入剂及其制备方法 |
ITMO20020297A1 (it) | 2002-10-16 | 2004-04-17 | Roberto Oliva | Inalatore per preparati monodose in capsule. |
MXPA05004578A (es) | 2002-10-31 | 2005-07-26 | Umd Inc | Composicion terapeutica para el suministro de drogas a y a traves de epitelios de proteccion. |
GB0225621D0 (en) | 2002-11-02 | 2002-12-11 | Glaxo Group Ltd | Medicament carrier |
AU2003276447A1 (en) | 2002-11-04 | 2004-06-07 | Cambridge Consultants Limited | Inhalers |
USD493220S1 (en) | 2002-11-06 | 2004-07-20 | Merck Patent Gmbh | Inhaler |
US20080015457A1 (en) | 2002-11-07 | 2008-01-17 | Silva Carlos D | Device for Monitoring Respiratory Movements |
USD483860S1 (en) | 2002-11-12 | 2003-12-16 | Pari Gmbh Spezialisten Fur Effektive Inhalation | Electronic inhaler and control unit |
US6904907B2 (en) | 2002-11-19 | 2005-06-14 | Honeywell International Inc. | Indirect flow measurement through a breath-operated inhaler |
GB0227128D0 (en) | 2002-11-20 | 2002-12-24 | Glaxo Group Ltd | A capsule |
US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
US20040138099A1 (en) | 2002-11-29 | 2004-07-15 | Draeger Eberhard Kurt | Insulin administration regimens for the treatment of subjects with diabetes |
MXPA05005864A (es) | 2002-12-02 | 2005-11-16 | Univ Alberta | Dispositivo y metodo para desaglomeracion de polvo para inhalacion. |
US7284553B2 (en) | 2002-12-12 | 2007-10-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Powder inhaler comprising a chamber for a capsule for taking up a non-returnable capsule being filled with an active ingredient |
AR042452A1 (es) | 2002-12-13 | 2005-06-22 | Otsuka Pharma Co Ltd | Dispositivo de inhalacion para la administrcion transpulmonar |
US20060057106A1 (en) | 2002-12-13 | 2006-03-16 | Chikamasa Yamashita | Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor |
EA008829B1 (ru) | 2002-12-17 | 2007-08-31 | Нэстек Фармасьютикал Кампани Инк. | Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения |
US6941947B2 (en) | 2002-12-18 | 2005-09-13 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
US6962006B2 (en) | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
US7185650B2 (en) | 2002-12-19 | 2007-03-06 | Arie Huber | Systems and methods for determining a minimum effective dose of an inhaled drug for an individual patient at a given time |
NZ541365A (en) | 2002-12-27 | 2009-09-25 | Diobex Inc | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
DE10300032B3 (de) | 2003-01-03 | 2004-05-27 | E. Braun Gmbh | Pulverinhalator |
GB0309154D0 (en) | 2003-01-14 | 2003-05-28 | Aventis Pharma Inc | Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia |
WO2004064705A2 (en) | 2003-01-17 | 2004-08-05 | Schering Corporation | Training device for medicament inhalers |
JP2006514119A (ja) | 2003-02-12 | 2006-04-27 | アール アンド ピー コリア カンパニー リミテッド | 溶解率が向上した難溶性薬剤の溶媒系 |
GB0303870D0 (en) | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US20040171518A1 (en) * | 2003-02-27 | 2004-09-02 | Medtronic Minimed, Inc. | Compounds for protein stabilization and methods for their use |
WO2004078196A1 (en) | 2003-03-04 | 2004-09-16 | The Technology Development Company Ltd. | Oral insulin composition and methods of making and using thereof |
WO2004078236A2 (en) | 2003-03-04 | 2004-09-16 | Norton Healthcare Limited | Medicament dispensing device with a display indicative of the state of an internal medicament reservoir |
AU2004220544B2 (en) | 2003-03-06 | 2010-06-17 | Emisphere Technologies, Inc. | Oral insulin therapies and protocol |
CA2458288A1 (en) | 2003-03-11 | 2004-09-11 | Institut De Cardiologie De Montreal / Montreal Heart Institute | Method and compound to reduce the incidence of diabetes in a subject with chronic heart failure |
USD499802S1 (en) | 2003-04-01 | 2004-12-14 | Chiesi Farmaceutici S.P.A. | Powder inhaler |
WO2004091707A2 (en) | 2003-04-09 | 2004-10-28 | Nektar Therapeutics | Aerosolization apparatus with capsule puncture alignment guide |
US20040204439A1 (en) | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
EP1468935A1 (de) | 2003-04-16 | 2004-10-20 | Alcan Technology & Management Ltd. | Blisterverpackung |
US7732403B2 (en) | 2003-05-15 | 2010-06-08 | Dmi Biosciences, Inc. | Treatment of T-cell mediated diseases |
AU155845S (en) | 2003-05-15 | 2004-07-13 | Glaxo Group Ltd | A dispensing device for example an inhaler device |
AU155632S (en) | 2003-05-16 | 2004-06-01 | Henkel Kgaa | Blister pack |
WO2004101040A1 (en) | 2003-05-16 | 2004-11-25 | University Of Alberta | Add-on spacer design concept for dry-powder inhalers |
GB0312007D0 (en) | 2003-05-24 | 2003-07-02 | Innovata Biomed Ltd | Container |
PL1631264T5 (pl) | 2003-06-02 | 2018-09-28 | Glaxosmithkline Biologicals Sa | Kompozycje immunogenne oparte na biodegradowalnych mikrocząstkach zawierających toksoid błonicy i tężca |
AU2004249166B2 (en) | 2003-06-13 | 2008-10-09 | Alkermes, Inc. | Low dose pharmaceutical powders for inhalation |
US20050008908A1 (en) | 2003-06-27 | 2005-01-13 | Ultracell Corporation | Portable fuel cartridge for fuel cells |
US7001622B1 (en) | 2003-06-30 | 2006-02-21 | Robert Berndt | Composition and method for treatment and prevention of pruritis |
GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
AU158576S (en) | 2003-07-05 | 2006-08-22 | Clinical Designs Ltd | Inhaler |
US7462367B2 (en) | 2003-07-11 | 2008-12-09 | Boehringer Ingelheim International Gmbh | Anticholinergic powder formulations for inhalation |
US8921311B2 (en) | 2003-08-01 | 2014-12-30 | Mannkind Corporation | Method for treating hyperglycemia |
USD569967S1 (en) | 2003-08-06 | 2008-05-27 | Meridica Limited | Inhaler |
US20050043247A1 (en) | 2003-08-18 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Spray-dried amorphous BIBN 4096, process for preparing and the use thereof as inhalative |
DE10338402A1 (de) | 2003-08-18 | 2005-03-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Sprühgetrocknetes, amorphes BIBN 4096, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum |
US20050056535A1 (en) | 2003-09-15 | 2005-03-17 | Makoto Nagashima | Apparatus for low temperature semiconductor fabrication |
DE10343668A1 (de) | 2003-09-18 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Arzneimittelblister |
WO2005037798A2 (en) | 2003-10-16 | 2005-04-28 | Cara Therapeutics, Inc | Amide or thiomide derivatives and their use in the treatment of pain |
GB2398065A (en) | 2003-10-16 | 2004-08-11 | Bespak Plc | Dispensing apparatus |
USD511208S1 (en) | 2003-10-24 | 2005-11-01 | Valois Sas | Metered dose inhaler |
US20050187749A1 (en) | 2003-10-24 | 2005-08-25 | Judy Singley | Method, system, and computer program for performing carbohydrate/insulin calculation based upon food weight |
US7451761B2 (en) | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
US7377277B2 (en) | 2003-10-27 | 2008-05-27 | Oriel Therapeutics, Inc. | Blister packages with frames and associated methods of fabricating dry powder drug containment systems |
WO2005044173A1 (en) | 2003-10-27 | 2005-05-19 | Oriel Therapeutics, Inc. | Blister packages and associated methods of fabricating dry powder drug containment systems |
US20050147581A1 (en) | 2003-11-19 | 2005-07-07 | The Board Of Trustees Of The University Of Illinois | Macromolecular drug complexes having improved stability and therapeutic use of the same |
SE0303269L (sv) | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
GB0329884D0 (en) | 2003-12-23 | 2004-01-28 | Glaxo Group Ltd | Method |
EP1701714A2 (en) | 2004-01-07 | 2006-09-20 | Nektar Therapeutics | Improved sustained release compositions for pulmonary administration of insulin |
US20070027063A1 (en) | 2004-01-12 | 2007-02-01 | Mannkind Corporation | Method of preserving the function of insulin-producing cells |
US20050153874A1 (en) | 2004-01-12 | 2005-07-14 | Mannkind Corporation | Method of reducing serum proinsulin levels in type 2 diabetics |
US7658721B2 (en) | 2004-01-16 | 2010-02-09 | Biodel Inc. | Sublingual drug delivery device |
DE102004006450B4 (de) | 2004-02-05 | 2012-09-27 | Ing. Erich Pfeiffer Gmbh | Dosiervorrichtung |
DE102004008141A1 (de) | 2004-02-19 | 2005-09-01 | Abbott Gmbh & Co. Kg | Guanidinverbindungen und ihre Verwendung als Bindungspartner für 5-HT5-Rezeptoren |
USD512777S1 (en) | 2004-02-19 | 2005-12-13 | Chrysalis Technologies Incorporated | Inhaler |
AU2005216205B2 (en) | 2004-02-24 | 2010-07-15 | Microdose Therapeutx, Inc. | Directional flow sensor inhaler |
MXPA06009515A (es) | 2004-02-24 | 2007-03-26 | Microdose Technologies Inc | Metodo y aparato para el suministro de medicamentos a base de un chorro sintetico. |
US7279457B2 (en) | 2004-03-12 | 2007-10-09 | Biodel, Inc. | Rapid acting drug delivery compositions |
ITMO20040060A1 (it) | 2004-03-18 | 2004-06-18 | Roberto Oliva | Inalatore per preparati in polvere |
USD515696S1 (en) | 2004-03-19 | 2006-02-21 | Innovata Biomed Limited | Inhaler |
EP1734938B1 (en) | 2004-03-26 | 2012-06-20 | Universita' Degli Studi Di Parma | Insulin highly respirable microparticles |
US8071552B2 (en) | 2004-04-05 | 2011-12-06 | Universite Bordeaux 2 | Peptides and peptidomimetics binding to CD23 |
USD533268S1 (en) | 2004-04-18 | 2006-12-05 | Bahram Olfati | Inhaler |
US8851069B2 (en) | 2004-04-21 | 2014-10-07 | Innovata Biomed Limited | Inhaler |
WO2005102428A1 (en) | 2004-04-23 | 2005-11-03 | The Governors Of The University Of Alberta | Enhanced drug delivery for inhaled aerosols |
ES2559410T3 (es) | 2004-04-23 | 2016-02-12 | Philip Morris Products S.A. | Generadores de aerosol y métodos para producir aerosoles |
USD527817S1 (en) | 2004-05-13 | 2006-09-05 | Novartis Ag | Inhaler |
GB0410712D0 (en) | 2004-05-13 | 2004-06-16 | Novartis Ag | Organic compounds |
US20050265927A1 (en) | 2004-05-17 | 2005-12-01 | Yale University | Intranasal delivery of nucleic acid molecules |
AR052759A1 (es) | 2004-05-19 | 2007-04-04 | Cipla Ltd | Dispositivo inhalador de medicamentos |
USD529604S1 (en) | 2004-05-28 | 2006-10-03 | Quadrant Technologies Limited | Dry powder inhaler |
USD548833S1 (en) | 2004-05-28 | 2007-08-14 | Quadrant Technologies Limited | Dry powder inhaler |
SE528190C2 (sv) | 2004-06-07 | 2006-09-19 | Mederio Ag | Inhalator |
BRPI0511891A (pt) | 2004-06-07 | 2008-01-15 | Mederio Ag | processo para assegurar a qualidade da dose de uma droga inalável |
NZ552029A (en) | 2004-06-25 | 2009-01-31 | Takeda Pharmaceutical | Metastin derivatives and use thereof |
US20060000469A1 (en) | 2004-07-02 | 2006-01-05 | Tseng Daniel C | Nebulizing apparatus for medical use with improved nozzle positioning structure |
JP2008507316A (ja) | 2004-07-23 | 2008-03-13 | インターキュア リミティド | 非接触マイクを使用する呼吸パターン決定のための装置と方法 |
US8171930B2 (en) | 2004-07-26 | 2012-05-08 | 135540 Ontario Inc. | Powder inhaler featuring reduced compaction inhaler |
EA200700391A1 (ru) | 2004-08-03 | 2007-10-26 | Байорексис Текнолоджи, Инк. | Комбинированное лечение с применением слитых белков трансферрина, содержащих glp-1 |
CA2575692C (en) | 2004-08-20 | 2014-10-14 | Mannkind Corporation | Catalysis of diketopiperazine synthesis |
WO2006023944A2 (en) | 2004-08-23 | 2006-03-02 | Mannkind Corporation | Pulmonary delivery of inhibitors of phosphodiesterase type 5 |
BR122019022692B1 (pt) | 2004-08-23 | 2023-01-10 | Mannkind Corporation | Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo |
GB0419849D0 (en) | 2004-09-07 | 2004-10-13 | Pfizer Ltd | Pharmaceutical combination |
WO2006031712A2 (en) | 2004-09-13 | 2006-03-23 | Oriel Therapeutics, Inc. | Tubular dry powder drug containment systems, associated inhalers and methods |
US8365725B2 (en) | 2004-09-13 | 2013-02-05 | Oriel Therapeutics, Inc. | Dry powder inhalers that inhibit agglomeration, related devices and methods |
USD537522S1 (en) | 2004-09-15 | 2007-02-27 | Glaxo Group Limited | Telescopic strap, particularly for a dust cap of a metered dose inhaler |
USD537936S1 (en) | 2004-09-15 | 2007-03-06 | Glaxo Group Limited | Cap with an extension, particularly for a dust cap of a metered dose inhaler |
USD518170S1 (en) | 2004-09-28 | 2006-03-28 | Vectura, Ltd. | Inhaler |
WO2006037636A2 (en) | 2004-10-06 | 2006-04-13 | Boehringer Ingelheim International Gmbh | Dispensing device, storage device and method for dispensing powder |
US7469696B2 (en) | 2004-10-13 | 2008-12-30 | Hewlett-Packard Development Company, L.P. | Thermal drop generator |
USD515924S1 (en) | 2004-11-01 | 2006-02-28 | Warner-Lambert Company Llc | Blister card |
DE102005033398A1 (de) | 2004-11-10 | 2006-05-11 | Alfred Von Schuckmann | Inhalier-Gerät |
SE0402976L (sv) | 2004-12-03 | 2006-06-04 | Mederio Ag | Medicinsk produkt |
EP1827381A1 (en) | 2004-12-03 | 2007-09-05 | Mederio AG | A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
GB0427028D0 (en) | 2004-12-09 | 2005-01-12 | Cambridge Consultants | Dry powder inhalers |
US20060130838A1 (en) | 2004-12-20 | 2006-06-22 | Lee Yong Y | Data logger for monitoring asthmatic conditions |
CA2592065A1 (en) | 2004-12-22 | 2007-04-26 | Centocor, Inc. | Glp-1 agonists, compositions, methods and uses |
EP1858486A2 (en) | 2005-01-10 | 2007-11-28 | MannKind Corporation | Methods and compositions for minimizing accrual of inhalable insulin in the lungs |
US20060165756A1 (en) | 2005-01-27 | 2006-07-27 | Catani Steven J | Method for weight management |
USD538423S1 (en) | 2005-02-04 | 2007-03-13 | Berube-White | Panda bear inhaler |
GB0503738D0 (en) | 2005-02-23 | 2005-03-30 | Optinose As | Powder delivery devices |
US20060219242A1 (en) | 2005-03-30 | 2006-10-05 | Boehringer Ingelheim International | Method for the Administration of an Anticholinergic by Inhalation |
JP4656397B2 (ja) | 2005-03-31 | 2011-03-23 | 株式会社吉野工業所 | 粉体用容器 |
CN100431634C (zh) | 2005-04-04 | 2008-11-12 | 陈庆堂 | 干粉气溶胶化吸入器 |
US7762953B2 (en) | 2005-04-20 | 2010-07-27 | Adidas Ag | Systems and methods for non-invasive physiological monitoring of non-human animals |
US7694676B2 (en) | 2005-04-22 | 2010-04-13 | Boehringer Ingelheim Gmbh | Dry powder inhaler |
EP1885335A1 (en) | 2005-04-27 | 2008-02-13 | BAXTER INTERNATIONAL INC. (a Delaware corporation) | Surface-modified microparticles and methods of forming and using the same |
US7219664B2 (en) | 2005-04-28 | 2007-05-22 | Kos Life Sciences, Inc. | Breath actuated inhaler |
BRPI0611357A2 (pt) | 2005-05-02 | 2010-11-23 | Astrazeneca Ab | disposição e método para abrir uma cavidade, embalagem médica e um dispositivo dispensador |
USD544093S1 (en) | 2005-06-02 | 2007-06-05 | Bang & Olufsen A/S | Inhaler |
HUE054887T2 (hu) | 2005-06-17 | 2021-10-28 | Wisconsin Alumni Res Found | Topikális érösszehúzó készítmények és eljárások sejtek védelmére rák kemoterápia és radioterápia alatt |
WO2007007110A1 (en) | 2005-07-13 | 2007-01-18 | Cipla Limited | Inhaler device |
US8763605B2 (en) | 2005-07-20 | 2014-07-01 | Manta Devices, Llc | Inhalation device |
USD550835S1 (en) | 2005-07-22 | 2007-09-11 | Omron Healthcare Co., Ltd. | Atomizer for inhaler |
DK1915171T3 (da) | 2005-08-01 | 2013-12-09 | Mannkind Corp | Fremgangsmåde til bevarelse af funktionen af insulin-producerende celler |
WO2007019229A1 (en) | 2005-08-05 | 2007-02-15 | 3M Innovative Properties Company | Compositions exhibiting improved flowability |
CA2618520C (en) | 2005-08-25 | 2015-01-27 | Oriel Therapeutics, Inc. | Drug containment systems with sticks, related kits, dry powder inhalers and methods |
US7900625B2 (en) | 2005-08-26 | 2011-03-08 | North Carolina State University | Inhaler system for targeted maximum drug-aerosol delivery |
JP2009506069A (ja) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
JP2007061281A (ja) | 2005-08-30 | 2007-03-15 | Hitachi Ltd | 吸入量測定システム |
US20100041612A1 (en) | 2005-09-08 | 2010-02-18 | Martin Beinborn | Fragments of the Glucagon-Like Peptide-1 and Uses Thereof |
HUE028691T2 (en) | 2005-09-14 | 2016-12-28 | Mannkind Corp | A method for formulating a drug based on increasing the affinity of crystalline microparticle surfaces towards active ingredients |
USD540671S1 (en) | 2005-09-21 | 2007-04-17 | The Procter & Gamble Company | Cap for product dispenser |
WO2007041481A1 (en) | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
US20070074989A1 (en) | 2005-09-30 | 2007-04-05 | Musculoskeletal Transplant Foundation | Container for lyophilization and storage of tissue |
GB0520794D0 (en) | 2005-10-12 | 2005-11-23 | Innovata Biomed Ltd | Inhaler |
ITMI20051999A1 (it) | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
USD566549S1 (en) | 2005-10-26 | 2008-04-15 | Reckitt Benckiser (Uk) Limited | Cap |
US8039432B2 (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect |
AR058290A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Dispensador de medicamento |
AR058289A1 (es) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | Colector para ser usado en dispensador de medicamento |
EP1968644B1 (en) | 2005-12-16 | 2012-06-27 | Nektar Therapeutics | Polymer conjugates of glp-1 |
RU2464973C2 (ru) | 2006-01-24 | 2012-10-27 | НексБио, Инк. | Технология изготовления макромолекулярных микросфер |
USD557798S1 (en) | 2006-01-25 | 2007-12-18 | Valois S.A.S. | Inhaler |
US7390949B2 (en) | 2006-02-01 | 2008-06-24 | Wanne, Inc. | Saxophone and clarinet mouthpiece cap |
GB0602897D0 (en) | 2006-02-13 | 2006-03-22 | Jagotec Ag | Improvements In Or Relating To Dry Powder Inhaler Devices |
JP2009526565A (ja) | 2006-02-14 | 2009-07-23 | バテル メモリアル インスティチュート | 正確な計測システム |
EP2471810A1 (en) | 2006-02-22 | 2012-07-04 | Merck Sharp & Dohme Corporation | Oxyntomodulin derivatives |
EP1986679B1 (en) | 2006-02-22 | 2017-10-25 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
DE102006010089A1 (de) | 2006-02-24 | 2007-10-18 | Aha-Kunststofftechnik Gmbh | Trockenpulver-Inhalator |
USD541151S1 (en) | 2006-03-20 | 2007-04-24 | The Procter & Gamble Company | Cap for product dispenser |
US8037880B2 (en) | 2006-04-07 | 2011-10-18 | The University Of Western Ontario | Dry powder inhaler |
JP2009533471A (ja) | 2006-04-12 | 2009-09-17 | バイオデル, インコーポレイテッド | 即効型および長時間作用型組合せインスリン製剤 |
EP1844806A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH | Medikamenten-Ausgabevorrichtung, Medikamentenmagazin dafür, und Verfahren zur Entnahme eines Medikaments aus einer Medikamentenkammer |
EP1844809A1 (de) | 2006-04-13 | 2007-10-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator |
US20070243216A1 (en) | 2006-04-14 | 2007-10-18 | Stanley Kepka | Stable solutions of prostaglandin and uses of same |
CN104288756A (zh) | 2006-04-14 | 2015-01-21 | 曼金德公司 | 高血糖素样肽1(glp-1)药物制剂 |
GR1005620B (el) | 2006-05-09 | 2007-09-03 | Βελτιωση συσκευης εισπνοων ξηρης σκονης | |
US20090151720A1 (en) | 2006-05-10 | 2009-06-18 | S.K.I. Net, Inc. | Small animal anesthesia system |
DE102006021978A1 (de) | 2006-05-10 | 2007-11-15 | Robert Bosch Gmbh | Vorrichtung und Verfahen zum Verstärken eines Blisters |
PT103481B (pt) | 2006-05-16 | 2008-08-01 | Hovione Farmaciencia S A | Inalador de uso simples e método de inalação |
GB0611656D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
GB0611659D0 (en) | 2006-06-13 | 2006-07-19 | Cambridge Consultants | Dry powder inhalers |
AP2009004733A0 (en) | 2006-06-16 | 2009-02-28 | Cipla Ltd | Improved dry powder inhaler |
EP2035068A1 (en) | 2006-06-27 | 2009-03-18 | Brin Tech International Limited | Inhaler |
MY147787A (en) | 2006-06-27 | 2013-01-31 | Otsuka Pharma Co Ltd | Powder inhaler |
GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
CN2917673Y (zh) | 2006-07-06 | 2007-07-04 | 兴安药业有限公司 | 一种胶囊型干粉吸入器 |
WO2008008021A1 (en) | 2006-07-14 | 2008-01-17 | Astrazeneca Ab | Inhalation system and delivery device for the administration of a drug in the form of dry powder. |
EP2076242B8 (en) | 2006-07-27 | 2013-02-20 | Nektar Therapeutics | Aerosolizable formulation comprising insulin for pulmonary delivery |
WO2008014613A1 (en) | 2006-08-04 | 2008-02-07 | Manus Pharmaceuticals (Canada) Ltd. | Multifunctional bioactive compounds |
GB0616299D0 (en) | 2006-08-16 | 2006-09-27 | Cambridge Consultants | Drug Capsules for dry power inhalers |
US20080066739A1 (en) | 2006-09-20 | 2008-03-20 | Lemahieu Edward | Methods and systems of delivering medication via inhalation |
US20080108574A1 (en) | 2006-09-27 | 2008-05-08 | Braincells, Inc. | Melanocortin receptor mediated modulation of neurogenesis |
US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
US20080173067A1 (en) | 2006-11-10 | 2008-07-24 | Farina Dino J | Automated nasal spray pump testing |
US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
AU2007317817B2 (en) | 2006-11-10 | 2012-09-20 | Cara Therapeutics, Inc. | Synthetic peptide amides |
US7824014B2 (en) | 2006-12-05 | 2010-11-02 | Canon Kabushiki Kaisha | Head substrate, printhead, head cartridge, and printing apparatus |
USD548618S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
USD549111S1 (en) | 2006-12-06 | 2007-08-21 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
USD548619S1 (en) | 2006-12-06 | 2007-08-14 | Eveready Battery Company, Inc. | Zinc-air hearing aid battery package |
WO2008077623A1 (en) | 2006-12-22 | 2008-07-03 | Laboratorios Almirall, S.A. | Inhalation device for drugs in powder form |
WO2008092864A1 (en) | 2007-01-29 | 2008-08-07 | Novo Nordisk A/S | Method and devices for aerosolizing a drug formulation |
US8172817B2 (en) | 2007-01-31 | 2012-05-08 | Allegiance Corporation | Liquid collection system and related methods |
BRPI0807728A2 (pt) | 2007-02-15 | 2012-04-17 | Univ Indiana Res & Tech Corp | co-agonistas de receptor glucagon/glp-1 |
US8196576B2 (en) | 2007-02-28 | 2012-06-12 | Microdose Therapeutx, Inc. | Inhaler |
WO2009005546A1 (en) | 2007-03-05 | 2009-01-08 | Board of Governors for Higher Education, State of Rhode Island and the Providence Plantations | High efficiency mouthpiece/adaptor for inhalers |
JP2008212436A (ja) | 2007-03-06 | 2008-09-18 | Canon Inc | 吸入装置 |
US8146745B2 (en) | 2007-03-09 | 2012-04-03 | Cardpak, Inc. | Environmentally separable packaging device with attaching base |
GB0704928D0 (en) | 2007-03-14 | 2007-04-25 | Cambridge Consultants | Dry powder inhalers |
JP2011505925A (ja) | 2007-04-11 | 2011-03-03 | スター ライフ サイエンシーズ コーポレイション | 移動性の動物用の非侵襲性フォトプレチスモグラフィセンサプラットフォーム |
JP4417400B2 (ja) | 2007-04-16 | 2010-02-17 | アンリツ株式会社 | はんだ検査ライン集中管理システム、及びそれに用いられる管理装置 |
ES2402172T3 (es) | 2007-04-23 | 2013-04-29 | Intarcia Therapeutics, Inc | Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos |
EP2152316A4 (en) | 2007-04-26 | 2011-03-23 | Quark Pharmaceuticals Inc | THERAPEUTIC DELIVERY OF INHIBITORY NUCLEIC ACID MOLECULES IN THE RESPIRATORY SYSTEM |
USD577815S1 (en) | 2007-04-30 | 2008-09-30 | Sun Pharma Advanced Research Company Limited | Inhaler |
USD583463S1 (en) | 2007-04-30 | 2008-12-23 | Sun Pharma Advanced Research Company Limited | Inhaler |
JP5356367B2 (ja) | 2007-04-30 | 2013-12-04 | サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッド | 吸入装置 |
CA2887187C (en) | 2007-05-16 | 2017-10-24 | Mystic Pharmaceuticals, Inc. | COMBINED DISPENSING CONTAINERS - UNIT DOSE |
EP1992378A1 (en) | 2007-05-16 | 2008-11-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dispensing device |
USD579547S1 (en) | 2007-06-07 | 2008-10-28 | Novartis Ag | Inhaler |
BRPI0812768A2 (pt) | 2007-06-08 | 2014-12-02 | Massachusetts Inst Technology | Igf para o tratamento de síndrome de rett e transtornos sinápticos. |
WO2008157751A2 (en) | 2007-06-21 | 2008-12-24 | Cara Therapeutics, Inc. | Substituted imidazoheterocycles |
EP3453418A1 (en) | 2007-07-06 | 2019-03-13 | Manta Devices, LLC | Delivery device and related methods |
US20090084379A1 (en) | 2007-10-02 | 2009-04-02 | Baxter International Inc. | Dry powder inhaler |
EP2048112A1 (en) | 2007-10-09 | 2009-04-15 | Kemira Kemi AB | Use of a nozzle for manufacturing sodium percarbonate |
AU2008316636B2 (en) | 2007-10-24 | 2014-02-06 | Mannkind Corporation | Delivery of active agents |
US8785396B2 (en) | 2007-10-24 | 2014-07-22 | Mannkind Corporation | Method and composition for treating migraines |
JP2011500850A (ja) | 2007-10-24 | 2011-01-06 | マンカインド コーポレイション | Glp−1による副作用を防止する方法 |
MX2010004507A (es) | 2007-10-25 | 2010-07-05 | Novartis Ag | Acondicionamiento de polvo de paquetes de farmaco dosis unitaria. |
GB0721394D0 (en) | 2007-10-31 | 2007-12-12 | Vectura Group Plc | Compositions for trating parkinson's disease |
EP2205302A4 (en) | 2007-11-06 | 2010-12-29 | 3M Innovative Properties Co | MEDICAL INHALATION DEVICES AND COMPONENTS THEREOF |
CN101317821B (zh) | 2007-11-15 | 2012-01-04 | 陈晓东 | 适用于肺部给药的超细干粉颗粒及其制备方法 |
EP2060268A1 (en) | 2007-11-15 | 2009-05-20 | Novo Nordisk A/S | Pharmaceutical compositions for pulmonary or nasal delivery of peptides |
USD594753S1 (en) | 2007-12-14 | 2009-06-23 | The Procter & Gamble Company | Blister card |
WO2009079078A1 (en) | 2007-12-14 | 2009-06-25 | Labogroup S.A.S. | Delivering aerosolizable food products |
CA2710274A1 (en) | 2007-12-20 | 2009-07-02 | Astrazeneca Ab | Device and method for deaggregating powder 854 |
US7584846B2 (en) | 2007-12-21 | 2009-09-08 | S.C. Johnson & Son, Inc. | Shaped packaging for a refill |
CA2728808A1 (en) | 2008-02-01 | 2009-08-06 | Vectura Limited | Pulmonary formulations of triptans |
GB0802028D0 (en) | 2008-02-05 | 2008-03-12 | Dunne Stephen T | Powder inhaler flow regulator |
USD614045S1 (en) | 2008-02-22 | 2010-04-20 | Ima Safe S.R.L. | Blister packaging |
KR101541209B1 (ko) | 2008-03-27 | 2015-07-31 | 맨카인드 코포레이션 | 건조 분말 흡입 시스템 |
CN102088997A (zh) | 2008-04-07 | 2011-06-08 | 国家免疫研究所 | 用于治疗糖尿病和其他慢性疾病的组合物 |
DE102008023376A1 (de) | 2008-05-13 | 2009-11-19 | Alfred Von Schuckmann | Spender für in einer gesonderten Verpackung enthaltenen, pulverförmigen Massen |
MX2010012452A (es) | 2008-05-15 | 2011-03-15 | Novartis Ag Star | Suministro pulmonar de una fluoro-quinolona. |
USD597418S1 (en) | 2008-05-22 | 2009-08-04 | Wm. Wrigley Jr. Company | Blister card |
USD598785S1 (en) | 2008-05-22 | 2009-08-25 | Wm. Wrigley Jr. Company | Blister card |
USD614760S1 (en) | 2008-06-13 | 2010-04-27 | Mannkind Corporation | Dry powder inhaler |
USD605753S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Cartridge for a dry powder inhaler |
USD613849S1 (en) | 2008-06-13 | 2010-04-13 | Mannkind Corporation | Cartridge for a dry powder inhaler |
AR072114A1 (es) | 2008-06-13 | 2010-08-04 | Mannkind Corp | Un inhalador de polvo seco y sistema para suministro de farmacos |
USD604833S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Dry powder inhaler |
USD605752S1 (en) | 2008-06-13 | 2009-12-08 | Mannkind Corporation | Dry powder inhaler |
USD635241S1 (en) | 2008-06-13 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
USD604832S1 (en) | 2008-06-13 | 2009-11-24 | Mannkind Corporation | Cartridge for a dry powder inhaler |
USD597657S1 (en) | 2008-06-13 | 2009-08-04 | Mannkind Corporation | Dry powder inhaler |
BRPI0914308B8 (pt) | 2008-06-20 | 2021-06-22 | Mannkind Corp | sistema de inalação |
TWI614024B (zh) | 2008-08-11 | 2018-02-11 | 曼凱公司 | 超快起作用胰島素之用途 |
USD629505S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
USD629888S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
USD629506S1 (en) | 2008-12-01 | 2010-12-21 | Mannkind Corporation | Dry powder inhaler |
USD635242S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
USD635243S1 (en) | 2008-12-01 | 2011-03-29 | Mannkind Corporation | Dry powder inhaler |
USD629887S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
USD629886S1 (en) | 2008-12-01 | 2010-12-28 | Mannkind Corporation | Dry powder inhaler |
WO2010078373A1 (en) | 2008-12-29 | 2010-07-08 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
JP5918539B2 (ja) | 2009-01-08 | 2016-05-18 | マンカインド コーポレイション | Glp−1を用いる高血糖症の治療方法 |
US8550074B2 (en) | 2009-01-15 | 2013-10-08 | Manta Devices, Llc | Delivery device and related methods |
TWI528982B (zh) | 2009-03-04 | 2016-04-11 | 曼凱公司 | 改良的乾粉藥物輸送系統 |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
CA2992927A1 (en) | 2009-03-18 | 2010-09-23 | Mannkind Corporation | Inhaler adaptor for a laser diffraction apparatus and method for measuring particle size distribution |
GB0907425D0 (en) | 2009-04-29 | 2009-06-10 | Glaxo Group Ltd | Compounds |
USD626836S1 (en) | 2009-04-30 | 2010-11-09 | Bryce Lien | Bottle cap |
USD628090S1 (en) | 2009-05-07 | 2010-11-30 | Mccormick & Company, Incorporated | Seasoning package |
USD620375S1 (en) | 2009-05-11 | 2010-07-27 | Mcneil-Ppc, Inc. | Blister |
BRPI1011194A2 (pt) | 2009-05-21 | 2016-12-27 | Microdose Therapeutx Inc | sistema de receptáculo rotativo para inalador de pó seco |
TWI695723B (zh) | 2009-05-29 | 2020-06-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道輸送活性劑的組成物以及相關方法與系統 |
KR101875969B1 (ko) | 2009-06-12 | 2018-07-06 | 맨카인드 코포레이션 | 한정된 비표면적을 갖는 디케토피페라진 마이크로입자 |
KR101782174B1 (ko) | 2009-06-12 | 2017-09-26 | 맨카인드 코포레이션 | 한정된 이성체 함량을 갖는 디케토피페라진 마이크로입자 |
US9180263B2 (en) | 2009-07-01 | 2015-11-10 | Microdose Therapeutx, Inc. | Laboratory animal pulmonary dosing device |
US8642548B2 (en) | 2009-08-07 | 2014-02-04 | Mannkind Corporation | Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome |
CA2770714A1 (en) | 2009-08-27 | 2011-03-17 | Stc.Unm | Methods and systems for dosing and coating inhalation powders onto carrier particles |
IT1395945B1 (it) | 2009-09-30 | 2012-11-02 | Oliva | Inalatore perfezionato per preparati in polvere |
USD647196S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
USD647195S1 (en) | 2009-10-09 | 2011-10-18 | Vectura Delivery Devices Limited | Inhaler having cover |
EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
USD650295S1 (en) | 2009-11-13 | 2011-12-13 | Avidiamed Gmbh | Blister pack for pharmaceuticals |
AU2010336338B2 (en) | 2009-12-23 | 2015-02-19 | Map Pharmaceuticals, Inc. | Enhanced eductor design |
WO2011082328A1 (en) | 2009-12-31 | 2011-07-07 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
AU332056S (en) | 2010-01-08 | 2010-08-04 | Teva Pharma Ireland | Inhaler |
USD641076S1 (en) | 2010-03-26 | 2011-07-05 | Oriel Therapeutics, Inc. | Dry powder inhaler |
GB201006901D0 (en) | 2010-04-26 | 2010-06-09 | Sagentia Ltd | Device for monitoring status and use of an inhalation or nasal drug delivery device |
PT105065B (pt) | 2010-04-26 | 2012-07-31 | Hovione Farmaciencia S A | Um inalador simples de cápsulas |
USD645954S1 (en) | 2010-05-21 | 2011-09-27 | Consort Medical Plc | Mechanical dosage counter apparatus |
USD636867S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
USD636868S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
USD636869S1 (en) | 2010-06-14 | 2011-04-26 | Mannkind Corporation | Dry powder inhaler |
RU2571331C1 (ru) | 2010-06-21 | 2015-12-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
CN101851213A (zh) | 2010-06-21 | 2010-10-06 | 于清 | 3,6-双(4-双反丁烯二酰基氨丁基)-2,5-二酮哌嗪及其盐取代物的合成方法 |
CN103228305B (zh) | 2010-08-19 | 2016-06-08 | 赛诺菲-安万特德国有限公司 | 使用电子传感器确定与药物容器相关的信息的方法和系统 |
USD643308S1 (en) | 2010-09-28 | 2011-08-16 | Mannkind Corporation | Blister packaging |
WO2012050945A1 (en) | 2010-09-29 | 2012-04-19 | Pulmatrix, Inc. | Cationic dry powders |
KR101931392B1 (ko) | 2010-11-09 | 2018-12-20 | 맨카인드 코포레이션 | 세로토닌 수용체 작용제 및 디케토피페라진을 포함하는 편두통 치료용 조성물 |
AU337357S (en) | 2010-12-01 | 2011-06-27 | Teva Pharma | Inhaler |
USD642483S1 (en) | 2010-12-03 | 2011-08-02 | Mccormick & Company, Incorporated | Seasoning package |
US8912328B2 (en) | 2011-02-10 | 2014-12-16 | Mannkind Corporation | Formation of N-protected bis-3,6-(4-aminoalkyl)-2,5,diketopiperazine |
JP6133270B2 (ja) | 2011-04-01 | 2017-05-24 | マンカインド コーポレイション | 薬剤カートリッジのためのブリスター包装 |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
RS58456B1 (sr) | 2011-08-01 | 2019-04-30 | Univ Monash | Postupak i formulacije za inhalaciju |
USD674893S1 (en) | 2011-10-20 | 2013-01-22 | Mannkind Corporation | Inhaler device |
JP6018640B2 (ja) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | 疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム |
CN102436238B (zh) | 2011-11-03 | 2014-04-16 | 广东轻工职业技术学院 | 基于生产线数据采集及信息管理系统的数据采集方法 |
JP6241682B2 (ja) | 2012-04-27 | 2017-12-06 | マンカインド・コーポレイシヨン | 活性化したエチルフマレートの合成のための方法および中間体としてのその使用 |
SG11201500218VA (en) | 2012-07-12 | 2015-03-30 | Mannkind Corp | Dry powder drug delivery systems and methods |
BR112015004418A2 (pt) | 2012-08-29 | 2017-07-04 | Mannkind Corp | composição de pó seco inalável, sistema de liberação de fármaco, processo para formar uma partícula e kit. |
US10159644B2 (en) | 2012-10-26 | 2018-12-25 | Mannkind Corporation | Inhalable vaccine compositions and methods |
CN103110611A (zh) | 2012-12-11 | 2013-05-22 | 苏州惠仁生物科技有限公司 | 吸入剂及其制备方法与普鲁兰糖作为吸入剂载体的应用 |
USD711740S1 (en) | 2013-01-22 | 2014-08-26 | H204K9, Inc. | Bottle cap |
WO2014144895A1 (en) | 2013-03-15 | 2014-09-18 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
AU2014290438B2 (en) | 2013-07-18 | 2019-11-07 | Mannkind Corporation | Heat-stable dry powder pharmaceutical compositions and methods |
WO2015021064A1 (en) | 2013-08-05 | 2015-02-12 | Mannkind Corporation | Insufflation apparatus and methods |
GB201319265D0 (en) | 2013-10-31 | 2013-12-18 | Norton Waterford Ltd | Medicament inhaler |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
USD771237S1 (en) | 2014-10-02 | 2016-11-08 | Mannkind Corporation | Mouthpiece cover |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
WO2017132601A1 (en) | 2016-01-29 | 2017-08-03 | Mannkind Corporation | Dry powder inhaler |
WO2017201463A1 (en) | 2016-05-19 | 2017-11-23 | Mannkind Corporation | Apparatus, system and method for detecting and monitoring inhalations |
-
2005
- 2005-08-23 BR BR122019022692-0A patent/BR122019022692B1/pt active IP Right Grant
- 2005-08-23 DK DK10075511.5T patent/DK2322180T3/en active
- 2005-08-23 JP JP2007530062A patent/JP4990142B2/ja active Active
- 2005-08-23 KR KR1020137011089A patent/KR20130066695A/ko active Application Filing
- 2005-08-23 CN CN200580028435.6A patent/CN101027057B/zh active Active
- 2005-08-23 BR BRPI0514293-8A patent/BRPI0514293B1/pt not_active IP Right Cessation
- 2005-08-23 MX MX2007002189A patent/MX2007002189A/es active IP Right Grant
- 2005-08-23 KR KR1020147011493A patent/KR101644250B1/ko active IP Right Grant
- 2005-08-23 PL PL10075512T patent/PL2314298T3/pl unknown
- 2005-08-23 PL PL10075511T patent/PL2322180T3/pl unknown
- 2005-08-23 CA CA2578175A patent/CA2578175C/en active Active
- 2005-08-23 KR KR1020077006720A patent/KR101306384B1/ko active IP Right Grant
- 2005-08-23 EP EP05791798.1A patent/EP1791542B1/en active Active
- 2005-08-23 EP EP10075512.3A patent/EP2314298B1/en active Active
- 2005-08-23 HU HUE10075511A patent/HUE026797T2/en unknown
- 2005-08-23 WO PCT/US2005/030026 patent/WO2006023943A1/en active Application Filing
- 2005-08-23 HU HUE05791798A patent/HUE025151T2/en unknown
- 2005-08-23 ES ES10075511.5T patent/ES2540886T3/es active Active
- 2005-08-23 EP EP10075511.5A patent/EP2322180B1/en active Active
- 2005-08-23 PL PL05791798T patent/PL1791542T3/pl unknown
- 2005-08-23 KR KR1020157004361A patent/KR20150039211A/ko not_active Application Discontinuation
- 2005-08-23 DK DK05791798.1T patent/DK1791542T3/en active
- 2005-08-23 ES ES05791798.1T patent/ES2540853T3/es active Active
- 2005-08-23 US US11/210,710 patent/US7820676B2/en active Active
- 2005-08-23 HU HUE10075512A patent/HUE026134T2/en unknown
- 2005-08-23 AU AU2005277041A patent/AU2005277041B2/en not_active Ceased
- 2005-08-23 DK DK10075512.3T patent/DK2314298T3/en active
- 2005-08-23 ES ES10075512.3T patent/ES2543007T3/es active Active
- 2005-08-23 CN CN201410655195.3A patent/CN104436170B/zh active Active
-
2007
- 2007-02-22 IL IL181516A patent/IL181516A/en active IP Right Grant
- 2007-12-04 HK HK07113251.0A patent/HK1105588A1/zh not_active IP Right Cessation
- 2007-12-04 HK HK11111047.7A patent/HK1156551A1/zh not_active IP Right Cessation
- 2007-12-04 HK HK11111719.4A patent/HK1157224A1/zh not_active IP Right Cessation
-
2010
- 2010-09-20 US US12/886,226 patent/US8278308B2/en active Active
-
2011
- 2011-11-30 IL IL216704A patent/IL216704A/en active IP Right Grant
-
2012
- 2012-08-22 US US13/592,142 patent/US8653085B2/en active Active
-
2014
- 2014-01-08 US US14/150,474 patent/US9259471B2/en active Active
-
2016
- 2016-01-08 US US14/991,777 patent/US9675674B2/en active Active
-
2017
- 2017-06-09 US US15/619,087 patent/US10130685B2/en active Active
-
2018
- 2018-10-04 US US16/151,766 patent/US10583176B2/en active Active
-
2020
- 2020-01-27 US US16/752,939 patent/US10912821B2/en active Active
-
2021
- 2021-01-05 US US17/141,419 patent/US11872265B2/en active Active
-
2023
- 2023-11-30 US US18/524,116 patent/US20240115664A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018754A1 (en) * | 1992-03-11 | 1993-09-30 | Pharmaceutical Discovery Corporation | Self-assembling diketopiperazine drug delivery system |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101027057B (zh) | 用于药物输送的二酮哌嗪盐、二酮吗啉盐或二酮二氧杂环己烷盐 | |
AU2014228415B2 (en) | Microcrystalline diketopiperazine compositions and methods | |
US20180221280A1 (en) | Heat-stable dry powder pharmaceutical compositions and methods | |
AU2012203627B2 (en) | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |